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Abstract 
 
The most commonly cultivated mushroom in Europe and North America is the Agaricus 
bisporus, also known as the button mushroom or Portobello mushroom. Bacterial diseases of 
Agaricus bisporus caused by Pseudomonas species are a cause of significant crop loss and 
downgrading of produce, resulting in considerable economic cost. Bacteriophage have long 
been an attractive option for biocontrol of bacterial contamination of food products, however 
the precise genetic interactions between phage, bacterium and host are often inadequately 
explored. 
 
This project aims to explore the genetic interactions between the mushroom pathogenic 
bacterium Pseudomonas tolaasii and Pseudomonas agarici with the newly identified 
bacteriophage Pseudomonas phage NV1 and Pseudomonas phage ϕNV3. Full genome 
sequencing has been performed on the P. tolaasii strain 2192T and P. agarici NCPPB 2472, 
and the genomes of both mined for potential biosynthetic clusters involved in virulence as well 
as genes involved in phage resistance. Within the genome of P. tolaasii 2192T, putative non-
ribosomal peptide synthases have been identified which are hypothesised to be involved in the 
production of the tolaasin toxin involved in disease symptom appearance on mushroom 
surfaces. Within the genome of P. agarici NCPPB 2472, a biosynthetic cluster was identified 
that is hypothesised to produce the siderophore achromobactin, an important virulence factor. 
P. agarici NCPPB 2472 was identified as possessing a single Type I-F CRISPR/Cas system, 
predicted to be involved in the development of phage resistance, as well as complete operon 
predicted to be involved in the production of the exopolysaccharide alginate. 
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A third Pseudomonas species was identified on the surface of disease free mushrooms which 
was identified as a potentially new species of Pseudomonas, named Pseudomonas sp. NS1. 
The genome of P. sp. NS1 was likewise sequenced and mined for potential biosynthetic gene 
clusters which identified a cluster demonstrated to be involved in the production of White Line 
Inducing Principle.  
 
The Pseudomonas phages NV1 and ϕNV3 were isolated from environmental samples and 
identified to be narrow host range phage specific for P. tolaasii 2192T and P. agarici NCPPB 
2472 respectively. Both phage NV1 and ϕNV3 were identified as new species of the 
Luz24likeviruses and phiKMVlikeviruses respectively. The genomes of both phages were 
isolated and sequenced, with phage ϕNV3 identified as containing a conserved Signal-Arrest-
Release endolysin system, which was confirmed by in vitro protein expression. Likewise, the 
lysis cassette proteins of ϕNV3 were identified and investigated via protein complementation 
assay in vitro. The full growth characteristics and life cycle of phage ϕNV3 has been 
investigated and reported in this study and a broad-host range mutant of ϕNV3 identified which 
has allowed the T7-like tail protein of ϕNV3 to be identified as the host specificity determinant.  
 
 Transcriptome analyses of non-infected P. agarici NCPPB 2472 and P. agarici NCPPB 2472  
infected with phage ϕNV3 at a multiplicity of infection (MOI) of 1 at 40 min post infection, 
were performed in triplicate using RNA-seq. A reliable method has been established that will 
be useful in future studies, although comparative gene expression analysis revealed no 
significant differences in expression between the two treatments at the multiplicity of infection 
and time point chosen in this case a significant quantity of phage transcripts were detected, 
demonstrating active phage infection. 
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List of Abbreviations and Acronyms 
 
Abs   Absorbance 
Amp Ampicillin 
ANIb Average Nucleotide Identity based on BLAST+ 
ANIm Average Nucleotide Identity based on MUMmer 
bp Base pair 
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crRNA CRISPR RNA 
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PCA Principal Component Analysis 
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RBP  Receptor Binding Protein  
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rRNA Ribosomal Ribonucleic Acid 
SAR Signal-Arrest-Release 
SD Standard Deviation 
SEM Standard Error of the Mean 
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sp.   Species 
ss Single Stranded 
TBE Tris/Borate/EDTA 
TE Thioesterase 
TEM Transmission Electron Microscopy 
U.K   United Kingdom 
UoR University of Reading 
UPEC Uropathogenic E. coli 
UV Ultraviolet 
vsd variance stabilising transformed 
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1.1       Cultivated mushrooms and their importance 
The most commonly cultivated mushroom in Europe and North America is Agaricus bisporus 
(Figure 1.1), which is known by many names depending on the colour and maturity of the 
mushroom but is most frequently known as the ‘button mushroom’ or ‘Portobello mushroom’. 
Global production of Agaricus bisporus is reported to exceed 1.8x106 tonnes per year, of which 
8-9x105 tonnes are cultivated in Europe alone, worth an approximate 2 billion Euros annually 
[1].  
 
 
Figure 1.1: Image showing Agaricus bisporus mushrooms with unopened caps and a cross 
section of an immature cap.  
 
Commercial mushroom production is a complex procedure that comprises of several distinct 
stages, these are: composting, spawning, casing, case run, pinning and harvesting. The material 
on which A. bisporus is cultivated varies but can include horse manure, wheat straw, plant 
wastes and animal wastes such as feather meal and chicken manure. This mixture is then 
composted, where it is mixed and wetted to allow aerobic fermentation to take place. When 
completed the mixture becomes pliable and capable of holding water. 
Once the composting has been completed spawning can begin, this involves the spreading of 
spawning grains (grains previously inoculated with the A. bisporus mycelium) and nutrient 
supplements over the compost. This stage requires high levels of cleanliness; therefore, all 
equipment and tools must be thoroughly disinfected before use. The mycelia from the spawning 
Mushroom!cultivation!and!diseases!!
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grains will then grow throughout the compost, forming a network of fine root-like threads that 
fuse together to form a continuous bed, this process normally takes between 14-21 days to 
complete [2]. 
 
 
1.2      Bacterial diseases of cultivated mushrooms  
Bacterial diseases of Agaricus bisporus include cavity disease, also known as rapid soft rot 
disease, that forms large cavities in the cap of the mushroom that may extend to the stipe, and 
the causal bacterium was initially identified as Pseudomonas cepacia [3]. However, 
Pseudomonas cepacia was renamed Pseudomonas gladioli pv. agaricicola [4] before finally 
being classified as Burkholderia gladioli pv. agaricicola [5]. The soft rot caused by B. gladioli 
pv agaricicola is believed to be caused by degradative enzymes such as chitinase and protease 
virulence factors that are secreted by the Type II secretion system [5].  
 
Another soft rot disease of Agaricus bisporus has also been reported to be caused by the Gram 
negative Janthinobacterium agaricidamnosum, the symptoms of which include pitting and 
sticky blotches on the mushroom cap and in some severe cases, complete dissolution of the 
mushroom [6]. Unlike the soft rot disease caused by B. gladioli pv. agaricicola, the symptoms 
of J. agaricidamnosum soft rot are caused by a singular virulence factor, jagaricin, which is 
produced as a secondary metabolite by non-ribosomal peptide synthetases (NRPS) [7].  
 
Several pathogenic Pseudomonads are known to cause discolouration of Agaricus bisporus, 
termed ‘blotch diseases’. This includes Pseudomonas tolaasii, that causes brown blotch [8]; 
Pseudomonas reactans that causes purple or light brown blotch; Pseudomonas gingeri that 
causes a reddish ginger-coloured blotch and Pseudomonas agarici, that causes both yellow 
blotch and a disease of the mushroom gill structures [9].  
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1.2.1      Pseudomonas tolaasii  
Of all the bacterial blotch disease causal organisms, Pseudomonas tolaasii is the most 
intensively documented in literature. As previously mentioned P. tolaasii is the causal 
organism of “brown blotch disease” on Agaricus bisporus [8] and other cultivated mushrooms 
such as Pleurotus ostreatus, also known as the oyster mushroom [10]. 
 
The symptoms of brown blotch disease commence as small (1-4mm) brown or cream lesions 
on the pileus and stipe that become darker and more sunken as the damage progresses, a large 
and sunken lesion of 1cm in diameter is shown in Figure 2. The individual lesions may merge 
to cover the entire surface of the mushroom [1].  
 
 
Figure 1.2. A characteristic dark, sunken lesion of approximately 1cm in diameter caused by 
P. tolaasii infection of an Agaricus bisporus mushroom.  
 
Mushroom loss due to brown blotch is economically important as P. tolaasii was previously 
estimated to be responsible for  5-10% of crop loss in the U.K and a further downgrading of 
10% of mushrooms produced [11]. It has been reported by Wong et al. [12] that the primary 
source of P. tolaasii on a mushroom farm is the peat and limestone mix used during the casing 
process. They have reported that P. tolaasii could not be detected in the compost, water supply 
or mushroom spawn, but was detected in the casing mix [12]. Once P. tolaasii has colonized a 
mushroom bed secondary sources of infection are plenty, including tools and equipment, hands 
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and clothing of farm workers, airborne dust as well as flies and mites that are frequent pests of 
mushroom farms [12].  
 
Phylogenetic analysis based on 16S rDNA places P. tolaasii in the Pseudomonas fluorescens 
subgroup [13] and has been officially placed in the taxonomic group of fluorescent 
Pseudomonas biotype II [1]. P. tolaasii can undergo phenotypic variation, a tactic that is 
beneficial for its survival in nutrient-poor environments [14]. The wild-type colony 
morphology is pathogenic, opaque, mucoid, non-fluorescent, able to hydrolyse casein and 
capable of normal growth on medium containing cetrimide; whereas the phenotypic variant is 
translucent, non-mucoid, non-pathogenic, fluorescent, does not have the ability to hydrolyse 
casein or to grow normally on medium containing cetrimide [14, 15], the observable 
differences in colony morphology are shown in Figure 1.3. 
 
 The phenotypic variant of P. tolaasii has also been shown to swim faster via flagellar motility 
and respond more rapidly to chemotactic gradients than the wild-type, as well as produce larger 
amounts of siderophore, which would confer advantages in nutrient-poor water-saturated 
environments such as the casing layer in mushroom production [16]. P. tolaasii has a distinct 
polar flagella type that does not conform to the H1 and H2 serotyping methods used to type 
Pseudomonas flagella, similar to P. fluorescens which also does not conform, as described by 
Guillorit-Rondeau et al. [17].  
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Figure 1.3. Colony morphology of P. tolaasii with the pathogenic wild-type colony on the 
left and the non-pathogenic translucent colony on the right.   
 
The phenotypic shift in P. tolaasii is positively regulated by a 99-kDa protein, PheN, which 
shows amino acid similarities to members of a family of two-component regulatory proteins 
including LemA of P. syringae pv. syringae [18], BvgC of Bordetella Pertussis [19] and RcsC 
of Escherichia coli [20] and is required to maintain the wild-type pathogenic phenotype [14]. 
It is believed that PheN is involved either directly or indirectly with the activation of expression 
of genes involved in tolaasin synthesis, protease production and mucus production but 
represses other genes such as those controlling motility, chemotaxis and siderophore 
production [14]. 
 
Sinha et al. [21] have demonstrated that inactivation of the PheN gene results in the phenotypic 
shift from pathogenic to non-pathogenic, due to a 661bp duplication within the gene which 
results in early termination of the PheN ORF and the synthesis of a truncated protein lacking 
the N-terminus periplasmic domain. This N-terminal domain has been deduced to be the 
environmental sensor, the loss of which is predicted to result in loss of gene function [21]. It 
has also been shown that phenotypic switching from the pathogenic wild-type to the non-
pathogenic phenotype is recA dependent whereas the reverse switch appears to be recA 
independent [22]. The precise stimuli that regulate expression are not known; however, it has 
been suggested that it is a ‘social phenomenon’ possibly due to quorum sensing and 
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autoregulatory compounds, which occurs when cells are present at a high enough density and 
in nutrient-poor conditions [14]. 
 
The brown blotch disease mushroom pitting symptoms of P. tolaasii infection are caused by a 
secondary metabolite, tolaasin, that is explained in detail in Section 1.3.2. Other enzymes and 
secondary metabolites of P. tolaasii that may play roles in pathogenicity are also outlined in 
Section 1.3. 
 
 
1.2.2      Pseudomonas agarici  
While P. tolaasii may be one of the most intensively studied causes of bacterial disease of 
cultivated mushrooms, P. agarici arguably takes the title as the least well studied mushroom 
pathogen in academic literature. P. agarici is a Gram negative, non-spore forming, short rod 
that can occur singly, in pairs or in chains, and based on 16S rRNA gene topology analysis, 
belongs to the P. fluorescens intragenic cluster [23, 24]. However, further phylogenetic 
analysis of P. agarici involving four ‘housekeeping’ genes 16S rRNA, gyrB, rpoB and rpoD 
by Mulet et al. failed to place P. agarici in any specific Pseudomonas subgroup [25].  
 
P. agarici was demonstrated by Young [24] in 1970 to be the causal agent of the disease ‘drippy 
gill’ in A. bisporus mushrooms. The disease is characterised by the appearance of small, dark 
pigmented spots on the gills of mature mushrooms which progressively increase to a diameter 
of 2mm or more, which contain a light cream or grey spot in their centre. The infection of the 
gills may cause a collapse of the locally affected tissue or in the case of severe infections the 
bacterial droplets may coalesce between gills and lead to a total collapse of gill tissue [24]. 
Outside of the gill tissue, the stipes of infected mushrooms also often show fine longitudinal 
splits that contain large numbers of bacteria, which as the mushroom matures become dark 
brown [24].  
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The droplets were also reported to be found inside unbroken veils of immature mushrooms, 
which appeared to indicate the bacterium was already present within the mycelium [24]; 
however, it was then shown that P. agarici has the ability to degrade the extracellular matrix 
and pass through protective membranes unnoticed, which allows it to infect the stipe and gills 
before the veil opens during the maturation process [26, 27]. In cases where the bacteria are 
observed to be intrahyphal, it is believed that it gains access by a break in the fungal cell wall 
and thus is opportunistic in this aspect [27]. 
 
Chitinase enzymes are found in many Pseudomonas species including Pseudomonas stutzeri 
YPL-1 [28], Pseudomonas aeruginosa [29] and members of Pseudomonas fluorescens biovar 
I, VI and III, frequently as antagonists of fungi [30]. Chitin is a simple polysaccharide that 
forms an essential component in the cell walls and septa of all fungi studied to date [31]. P. 
agarici is distinct from other Pseudomonas species pathogenic to fungi in its inability to 
produce the chitinase enzyme, which prevents it from actively penetrating hyphal cell walls 
[26]. 
 
While the majority of large U.K based outbreaks were reported before 1980, outbreaks of P. 
agarici have also been reported in New Zealand in 1991 [26] and in Serbia as recently as 2008 
[32]. 
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1.3      Secondary metabolites, non-ribosomal peptide synthesis and bacteriocins in 
Pseudomonas 
The Pseudomonas genus is well known for its production and use of secondary metabolites, 
they have been reported to produce compounds such as lipids, phenazines, pyrroles, indoles, 
amino acids and peptides, pterines and other miscellaneous compounds [33].  
 
One method for production of peptide secondary metabolites in Pseudomonads is via the use 
of non-ribosomal peptide synthetases (NRPSs), NRPSs are very large multimodular enzymes 
that synthesise specific peptide products. NRPSs are comprised of multiple modules which 
each contain three catalytic domains, the first is the adenylation domain (A domain) which is 
involved in the activation of the amino acid, the second a thiolation or peptidyl carrier protein 
(PCP domain) which is involved in the extension of the peptide and the third which is the 
condensation (C domain) domain which is involved with the condensation of the amino acids. 
A final fourth catalytic domain which is located only in the termination module is the 
thioesterase (TE) domain [34].  
 
The NRPS produced secondary metabolites perform a wide variety of roles such as in 
phytopathogenicity, microbial and predatory antagonism, swarming motility and biofilm 
formation [35, 36]. 
 
In Pseudomonads, NRPSs are heavily involved in the production of cyclic-lipopeptides, which 
are important secondary metabolites. These cyclic lipopeptides produced by Pseudomonads 
are classified into six groups primarily based on their length and amino acid sequence, these 
groups are: viscosin, amphisin, tolaasin, syringomycin, putisolvin and syringopeptin [37, 38].  
However, some lipopeptides produced do not fit into these groups, these include; entolysin of 
Pseudomonas entomophila [39], orfamide produced by Pseudomonas fluorescens Pf-5 [40] 
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and linear lipopeptides produced by strains of Pseudomonas syringae such as syringofactins of 
Pseudomonas syringae pv. tomato strain DC3000 [36] and a structural variant of syringopeptin, 
peptin31, produced by P. syringae strain 31R1 [40].  
 
A major group of these Pseudomonas lipopeptides produced by NRPSs is the viscosin-related 
nonapeptides, which has six-subtypes that have been identified: viscosin, massetolide, 
viscosinamide, pseudophomin and white line-inducing principal (WLIP) [41]. Within this 
group, a minor difference in amino acid sequence confers significantly different biological 
properties, making predictions on function based on amino acid sequence difficult, such as with 
the WLIP and viscosin. WLIP produces a precipitate in agar medium when a WLIP producing 
Pseudomonas strain is co-cultured alongside a strain of tolaasin producing Pseudomonas 
tolaasii. However, viscosin, which is extremely similar structurally to WLIP (differing only in 
the fifth amino acid residue where D-Leu is replaced with L-Leu) or viscosinamide (similar to 
viscosin but with D-Gln instead of D-Glu at amino acid position 2) fail to produce this 
precipitate [42].  
 
1.3.1      Tolaasin  
 
While it had been known since 1973 that nutrient broth suspensions of P. tolaasii that had been 
placed on mushroom surfaces, but separated by dialysis membranes, were able to produce 
disease symptoms [43]; it was not until 1986 that J. T Peng devised a method for isolating the 
tolaasin toxin. It was reported that addition of a partially purified toxin, which he had identified 
as a polypeptide between 1 and 10 kDa in weight, reproduced P. tolaasii disease symptoms 
and interacted with the WLIP of P. reactans [44].  
 
The molecular structure of tolaasin was determined by Nutkins et al. [45] and was published 
in 1991, they showed that tolaasin is comprised of 18 amino acids, with a mass of 1,985Da and 
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due to the presence of two positive charges a the C-terminus, that it is an amphipathic peptide 
[45].  
 
Nutkins et al. reported to have isolated two isomers of tolaasin, Tol I and Tol II, with Tol II 
being a structural analogue of Tol I, which is identical to Tol I, except for a substitution of 
homoserine for glycine at amino acid position 16 [45]. Since then, Shirata et al. in 1995, 
identified 8 isomers of tolaasin I, of which 4 and 6 were identified as Tol I and Tol II 
respectively [46]; and in 2004 Bassarello et al. reported the discovery of 5 new minor products, 
Tol A-E produced by P. tolaasii NCPPB 2192 together with Tol I and Tol II, of which only 
two differ structurally from those hypothesised by Shirata et al. [46, 47] 
 
Tolaasin can cause disruption of Agaricus bisporus cells via two distinct methods, the first is 
as a result of its ability to form Zn2+-sensitive ion channels, which is observed at low tolaasin 
concentrations [48]. The second is due to the surfactant properties of tolaasin, which is 
observed at higher concentrations. Interestingly, the surfactant properties are reported to be 
responsible for causing damage on the mushroom caps, whereas it is the ion channel properties 
that induce cell lysis in cut mushroom tissue [49].  
 
Scherlach et al. [50] have demonstrated in P. costantinii, which also produces tolaasin, that 
tolaasin production is dependent on a biosynthetic gene cluster comprised of 5 NRPS proteins. 
This NRPS cluster is reported to contain 18 biosynthetic ‘modules’ each comprised of a 
condensation, adenylation and thiolation domain [50]. 
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1.3.2      Siderophores 
Under iron limited conditions the majority of fluorescent Pseudomonads produce yellow-green 
fluorescent siderophores called pyoverdines [33]. While pyoverdine was first described as a 
pigment in the late 19th century [51], it was not until 1978 that the link between Fe3+ 
concentrations and P. fluorescens pyoverdine synthesis and its role in the transport of iron was 
correlated [52]. Pyoverdines are powerful iron(III) scavengers and transporters with a 
conserved structure comprised of 3 domains; the first is a dihydroxyquinolone chromophore, 
the second, a variable peptide chain of between 6-12 amino acids in length and finally a third 
domain comprising of a side chain which is usually either a dicarboxylic acid or dicarboxylic 
amide [53].  
Several genes have been identified to be involved in the biosynthesis of pyoverdine in P. 
aeruginosa, P. putida [54] and P. fluorescens, including the NRPSs pvdD [55] and pvdIJK [56] 
of P. aeruginosa. Likewise, Mossialos et al. have identified a NRPS of P. fluorescens ATC 
17400, PvsA that is necessary for pyoverdine biosynthesis [57].  
 
The biosynthesis of siderophores by NRPSs within the Pseudomonas is not limited to 
pyoverdine, with a second siderophore of P. aeruginosa, pyochelin, also synthesised by NRPSs 
[58]. Synthesis of pyochelin in P. aeruginosa is dependent on two gene clusters, pchEF [59] 
and pchDCBA [60], with the proteins PchE and PchF having been identified as showing 
significant characteristics of NRPSs.  
 
However not all of Pseudomonas siderophores are dependent on NRPSs for biosynthesis. For 
example, P. syringae pv. syringae B728a has been demonstrated by Berti and Thomas [61] to 
produce a siderophore, achromobactin, via the NRPS-independent synthetases AcsD, AcsA 
and AcsC from the precursor citrate.  
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1.3.3 Bacteriocins and phage tail-like bacteriocins 
Bacteria possess and produce a diverse range of defence systems against other microorganisms, 
including broad-killing antibiotics and bacteriocins, which often demonstrate more narrow 
killing activity [64]. 
 
Phage tail-like bacteriocins (PTLBs) are an example of antimicrobial peptides produced by 
bacterial ribosomal protein synthesis, in contrast to the peptides produced by alternative 
mechanisms such as NRPSs. While other antimicrobial compounds produced by the 
Pseudomonads tend to offer antimicrobial action against a broader spectrum of 
phylogenetically distant species, bacteriocins such as the pyocins produced by Pseudomonas 
aeruginosa frequently possess a narrower target range which often include closely related 
Pseudomonas species [62] [63].  
 
Bacteriocins, such as PTLBs, offer a commercially attractive alternative to chemical 
preservatives in food production and preservation for a variety of reasons and their use in these 
situations has been well documented in literature. The primary allure of the use of bacteriocins 
stems from their sheer variety and abundance, with estimates that over 99% of bacteria are 
capable of producing one or more bacteriocin [64], offering a large pool of potential 
commercially viable products. Furthermore, as public opinion on the use of chemical 
preservatives in food has shifted and the legal and the moral implications of the presence of 
antibiotics or their associated residues in food the appeal of proteinaceous ‘naturally’ produced 
compounds such as bacteriocins that have been demonstrated to be sensitive to and degraded 
by proteases in the stomach [65], is amplified. Finally, the use of bacteriocins, such as the FDA 
approved nisin that is produced by Lactococcus lactis [64, 66], in food to prevent spoilage has 
been well studied and demonstrated to be both safe and effective. 
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While the ability of bacteria to produce PTLBs has been known for over 60 years, to date few 
studies have specifically detailed the scope of their production among bacteria. PTLBs are very 
large (1x106-1x107 Da) protein structures that are encoded in distinct gene clusters, similar to 
those of the related phage tail proteins encoded in phage structural protein regions, which often 
likewise contain assembly and/or chaperone proteins necessary for assembly as well as 
associated regulatory genes [67].  
 
PTLBs are comprised of two broad groups, R-type and F-type, as illustrated in Figure 1.4. The 
F-type PTLBs are phylogenetically related to the tails of Siphoviridae bacteriophage and are 
non-contractile, comprised only of a tube and no sheath.  The R-type PTLBs are related to the 
tails of Myoviridae phage and are contractile, consisting of a central tube surrounded by a 
sheath which is connected to an additional baseplate structure to which receptor-binding 
proteins such as tail fibers are bound [69] [67].  
 
 
Figure 1.4. Diagrammatic representation of: F. F-Type non-contractile PTLB consisting only 
of a central tube and no sheath; R, R-Type contractile PTLB possessing both a tube and 
contractile sheath as well as a baseplate and tail fiber-like proteins. Generated in Microsoft 
PowerPoint, based on data from [67, 68]. 
 
 
F. R.
 26 
Examples of R-type and F-type PTLBs include the R-type and F-type pyocins produced by 
Pseudomonas aeruginosa, which are reported to be produced by 90% of P. aeruginosa strains. 
It has been demonstrated by Köhler et al. [62] that in the case of the R1, R2 and R5 (R-type) 
pyocins, that the binding receptors are specific residues of the lipopolysaccharide core, 
accounting for their O-serotype specific binding affinities.  
 
The precise stimuli behind the timing of PTLB expression is not known although it has been 
reported that expression can be induced by DNA damage [67]. In Pseudomonas fluorescens 
SF4c PTLB expression can be induced by mitomycin C, UV light and hydrogen peroxide [70]. 
In Pseudomonas aeruginosa PAO1, control over expression of the pyocin genes is controlled 
by the prtN gene, which encodes a transcriptional activator, which in turn in controlled by the 
PrtR repressor protein. PrtR is reported to be inactivated by the presence of the RecA protein 
which is activated by DNA damage [71]. 
 
 
1.4      Bacteriophage Treatments of Pseudomonas infections  
Bacteriophage are viruses that infect and frequently kill bacteria, which were first discovered 
early in the 20th century by Fredrick Twort and Felix d’Hérelle [72].  Bacteriophage offer an 
attractive biocontrol agent for Pseudomonas infections of cultivated mushrooms as some 
Pseudomonas strains such as Pseudomonas putida, which colonises the casing layer, are 
beneficial for mushroom growth and maturation [73]. Therefore, total sterilisation of the casing 
material could potentially harm mushroom production and a more targeted approach is 
necessary.  
 
While little research has been conducted on phage capable of infecting P. agarici, several 
phages have been characterized that utilise P. tolaasii as a host. Recently Kim et al. have 
 27 
isolated 21 environmental phage of P. tolaasii of varying lytic ability [74]. With two phage, 
hb1a and hb2d, they achieved complete bacterial lysis after 12 hours with a multiplicity of 
infection (MOI) of 100. Similarly, they also managed to suppress blotch formation on oyster 
mushroom (P. ostreatus) surfaces when phage hb1a was added simultaneously with P. tolaasii 
[74].  
 
1.5      Bacteriophage background 
Bacteriophage are thought to be the most numerous organism on Earth, with estimates of the 
global population of bacteriophages being as high as 1031 virus particles [75]. Broadly, 
bacteriophage can be split in to two groups based on life cycle, either ‘lytic’ in the case of 
virulent phage or ‘lysogenic’ in the case of temperate phage. A lytic or virulent phage lyses the 
host cell soon after initial infection, whereas a lysogenic or temperate phage may establish a 
latent infection and become dormant for a period of time [76]. Lysogenic infections most often 
involve integration of the phage genome into the host chromosome or plasmid as a ‘prophage’, 
which is passively copied to daughter cells when the host cell divides. A prophage can be 
activated in response to environmental stimuli, for example if the host cell is damaged,  to 
produce phage via the lytic cycle [76]. Other temperate phage establish lysogenic infections by 
forming autonomous plasmids within the host [76, 77].  
 
Taxonomic classification of bacteriophage is based on several factors, including host range, 
phage particle morphology, genome type and protein structures such as tails, the most 
important of these factors being the phage particle morphology and genome type. The largest 
order of bacteriophages is the Caudovirales, which are the tailed dsDNA containing phages, 
that represent 96% of all known phage [78].  
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The Caudovirales comprises of three families, depending on tail structure; the Myoviridae that 
possess contractile tails consisting of a sheath and a central tube; the Siphovoridae which 
possess long, non-contractile tails; and the Podoviridae which possess short, non-contractile 
tails. The Podoviridae will be explored in greater detail in Section 1.5.1.  
 
1.5.1      The Podoviridae, subfamily Autographivirinae and genus Luz24likeviruses 
The Podoviridae are a family of bacteriophage within the Caudovirales that are 
characteristically non-enveloped, with a dsDNA genome, an icosahedral head and a short non-
contractile tail, as illustrated in Figure 1.5. As of 2016 the Podoviridae family now comprises 
of three subfamilies, the Autographivirinae, Picovirinae and the newly added Sepvirinae as 
well as 21 genera, such as the Luz24likevirus [79].  
 
 
Figure 1.5. Diagram representing standard virion morphology of the Podoviridae, visible are 
A. Icosahedral head, B. Tail Fibers, C. Short Tail. Generated by Microsoft PowerPoint, based 
on data from Fokine and Rossman [80]. 
 
The Autographivirinae are a subfamily of the Podoviridae and is comprised of 7 confirmed 
genera to date: Fri1virus, Kp32virus, Kp32virus, Phikmvvirus, Pradovirus, Sp6virus and 
T7virus [81]. The Autographivirinae contains 40 species to date of which only 3 are unassigned 
to a genus, Prochlorococcus virus PSSP7 and Synechoccus virus P60 and Syn5 [81]. The 
bacteriophage Escherichia virus T7, also known as Enterobacteria phage T7 or simply T7 
phage, is the most extensively studied phage of the Autographivirinae subfamily. Phage T7 
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was first isolated and identified around 1944 by Demerec and Fano [82] who demonstrated its 
ability to cause large plaques with a large halo on plates of E. coli. Since it was identified it has 
been the subject of intense study, with the first genetic ‘map’ of T7 being published in 1969 by 
William Studier who identified a total of 19 genes [83], from which he identified 12 protein 
products [84].  
 
In 1983 the complete nucleotide sequence of phage T7 was published by Dunn et al. [85], who 
reported that the genome contained 39,936bp with a low GC content of 49% and coding for 50 
genes. The nucleotide sequence of T7 has been subject to several minor revisions in subsequent 
years, including the addition of a single ‘T’ nucleotide, bringing the total nucleotide count to 
39,937bp [86-88]. It is now predicted that the genome of phage T7 contains up to 57 genes 
encoding 60 potential proteins, of which only 35 have a known function [89]. The genes of 
phage T7 are arranged linearly within the genome and are categorised in to three temporal 
classes [90, 91]:  
Class I:  These genes are expressed early in in infection and encode proteins that are 
involved in host conversion. 
Class II: These genes are expressed mid-infection and are encode proteins primarily 
involved in DNA replication. 
Class III:  These genes are expressed late in infection and encode proteins involved in 
virion structure and assembly.  
Structurally, phage T7 is characteristic of the Podoviridae, composed of an icosahedral capsid 
‘head’ ~60nm in diameter [92], a short stubby tail of 23nm in length that is attached to the 
capsid by way of a head-tail connector protein [90]. Attached towards the head end of the tail 
are six tail fibers, each composed of three copies of a single protein Gp17, that form a kinked 
structure [93]. Initial host recognition is performed by these tail fibers, although this stage is 
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reversible; before a second irreversible host cell binding is hypothesised to be mediated by a 
tail-tube protein [94]. Upon binding, genomic DNA is injected in to the host by extension of 
the T7 tail [95]. Only a small fraction of the genomic DNA (~1kb) is ejected at this initial stage 
of infection and is pulled in to the host cell by the action of the host RNA polymerase, which 
recognises promotors present early in the phage genomic DNA [96]. Transcription of the phage 
DNA is halted approximately 19% through, at which point the phage RNA polymerase that has 
been produced from the initial genes begins transcription, acting to ‘pull’ the remaining 
genomic DNA from the phage particle [96, 97]. Temporal regulation of phage T7 genes 
throughout replication is achieved by promotors specific for T7 RNA polymerase, while the 
host RNA polymerase is inhibited by a Class II gene Gp2 to prevent the detrimental effects of 
uncontrolled transcription [91, 98]. The specificity of T7 RNA polymerase for T7 promotors 
has resulted in the adaptation of T7 RNA polymerase for a number of research applications.  
 
PhiKMV-like viruses 
The “PhiKMV-like viruses” are a phage genus of the subfamily Autographivirinae which 
contains 4 confirmed species to date, including the type species Pseudomonas phage ϕKMV, 
Pseudomonas phage LKA1 and Pantoea virus LIMElight [99].  
 
The type strain, Pseudomonas phage ϕKMV was first identified in literature in 2003 by 
Lavigne et al. [100], and was reported to infect several clinical isolates of Pseudomonas 
aeruginosa including P. aeruginosa PA01.  ϕKMV possesses a dsDNA genome of 42,105bp 
in length with a relatively high GC content of 62.3%, which is predicted to encode 48 ORFs 
[100]. The genomic structure of ϕKMV is similar to that of phage T7, illustrated in Figure 1.6, 
in that it comprises of three distinct clusters: 1. Early genes (host conversion), 2. Middle genes 
(DNA metabolism), 3. Late genes (structural and host cell lysis); with the exception of the 
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location of the DNA-dependent RNA polymerase which, in ϕKMV, is located in the middle-
stage genes, rather than within the early genes as is the case in T7 [100]. 
 
 
Figure 1.6. Genomic organisation diagram of 1. Escherichia virus T7, 2. Pseudomonas phage 
ϕKMV. Early (host conversion) genes are illustrated in green, middle genes (DNA metabolism) 
in yellow, late (structural and host cell lysis) genes in orange; the location of the DNA-
dependent RNA polymerase gene is illustrated in red. Diagram generated in Microsoft 
PowerPoint from data reported by Lavigne et al. [100] and Dunn et al. [85]. 
 
 
For ϕKMV, adsorption and infection is dependent on the type IV pili, as reported by Chibeu et 
al. [101]; who identified a spontaneous mutant of P. aeruginosa PAO1 that was resistant to 
ϕKMV infection, named P. aeruginosa PAO1KR. Using cosmid complementation they found 
that a common regulatory mechanism of, or an interaction between, the gene products of ponA 
and pilMNOPQ is responsible for the demonstrated resistance, due to atypical type IV pili 
expression caused by poorly regulated transcription of these genes [101]. Host cell lysis for 
phage ϕKMV is achieved using a Signal-Anchor-Release (SAR) endolysin system comprising 
of a holin, endolysin, Rz and Rz1 proteins [102], which will be detailed further in Section 1.5.4. 
 
The phage Pantoea virus LIMElight and Pantoea virus LIMEzero, infect the bacterium 
Pantoea agglomerans [103], a Gram negative member of the Enterobacteriaceae that, similar 
to the Pseudomonadaceae, are ubiquitous in nature and found in water, soil and plant surfaces, 
as a host [104, 105]. The phages LIMEzero and LIMElight were isolated from soil samples in 
Belgium and were identified as causing plaques on the Pantoea agglomerans strain 
GBBC2043. However, the plaques of each phage varied in morphology with those of 
LIMEzero showing plaques of ~2mm with a halo like appearance while LIMElight showed a 
1.
2.
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clear ~1mm plaque morphology [103]. Both phage have a classic Podoviridae virion structure, 
with EM images reported as showing a head of 60nm in diameter, a short (12nm) stubby tail 
and a number of tail spikes. While both phage share similarities in terms of morphology and 
host, there are stark differences in their growth characteristics; while the latent period for phage 
LIMEzero is relatively short, at 30 min, the latent period for LIMElight is significantly larger 
at 270 min; similarly, while the adsorption constant of LIMEzero is high, at 8.2x10-9 ml/min, 
the adsorption constant of LIMElight is significantly lower at 1.2x10-9 ml/min [103].  
 
The genomes of LIMElight and LIMEzero are relatively similar in size, at 44,546bp and 
43,032bp respectively (54% and 55.4% GC content) and are predicted to encode 57 and 55 
ORFs respectively. However, to date, direct terminal repeats of 277bp have only been 
identified in the genome of LIMElight, while they are expected in the genome of LIMEzero.  
Both phage possess 18 ORFs that are similar in amino acid sequence to those found in ϕKMV, 
there is no significant DNA similarity between either LIMEzero or LIMElight and ϕKMV. 
Phage LIMEzero and LIMElight share the common genome architecture of the 
PhiKMVlikevirus genus, with three distinct regions of early, middle and late genes with the 
unusual location of the DNA-dependent RNA polymerase, which is located in the middle-stage 
genes, rather than within the early genes [100, 103]. 
 
Luz24likeviruses and UFV-P2 
The Luz24likevirus, is a genus of phage within the family Podoviridae, similar to the subfamily 
Autographivirinae. The Luz24likevirus genus to date contains 7 confirmed species, including 
the type strain Pseudomonas virus LUZ24 and Pseudomonas virus PaP3 and PaP4 [81].  
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The virulent type strain, LUZ24, was originally isolated from hospital sewage samples in 
Belgium, where it was observed to cause zones of lysis on lawns of the P. aeruginosa strain 
Li010. The phage particle morphology of LUZ24, of an icosahedral head of 63nm and a short 
tail of 12nm in length, is characteristic of the Podoviridae family. The LUZ24 genome consists 
of a linear dsDNA of 45,625bp (52% GC), includes two 184bp direct terminal repeats, and 
possesses 68 protein encoding ORFS in a bidirectional organisation, with 47 encoded on the 
positive strand and 21 on the negative [106]. 
 
Phage UFV-P2, a tentative member of the Luz24likeviruses was isolated from dairy industry 
waste water in Brazil and shown to be capable of infecting P. fluorescens 07A. UFV-P2, similar 
to LUZ24, possesses a linear dsDNA genome of 45,517bp (51.5%GC) and was initially 
reported to encode 41 ORFs in a bidirectional organisation with 19 encoded on the positive 
strand and 22 on the negative strand [107]. However, further analysis revealed the genome to 
encode a total of 75 ORFs.  55 of these ORFs are encoded on the positive strand and are 
involved in nucleotide biosynthesis and replication; and 20 encoded on the negative strand 
involved with virion particle assembly and composition, DNA packaging and host cell lysis 
[108].  
 
Alignment and pairwise comparisons of the genomic sequences of phage UFV-P2 and other 
members of the Podoviridae showed that UFV-P2 shares a large degree of nucleotide identity 
with other members of the Luz24likeviruses, such as LUZ24, PaP3 and PaP4 (56.8%, 56.7% 
and 56.2% respectively), however it also shared a 46.4% identity with Pseudomonas phage 
PhiKMV. Analysis of conserved locally collinear blocks within the members of the LUZ24 
and phage UFV-P2, as well as the presence of a shared conserved bidirectional genome 
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organisation, are reported to show that UFV-P2 is highly likely to be a member of the 
Luz24likevirus genus [108].  
 
 
1.6      Endolysin systems  
At the end of the late phase of the bacteriophage infective cycle, once progeny phage have been 
created, they must escape into the environment. To do this, most dsDNA phage such as the 
Autographivirinae, use a lytic enzyme, or lysin, to achieve lysis of their hosts and release 
progeny virions out into the external environment. These lysins are termed endolysins to 
distinguish them from a second type of bacteriophage lysin, a glycosylase, that is associated 
with the phage tail proteins and is involved in penetration into the host at the start of the 
infection cycle [109].  
 
Endolysins attack the four major bonds in the peptidoglycan host cell wall via a variety  of 
actions [110]. This catalytic activity can be classified into several groups, the N-
acetylmuramidases (lysozymes or muramidases), endo-β-N-acetylglucosaminidases 
(glucosaminidases), N-acetylmuramoyl-L-alanine amidases (NAM-amidases), endopeptidases 
and lytic glycosylases. The glucosaminidases and lytic glycosylases cleave the glycan 
component of the peptidoglycan, whilst the endopeptidases cleave the peptide cross-bridge and 
the NAM-amidases hydrolyze the amide bond connecting the sugar and peptide constituents 
of the peptidoglycan. [110-112]. Despite the variety of enzymatic activities, the endolysins 
weaken the integrity of the cell wall and bacteriolysis occurs when the cell ruptures due to the 
internal osmotic pressure [113].  
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1.6.1      Types of host cell lysis systems 
The host cell lysis systems of bacteriophage, also termed the ‘lysis cassette’, can be broadly 
categorised into two functional classes, canonical and signal-anchor-release (SAR) lysis 
systems. Both systems require the action of transmembrane proteins, holins, to control the 
precise timing of host cell lysis, however the mechanisms by which these proteins perform 
their roles differs dramatically between these two classes [114].  
 
Within the first system, canonical lysis, the majority of endolysins have no intrinsic secretory 
signals and thus accumulate in the host cytoplasm in their active form, restricted from accessing 
the peptidoglycan by the host cytoplasmic membrane [109, 115]. In these cases, a second 
protein is required to allow the endolysin protein to physically access the peptidoglycan, termed 
a ‘holin’.  
 
The holin proteins accumulate in the cytoplasmic membrane until at a genetically 
predetermined time, they form clusters [116]. These clusters form non-specific lesions, or 
holes, in the cytoplasmic membrane that allows the endolysin direct physical access to the 
peptidoglycan layer [117]. The formation of these large, micron scale holes that allow the fully 
active and pre-folded endolysin access to the peptidoglycan is characteristic of the canonical 
lysis systems. These holins are also non-specific, that is, they can serve unrelated canonical 
endolysins of different phage species [116].  
 
The second type of endolysin system is the Signal-Anchor-Release (SAR) lysis system, such 
as that found in phage ϕKMV and enterobacteriophage P1 [102, 118]. Some phage endolysins 
possess an N-terminal signal sequence that allows the endolysin to be exported by the host sec 
system to the cytoplasmic membrane where they are tethered and accumulate as inactive 
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proteins [119]. They become active when their SAR domains leave the membrane and form 
the mature, fully folded form in the periplasm. This can either occur gradually at a slow rate 
by spontaneous release, or simultaneously when the cytoplasmic membrane is depolarized 
[120]. This membrane depolarization is caused at a genetically predetermined time again by 
the holin, however, these holins which are known as ‘pinholins’ do not form the large micron 
scale holes as in the canonical system, but instead form small nanometer scale (~2nm) holes 
that result in membrane depolarization, rather than allow passage of the endolysin [116]. This 
depolarization causes the release of the SAR domain of the endolysin, resulting in the refolding 
of the lysozyme into its active state [102]. Differences in the mechanisms of the canonical and 
SAR-endolysin systems are illustrated graphically in Figure 1.7.  
 
 
Figure 1.7. Schematic representation of canonical (1.) and SAR-endolysin (2.) lysis systems. 
Endolysins are illustrated by red circles, holins/pinholins by brown ovals and Rz/Rz1 proteins 
by grey squares. Within the canonical lysis diagram (1.); A. illustrates the accumulation of 
active endolysin within the cytoplasm and the accumulation of holin proteins within the inner 
membrane before reaching a critical concentration in B. showing the formation of holin clusters 
and micron scale holes allowing the endolysin access to the peptidoglycan. Within the SAR-
endolysin lysis diagram (2.); A. illustrates the accumulation of the inactive endolysin proteins, 
Rz/Rz1 proteins and pinholin proteins within the inner membrane before the critical 
concentration of pinholin proteins is reached in B. where pinholins aggregate to form pinholes, 
depolarizing the membrane and releasing active form endolysins, simultaneously the outer and 
inner membranes are pulled into close proximity by the Rz/Rz1 proteins. Generated in 
Microsoft PowerPoint, based on data from [121, 122]. 
 
A.
B. B.
A.
1. 2.
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Timing of host cell lysis is performed by the holin in both canonical and SAR endolysin 
systems, however the precise mechanism involved in timing of holin triggering is unknown. 
The leading model is that the timing of holin triggering is encoded in the physical structure of 
the holin protein itself and is allele-specific [123]. The holin or pinholin proteins accumulate 
harmlessly in the cytoplasmic membrane until a critical concentration of proteins is reached, 
at which point a reduction in membrane potential reaches a triggering threshold causing the 
holin proteins to aggregate in to two-dimensional ‘rafts’ [124, 125]. The formation of rafts 
results in the creation of large holes or pinholes, depending on the lysis system, further reducing 
membrane potential and instigating further holin aggregation resulting in a complete collapse 
of the proton motive force (PMF) [126]. This model is validated by the observations that 
treatment of phage infected cells with compounds that reduce the membrane polarization and 
PMF results in premature lysis of the host cells [124].  
 
 
1.6.2      Lysis systems and host cell wall structure 
Endolysins instigate host cell lysis by damaging peptidoglycan within the host cell wall. One 
of the key differences between the Gram positive and Gram negative cell wall structure is the 
thickness and location of the peptidoglycan layer. In Gram negative bacteria the peptidoglycan 
lies between the inner cell membrane and outer membrane, within the periplasmic space. It is 
relatively thin and lacking in surface proteins and carbohydrates. In comparison the 
peptidoglycan layer in Gram positive bacteria is much thicker, external-facing and is embedded 
with a variety of surface proteins and carbohydrates [127]. These differences are reflected in 
the structure and function of the endolysins and lysis systems that have evolved to target Gram 
negative vs. Gram positive cell walls.  
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Endolysins that target Gram negative bacteria tend to be single domain globular proteins 
composed of only a single catalytic domain. However, some endolysins such as that from 
Pseudomonas phage KZ144 have been shown to possess both a lytic domain and an N-terminal 
cell wall-binding domain [112, 128]. The binding domain of KZ144 is of particular interest as 
it recognizes a common peptidoglycan composition of all Gram negative species, which 
provides it with a wide binding spectrum and can be combined with peptidoglycan hydrolases 
of other phages in order to enhance their specific activity [129].  
A further, recently identified, common feature of the lysis cassettes of Gram negative infecting 
bacteriophage is the presence of Rz/Rz1-like lysis proteins, known as spanins [130]. The Rz 
and Rz1 genes were initially identified in bacteriophage λ, where it was documented that 
nonsense mutations in either Rz or Rz1 prevented host cell lysis if the growth medium contained 
divalent cations at concentrations >5mM [131]. An unusual feature of the phage λ Rz and Rz1 
genes which drew initial interest, is that the Rz1 gene is nested within Rz gene in the +1 reading 
frame [131]. It is now known that the Rz protein resides within the inner membrane and the 
Rz1 protein within the outer membrane and interact via their associated periplasmic domains, 
spanning the periplasm and linking the inner and outer membranes [132]. It has been recently 
demonstrated by Berry et al. [133] that the presence of the Rz and Rz1 proteins is essential for 
complete host cell lysis by phage λ and that expression of λ prophages lacking these proteins 
prevents lysis and results instead in host cells with a spherical shape. It is believed that fusion 
of the inner and outer membranes, mediated by a Rz and Rz1 protein complex bringing the two 
membranes in close proximity following degradation of the peptidoglycan by the endolysin 
causing host cell lysis [122].  
 
Endolysins that target Gram positive bacteria, which possess no outer membrane but instead 
have a much thicker peptidoglycan layer that is heavily cross-linked and decorated with surface 
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proteins and carbohydrates, typically use a modular structure. These modular endolysins 
typically have one or more catalytic domains and a cell-wall binding domain that often allows 
strain or species-specific binding [112].  
 
 
 
 
1.6.3      Endolysins in the treatments of bacterial infections 
Due to their bacteriolytic activities, endolysins offer an attractive alternative to antibiotics in 
the treatment of bacterial infections, both within the medical field and food industries. The rise 
of antibiotic resistance and increasing pressure to reduce the use of antibiotics in agriculture 
has seen a surge in interest in the use of ‘enzybiotics’.  The term ‘enzybiotic’ is a fusion of the 
words ‘enzyme’ and ‘antibiotic’, although it can refer to any enzyme with antimicrobial 
activity, but most commonly refers to phage associated lysins and was first utilised in this 
context by Daniel Nelson et al. in 2001 [112, 134]. 
 
A great deal of research has been performed on endolysins from phage that affect Gram positive 
bacteria as they can be added exogenously to act as exolysins due to the peptidoglycan, in most 
cases, being accessible from the outside [111]. For example, Nelson et al. reported that with a 
lysin of Streptococcal phage G, addition of 1,000 units (10ng) of purified lysin in vitro is 
sufficient to sterilize a culture of ~107 group A streptococci within 5 seconds [134]. The use of 
phage endolysins has also been studied in vivo, Loeffler et al. show that the use of a lysin, Cpl-
1 of a pneumococcal bacteriophage has potential as a therapy for pneumococcal bacteraemia 
in mice. They report that a 2000µg dose of lysin could reduce pneumococcal titres from a 
median of log10 4.7 cfu/ml to undetectable levels within 15 minutes; and that this dose given 1 
hour post intravenous infection, led to 100% survival at 48 hours, compared to 20% survival 
of buffer-treated control mice [135]. 
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As these studies show, endolysins offer promise as treatment for bacterial infections, however 
they are not without their drawbacks. The most pressing being that lysins, as proteins, can 
trigger an immune response, unlike the majority of antibiotics, that are generally not 
immunogenic. However, the majority of studies regarding the immunogenicity of phage lytic 
enzymes are based on their use intravenously, where it has been shown that hyperimmune 
rabbit serum only modestly inhibits enzymatic activity and that no signs of anaphylaxis or 
adverse side effects were observed in mice, although human studies would be needed to be 
certain that there are no adverse effects of endolysin based therapies [135].  
 
While the use of lysins for treating Gram positive infections is relatively straightforward, the 
use of lysins for treating Gram negative infections is more complex due to the outer membrane 
shielding the peptidoglycan from their lytic activity. There are several methods that have been 
proposed to overcome this challenge, including the use of outer membrane permeabilizers. For 
example, Briers et al. have researched the use of various compounds such as ethylene diamino 
tetraacetic acid disodium salt dehydrate (EDTA), citric acid, poly-L-lysine and polymyxin B 
nonapeptide (PMBV) as membrane permeabilizers of various Pseudomonas aeruginosa strains 
[136]. They concluded that EDTA was the most suitable, however EDTA has been shown to 
inhibit blood coagulation at very low concentrations (1.3 mmol-1) and thus is unlikely to be 
used in the treatment of systemic infections or as a treatment for food products [136]. 
 
Another approach is the use of high hydrostatic pressure (HHP), a technique that uses a liquid, 
often water and high pressures (200-500MPa) to inactivate pathogenic and food spoilage 
organisms [137]. HHP can be combined with lysozymes to inactivate bacteria, and has been 
shown to inactivate the Gram positive bacteria Staphylococcus aureus and Listeria innocua in 
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vitro by Masschalk et al. (2002) [138]. In relation to Gram negative organisms, HHP is capable 
of permeabilizing the outer membrane and allowing access for bacteriophage lysins to act. This 
has been demonstrated with P. aeruginosa, where under high hydrostatic pressure (175MPa) 
for 15 mins, the bacteriophage endolysins KZ144 and EL188 showed a reduction in bacterial 
cell numbers of ~3.5 log units, of which two thirds was caused by the lytic enzymes alone 
(3.5±0.2 log units vs. 1.4±0.2 log units for HHP alone)  [139]. As HHP is already used 
frequently in the food industry it offers a more practical approach to membrane 
permeabilization, however due to the high pressures involved and large costs associated with 
producing these pressures, it may not be suitable for all food based applications. 
 
1.7       Host cell receptors and phage host specificity determinants 
Bacteriophage specificity is frequently determined by the interaction of a phage receptor-
binding protein (RBP) and a specific receptor on the host cell surface, for Gram negative 
bacteria such as the Pseudomonas, these receptors can be extremely diverse and include both 
protein receptors, lipopolysaccharide receptors [140] and capsular polysaccharides, present in 
the cell wall or via interaction with a specific bacterial structure such as a capsule, pili and 
flagellum [141].  
 
Rakhuba et al. classify the potential protein receptors of the outer membrane of Gram negative 
bacteria into 5 classes: 1. Structural proteins interacting with the peptidoglycan layer; 2. 
Specific and non-specific porins forming membrane channels; 3. Enzymes; 4. Substrate 
receptors with high affinity; 5. Transport proteins responsible for secretion [141]. Examples 
include: OmpA, an outer membrane protein of Escherichia coli involved in conjugation and 
resistance to chelating agents and acts as a receptor for bacteriophage K3 binding [142-145]; 
OmpC, a major outer membrane porin protein of E. coli K-12 which acts as a receptor for 
 42 
phage T4 (however lipopolysaccharide is also required for T4 binding) [146, 147]; and TonA, 
now named FhuA, and TonB, which are membrane transport proteins of E. coli and act as 
binding receptors for many phage including T1, T5, φ80, and UC-1 [148]. 
 
 
1.7.1      Lipopolysaccharide (LPS) receptors 
Lipopolysaccharide (LPS) is ubiquitously expressed by all Gram negative bacteria and is vital 
to the structural and functional integrity of the bacterial outer wall [149]. LPS is a complex 
polymer comprised of a lipid moiety attached to a long chain polysaccharide and comprises of 
three structural regions: 1) Lipid A; 2) An inner and outer polysaccharide core; 3) Distal 
polysaccharide (O-antigen) [150]. Lipid A, the highly hydrophobic and endotoxically active 
part of LPS, is different from typical phospholipids found in prokaryotic membranes as it 
contains six saturated fatty acid chains rather than two saturated or unsaturated chains [149, 
151]. The polysaccharide core is branched and contains 6 to 10 sugars and 3-deoxy-D-manno-
octulosonic acid and some regions are highly conserved among strains and species. The O-
antigen is an immunogenic oligosaccharide which is attached to the polysaccharide core and is 
comprised of repeating saccharide subunits and differs greatly among Gram negative species 
[149, 151]. 
 
There are several morphologies of colonies caused by LPS truncations; the wild-type which 
contains intact LPS have the ‘smooth’ morphology, those which have lost the O-antigen 
portion, termed ‘rough’ and those that have lost both the O-antigen and outer core 
polysaccharide termed ‘deep rough’[152]. Most phage appear to be specific for a single 
morphology, either smooth or rough. Those that are specific for the ‘smooth’ type tend to 
display a very narrow host range as they depend on the O-antigen for binding, which is highly 
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variable in structure; for example, bacteriophage Sf6 of Shigella flexneri, which has a very 
narrow host range (those with the 3,4 group antigen) [153]. Another example is the “ϕKMV-
like” phage LKA1 that infects P. aeruginosa, which is dependent on algC expression for 
successful infection [154]; the algC gene encodes the enzyme phosphomannomutase and 
mutants lacking this gene do not express the O-antigen or A-band antigen and the LPS is more 
similar to that of rough-type colonies [155].  
 
1.7.2      Capsule phage 
A large number of bacteria possess an external protective layer or “capsule” that protects them 
both from the environment and from the host immune system, and can be an important 
virulence factor of pathogens [156]; for example the capsule of Pasteurella multocida, an 
important livestock pathogen, is a key virulence determinant that prevents phagocytosis by host 
macrophages [157]. Capsules are typically composed of polysaccharide chains, repeating 
chains of monosaccharide units linked by glycosidic linkages, known as capsular 
polysaccharides [158, 159]. While the capsule may offer protection from external stress it also 
provides an attachment site for many phage species that possess polysaccharide depolymerases 
as tail-associated proteins [160]. An example of phage that infect via the capsule are the “K 
Phage” of Escherichia coli such as phage phi K1A and phi K1F which are specific for the K1 
capsular polysaccharide antigen of E. coli [161-163]. However, while some phage such as K1F 
and K15 appear to have evolved to utilise the K1 capsule as a receptor, the K1 capsule acts to 
block infection of other phage such as phage T7, which uses a LPS-binding receptor [164]. The 
use of capsular receptors is not limited to E. coli phage, for example the Camplyobacter jejuni 
phage F336, F198, F287, F303 and F326 all utilise a capsular polysaccharide receptor, in this 
case it is the phase variable O-methyl phosphoramidate moiety [165].  
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1.7.3      Pili phage 
The use of the pili of Gram negative bacteria as a receptor for bacteriophage attachment has 
been documented as early as 1949 [166]. In order to understand the diversity of phage that 
target pili, it is first necessary to understand the inherent diversity of pilus types and uses. The 
pili of Gram negative bacteria, such as those of the Pseudomonas genus, can be broadly 
categorised based on their associated assembly pathways into four categories.  
 
The first category is broadly defined as the ‘pili assembled by the chaperone-usher’ pathway 
[167]. This includes the Type I pili that are found on the majority of E. coli strains, particularly 
the uropathogenic E. coli (UPEC) strains where binding to the host cells is mediated by the 
FimH adhesin located at the distal tip of the pilus [168, 169]. 
 
The second category is defined as the ‘Type IV pili’, which are homopolymers of a 15-20kDa 
pilin subunit and are found in a large variety of Gram negative bacteria including Pseudomonas 
aeruginosa, Neisseria gonorrhoeae and enteropathogenic E. coli [170, 171]. Type IV pili 
perform a wide variety of functions including host cell adhesion, DNA uptake in 
transformation, phage transduction as well as twitching and gliding motility [171]. The 
assembly of Type IV pili requires a large number of genes, unlike other pilus structures which 
may require only one or two genes, in the case of Pseudomonas aeruginosa studies have shown 
that Type IV pilus assembly requires at least 35 genes [172]. Due to their ubiquity in Gram 
negative bacteria Type IV pili present an attractive target and thus a large number of 
bacteriophage utilise the Type IV pili as a binding site including phage PA1Ø, a member of 
the Siphoviridae, and as previously mentioned, Pseudomonas phage ϕKMV infection has been 
demonstrated to be dependent on Type IV pili. Interestingly, while ϕKMV is limited in host 
range to strains of P. aeruginosa, phage PA1Ø is capable of forming plaques on lawns of P. 
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aeruginosa, Staphylococcus aureus, Staphylococcus epidermis, Listeria monocytogenes 
among others, despite the common binding receptor [101, 173]. 
 
The third category of pili are the curli pili, which were first described in 1989 by Olsén et al. 
as coiled surface structures comprised of a single subunit on the surface of E. coli [174]. Curli 
pili have subsequently been found in both E. coli and Salmonella species and are implicated in 
host cell adherence, biofilm formation and surface adhesion [175, 176].  
 
Finally, the fourth category of pili are the CS1 pili, which are a serologically distinct family of 
pili associated with enterotoxigenic E. coli (ETEC) and are also known as the ‘alternative 
chaperone usher family’, Class 5 or α-fimbriae [167]. CS1 pili are implicated in mediating 
adhesion of ETEC cells to the intestinal wall of the host as well as attachment to bovine 
erythrocytes resulting in hemagglutination [177].  
 
1.7.4      Flagella phage 
Bacterial flagella are complicated organelles that protrude out of the bacterial cell surface and 
can be considered to be the ‘propellers’ driving bacterial movement, involved in many 
processes from chemotaxis to exiting biofilms in order to find new habitats [178, 179]. 
However, similar to pili, as an appendage extruding from the cell surface into the environment 
they offer a site for bacteriophage binding. For example, the Salmonella typhimurium phage 
iEPS5, a member of the Siphoviridae, requires both the presence of flagella and flagellar 
movement for phage adsorption and successful infection [180]. Similarly, the phage PhiAT1, 
a member of the Myoviridae, which is capable of infecting the phytopathogenic bacterium 
Erwinia carotovora ssp. Attroseptica, has been shown to be dependent on the bacterial 
flagellum for successful infection [181].  
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1.7.5      Phage receptor binding proteins 
The previous section focused on the host receptor to which bacteriophage adsorb. This section 
describes the phage associated proteins involved in host recognition and binding, the phage 
receptor binding proteins (RBPs), with a primary focus on the RBPs of the Podoviridae, such 
as the Escherichia coli phage T7.  
 
In the majority of Caudovirales, that is the tailed bacteriophages, the first stage of recognition 
and binding to the host cell is performed via the tail-spike proteins or tail fibers, this stage is 
reversible [94, 182]. Positive recognition by these tail fibers will then lead to a second, 
irreversible binding to the host membrane followed by DNA ejection by the phage tail proteins 
[94, 182]. 
 
In the case of the initial reversible binding of phage T7 to the host lipopolysaccharide receptor 
in the E. coli outer membrane is mediated via six tail fibers, each comprised of three copies of 
the protein gp17 [94, 183]. While the tail fibers of the E. coli phage T7 simply recognise the 
host cell surface receptor, in some cases such as with the Salmonella phage P22 (Podoviridae); 
not only do the tail spike proteins bind to the O-antigen moiety of the LPS, it also possesses an 
enzymatic ability that allows it to cleave the O-antigen, although the current purpose of this is 
unclear it is hypothesised that it may facilitate access to the membrane and a secondary receptor 
[184].  
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1.8      Host resistance and phage response   
Bacteria and phage have been evolving alongside each other for millions of years and so 
bacteria have evolved a wide variety of mechanisms for phage resistance, and in response the 
phage have similarly evolved a variety of mechanisms by which to overcome or avoid these 
resistance mechanisms. For bacteriophages to be a viable form of antimicrobial treatment or 
for the identification of novel antimicrobials produced by phages, a greater understanding of 
the mechanisms behind these adaptations of both host and phage is needed. A brief outline of 
the various mechanisms of host resistance and the phage responses is outlined below. 
 
 
1.8.1      Prevention/inhibition of adsorption 
Bacteriophage adsorption and successful infection is dependent on access to the host cell 
surface receptor, therefore the most effective method of resistance to infection is to prevent the 
interaction between the bacteriophage receptor binding protein and the host cell surface 
receptor. This can be via several methods, such as blocking the receptor, modification of the 
receptor or even preventing the receptor from being synthesised, which will be outlined in 
further detail below.  
 
The first method, blocking of the phage binding receptor has been documented as far back as 
1974 where it was reported by Nordström and Forsgren [185] that Staphylococcus aureus 
strains that expressed higher levels of ‘protein A’, which is located in the outermost part of the 
cell wall, were more resistant to staphyloccocal phage 80 than those deficient in the protein, 
and it was hypothesised that this was due to masking of the phage binding receptor. Similarly, 
Riede and Eschbach [186] have demonstrated that the E. coli outer membrane protein OmpA, 
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which acts as a receptor protein for a variety of bacteriophage including phage K3, can be 
blocked by expression of the outer membrane lipoprotein TraT, preventing phage adsorption.  
 
The second method, modification of the phage binding receptor, is more likely to occur as a 
method of superinfection exclusion (detailed further later in this section) in temperate phage, 
rather than prevention of initial phage infection. For example, lysogenization of Salmonella 
enterica serovar Typhimurium by the temperate bacteriophage P22 results in a change in 
serotype by modification of the LPS O-antigen, which results in the prevention of further 
binding by phage P22 and other serovar Typhimurium phage [187]. Similarly, the temperate 
E. coli phage PhiV10 is capable of modifying the host O-antigen to prevent further O-antigen 
dependent phage infection; however, in this case it is due to the expression of a specific 
enzyme, a serotype converting O-antigen acetyltransferase, encoded within the PhiV10 
genome [188].  
 
The third method is a total removal of the phage binding receptor, for example the O1 Vibrio 
cholerae phage K139 is dependent on the O1 antigen for host cell binding; in response several 
K139 resistant strains have been identified which completely lack the O1 side chain, caused by 
an insertion of a transposable element (IS1004) into the biosynthetic gene cluster encoding the 
O antigen [188].  
 
Methods such as blocking or removal of phage binding receptors, by which bacteria acquire 
resistance, are often permanent and frequently come at a significant cost to the bacteria. For 
example, the O-antigen of UPEC provides a significant survival advantage to these bacteria 
and thus modification or loss could have significant knock on effects [189]. One method 
bacteria use to overcome this is phase-variable transient resistance mechanisms. Phase 
 49 
variation is frequently described as an ‘all-or-none’ control mechanism; this is because the 
expression of the factor(s) is either completely on or completely off. However, they are usually 
reversible, as well as being heritable and are in general randomly switched on and off at high 
frequency (between 10-5 to 10-1 per generation), although the frequency can be impacted by 
environmental signals. This rapid switching results in a phenotypically diverse population, 
which when applied to bacteriophage binding receptors can be extremely beneficial in 
maintaining resistant populations [190, 191]. For example, as previously mentioned in Section 
1.7.2, the C. jejuni phage F336, among others, utilises a capsular polysaccharide as a binding 
receptor and it has been reported by Sørensen et al. that resistance of C. jejuni to infection by 
phage F336 was due to the loss of the capsular polysaccharide receptor caused by phase 
variation of the gene encoding the receptor [165]. Another example is reported by Kim and 
Ryu [192] who have demonstrated that the Salmonella enterica subspecies enterica serovar 
Typhimurium bacterium is capable of acquiring resistance to phage SPC35 through phase-
variable modification of the surface O-antigen. 
 
 
1.8.2      Exopolysaccharides  
Exopolysaccharides (EPSs) are polysaccharide substances secreted into the external 
environment by many bacterial species. These polysaccharides can be covalently bound 
cohesive layers as capsular exopolysaccharides which are found in a wide range of bacteria 
including Acinetobacter baumannii [193], Pseudomonas putida [194] and even species as 
diverse as Cyanobacteria [195]; or excreted fully in to the external environment as a viscous 
material such as in alginate production by Pseudomonas aeruginosa [196] or EPS by lactic 
acid producing bacteria used in the dairy industry [197]. These EPSs can perform a wide variety 
of roles, from avoidance of host immune systems [193], surface adhesion, biofilm formation 
[198] and even binding of heavy metals [199].  
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These EPS compounds or capsules can block access to or mask the phage binding receptor, 
however many phage have evolved tools to overcome this. For example, in the case of the K1 
polysaccharide capsule of E. coli, which has been shown to block phage T7 infection, can be 
broken down by endosialidases produced by the K1-specific phages K1F and K1-5 that can 
hydrolyze the K1 structure [164]. Similarly, in the case of the Pseudomonas phage PT-6, a 
member of the Podoviridae, produces a 37kDa alginate lysase that is capable of reducing 
viscosity of secreted alginate, presumable to facilitate access to the phage binding receptors 
[200].  
 
1.8.3      Superinfection exclusion systems 
Superinfection exclusion is the process by which a bacteriophage prevents secondary infection 
of its host by further phage; while not being a true method of host resistance, is still a relevant 
method by which a phage is prevented from infecting a host cell and so will be covered very 
briefly. A further example of a superinfection exclusion system is the temperate Pseudomonas 
phage D3112 which utilises a protein, D3112 protein gp05, to inhibit the Type IV pili assembly 
protein PilB, with the effect of a loss of surface pilation and consequently a loss of twitching 
motility [201]. Most notably, this loss of surface pili has been demonstrated to prevent the 
further infection of the host Pseudomonas aeruginosa cell by other phage that utilise the Type 
IV pili as a binding receptor and enabling the hosts to become resistant to superinfection [202].  
 
1.8.4      Restriction modification systems 
After succeeding in binding to the host cell and ejecting its genome, a phage may still have to 
overcome bacterial defence systems in order to complete the infection process. One of the most 
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well documented is the restriction-modification (R-M) systems that are ubiquitous among 
prokaryotes [203].  
 
R-M systems are frequently referred to as an aspect of the prokaryotic ‘immune system’ in that 
they recognise and attack foreign DNA that enters the cell and are usually comprised of 
enzymes with two distinct actions: 1) an endonuclease; and 2) a methyltransferase. The 
restriction endonuclease recognises a specific DNA sequence (a restriction site) as a target for 
cleavage. The methyltransferase adds methyl groups to either adenine or cytosine within the 
same target sequence, which prevents cleavage by the restriction endonuclease. Working in 
tandem, these two enzymes constitute a basic ‘self’ and ‘non-self’ recognition system [204]. 
The methyltransferase modifies the bacterial genome, effectively labelling it as a ‘self’ 
sequence. When foreign DNA that enters the cell, such as phage genomes or plasmids, the non-
methylated (‘non-self’) restriction sites are susceptible to cleavage by the bacterial restriction 
endonuclease.  
 
R-M systems are classified into four major groups (Type I-IV) depending on their subunit 
composition, cleavage position, cofactor requirement and recognition site and each will be 
briefly outlined below [204, 205].  
 
Type I  
Type I R-M systems are multifunctional hetero-oligomeric enzymes that typically comprise of 
two restriction subunits (R subunits), a specificity subunit (S subunit) and two 
methyltransferase (M subunits) that utilise S-adenosylmethionine (SAM) to methylate 
adenosine within the target sequence [204]. The target sequence recognised by Type I R-M 
systems are asymmetric and comprised of two separate components and a nonspecific spacer 
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sequence and the reaction requires SAM, ATP and Mg2+ as cofactors [204, 206]. An example 
of a Type I R-M enzyme is EcoKI, originally isolated from E. coli K-12 [207].  
 
Type II  
Type II R-M systems are among the most widely documented with over 3600 systems 
identified to date [204]. Type II restriction endonucleases and methyltransferases recognize the 
same short, palindromic sequence that is normally between 4-8bp in length; all Type II 
restriction endonucleases cleave within or adjacent to its recognition site, are usually Mg2+ 
dependent and do not require ATP [203, 204]. An example of a Type II restriction endonuclease 
is the well-known EcoRI enzyme [208]. 
 
Type III 
Type III R-M systems are comprised of two subunits, a ‘Mod’ subunit that is involved in site 
recognition and methylation, and a ‘Res’ subunit that is involved with DNA and ATP 
hydrolysis [209]. While the Mod subunit can act independently as a methyltransferase, the Res 
subunit is only active in a Res(2)Mod(2) complex with the Mod subunit [210]. Type II R-M 
systems recognize two inversely oriented, asymmetric recognition sequences of 5-6bp in length 
and require both Mg2+ and ATP for cleavage [204]. An example of a Type III R-M system is 
the EcoP1I system of the P1 prophage [211].  
  
Type IV  
Type IV R-M systems are unusual in that they target DNA that have been modified, for 
example DNA that has been methylated [204]. The Type IV R-M systems usually combine 
both the methyltransferase and restriction endonuclease activities into a single polypeptide 
chain [212]. While the endonuclease action is reported to be positively impacted by SAM and 
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Mg2+ is required for activity, ATP does not impact on either enzymatic action [204, 212]. Type 
IV enzymes typically recognise asymmetrical DNA sequences [212]. An example of a Type 
IV R-M system is the McrBC system isolated from E. coli K12 [213].  
 
These R-M systems present a barrier to successful phage infection, however phage themselves 
have, perhaps unsurprisingly, evolved a multitude of ways in which to overcome this challenge 
that can be broadly categorised into passive and active systems, as outlined below.  
 
 
Passive evasion of R-M systems 
A phage can be protected from the R-M defence system if the host methyltransferase is fast-
acting that it rapidly methylates the injected phage genomic DNA before it is cleaved by the 
restriction endonuclease. This will also protect the progeny phage when infecting other 
bacterial cells that express the same R-M system [214]. Alternatively, the phage can acquire 
mutations that remove the restriction site from the genome sequence: a phage with less 
restriction sites will have an advantage over a phage with more. As previously mentioned, 
many restriction endonucleases require specific orientation of their recognition sites and 
therefore a shift in orientation will confer resistance to this R-M system; this is apparent in the 
genome of phage T7 where the recognition sites of the EcoP15I (a Type III R-M system related 
to the previously mentioned EcoP1I system [210]) are in the same orientation rather than in the 
inverse orientation required for recognition by the restriction endonuclease [215]. Some phage 
instead resort to the incorporation of unusual bases into their DNA as a method of avoiding R-
M systems, such as the E. coli phage Mu whose genome contains a modified purine that confers 
resistance to a variety of restriction enzymes [216, 217]; or the Shigella phage DDVI which 
contains a methylated guanine which provides a protective function [218].  
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Active evasion of R-M systems  
Active evasion systems involve proteins produced by the phage and can involve methods such 
as subverting the activities of the R-M systems or by direct inhibition of these systems. An 
example of subversion would be the activity of the phage λ gene ral, which has been shown to 
prevent restriction of the phage genome in E. coli K and E. coli B by enhancing the methylation 
modification properties of their associated R-M genes, thus allowing the genome to be 
methylated and protected before the host restriction endonuclease can act [219]. Another 
method by which phage can subvert the host R-M systems is masking of the recognition sites 
by phage encoded proteins; as is the case with the DarA and DarB proteins of coliphage P1, 
which are injected into the host along with the phage genome and bind to the phage DNA 
effectively masking the R-M system recognition sites [220]. Direct inhibition of the R-M 
systems is a method employed by many phage; for example phage T7 utilises a protein ‘ocr’ 
which is similar in structure to the DNA target of the EcoKI R-M system and binds to the 
restriction enzymes, blocking and overwhelming them, thus allowing successful phage 
infection [221].  
 
 
1.8.5      Abortive-infection systems 
Abortive infection systems, also known as ‘Abi(s)’ are another bacterial defence mechanism, 
sometimes referred to as the ‘innate immune system’ of bacteria. Similar to R-M systems they 
are a form of post-infection response, however in the case of Abi systems they act by killing 
the infected cell in an effort to limit the spread of phage throughout the bacterial population, 
and has therefore been referred to as ‘altruistic cell suicide’ [222]. These Abi systems are 
widespread among bacteria and have been documented in a wider variety of species including, 
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Erwinia carotovora subspecies atroseptica [223], Lactococus lactis [224], E. coli [225] and 
Shigella dysenteriae [226]. 
 
Abi systems frequently operate on the basis of a toxin/antitoxin (TA) pair, under normal 
conditions both the toxin and the antitoxin are expressed, preventing the action of the toxin; 
upon phage infection the expression of both is suppressed. Antitoxins are less stable than their 
associated toxins, therefore when both cease being synthesized the antitoxins break down 
before the toxins, allowing them to act, thus killing the infected cell and preventing completion 
of prophage development [222-224]. For example, the ToxIN system of the phytopathogen 
Erwinia carotovora subspecies atroseptica, the action of the growth-inhibiting protein ToxN 
is suppressed by the RNA product of the toxI gene (an antitoxic RNA); upon phage infection 
the ratio of ToxI:ToxN is disrupted, which allows ToxN to act and restrict growth [223].  
 
 
1.8.6      CRISPR/Cas Systems  
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated 
genes (cas) are often regarded as the ‘adaptive’ immune system of prokaryotes. The first 
CRISPR elements were described in 1987 by Ishino et al. [227] although their significance was 
not noted until early 2002 when it was discovered by Jansen et al. [228] that these repeat 
elements were present in both Archaea and Bacteria, that they were direct repeats between 21-
37bp separated by spacer regions of DNA and the presence of the cas genes was identified, 
although the exact function of the system remained elusive. In 2005 Bolotin et al. [229] 
reported that these spacer regions were comprised of extrachromosomal DNA from both phage 
and plasmid sources, with a ratio of approximately 3:1 phage to plasmid origin; they also 
reported a correlation between the number of spacer regions to resistance to phage infection 
although the mechanism that mediated this effect continued to remain elusive. In 2007 
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Barrangou et al. [230] demonstrated in S. thermophilus that spontaneous resistance to phage 
infection corresponded to the addition of 1 to 4 spacers within the CRISPR region and that the 
addition of these spacers was polarised to one end of the CRISPR region; they also 
demonstrated through selective addition and deletion of spacers that resistance to particular 
phage could be specifically modulated by addition of phage homologous DNA within the 
spacer region. Since 2007, CRISPR/Cas systems have undergone a significant amount of 
research due to their potential uses in genome editing technologies [231]. 
 
In order to understand the mechanisms behind the CRISPR/Cas systems it is first necessary to 
understand the diversity of the CRISPR/Cas sytems in prokaryotes. CRISPR/Cas systems are 
broadly categorised into two classes, Class 1 and Class 2, although these are then further 
categorised into five types and sixteen subtypes [232]. Each of the two main classes has a 
signature Cas protein, for Type I the signature protein is Cas3 and in Class 2 the signature 
protein is the Cas9 protein [233]. Type 1 is the most common and is divided into seven 
subtypes, Type I-A to I-F and I-U [234].  
 
It is now known that the activity of the CRISPR/Cas system can be split in to three distinct 
stages; the first stage is known as the activation stage, the second is known as the ‘expression 
and processing’ stage and the third stage is known as the interference stage, illustrated below 
in Figure 1.8 [235].  
 
 57 
 
Figure 1.8. Schematic representation of the stages of CRISPR/Cas system. 1. Activation stage: 
Acquisition of proto-spacers (red) and integration in to the CRISPR loci. 2. Expression and 
Processing stage: Transcription of the CRISPR locus and processing in to crRNAs. 3. 
Interference stage: Targeting of foreign DNA/RNA by crRNA and Cas proteins. Generated in 
Microsoft PowerPoint and adapted from [236, 237]. 
 
The first stage, known as the activation stage and as described by Barrangou et al. [230], is the 
stage in which short spacers (known as proto-spacers) that are acquired from 
extrachromosomal phage or plasmid DNA are integrated in to the CRISPR loci. In most 
CRISPR/Cas systems the two distinct Cas proteins Cas1 and Cas2 are involved in the 
acquisition and integration of new spacer by forming an integrase complex [238], however in 
Type 1 subtype I-F CRISPR systems, such as found in Pseudomonas aeruginosa PA14 the 
Cas2 protein is in fact a fusion of the Cas2 and Cas3 proteins into a single protein (Cas 2/3) 
[239]. Some CRISPR/Cas systems also require the presence of short motifs adjacent to the 
proto-spacer, known as proto-spacer adjacent motifs (PAMs), for acquisition of these proto-
spacer sequences [240].  
 
The second stage, the ‘expression and processing’ stage is where the CRISPR locus is 
transcribed into a long transcript, known as the precursor transcript (pre-crRNA), which is then 
1.
2.
3.
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processed into small crRNAs by endoribonucleases that cleave the repeat regions, either 
bacterial RNase III [241] or, as is the case for Type 1 CRISPR/Cas systems, an 
endoribonuclease subunit of a larger protein complex known as Cascade (CRISPR-associated 
complex for antiviral defence) [235]. 
 
The final stage, the interference stage, is where the ‘invading’ DNA or RNA is targeted by a 
ribonucleoprotein complex comprised of the crRNA guide and Cas proteins which cleaves the 
target DNA/RNA [232].  
 
Phage CRISPR/Cas Resistance 
Similar to the resistance mechanisms of phage again R-M systems, phage resistance 
mechanisms against CRISPR/Cas systems can be broadly categorised into active and passive 
mechanisms. Passive mechanisms involve mutations in either the phage proto-spacer sequence 
or PAM that confer protection from the host CRISPR/Cas system; it has been shown that a 
single base mutation in the PAM region or certain positions within the proto-spacer can confer 
resistance to CRISPR/Cas degradation, these can be substitutions or deletions [242]. It is worth 
noting, however, that it has also been demonstrated that the CRISPR/Cas systems can be 
tolerant of single nucleotide mismatches at certain positions within the proto-spacer sequence 
[243]. It has also been reported by Datsenko et al. [244] that these substitutions within the 
proto-spacer or PAM that confer initial protection from the CRISPR/Cas system actually 
stimulate the acquisition of new spacers.  
 
Active mechanisms involve proteins produced by phage in order to inactivate the host 
CRISPR/Cas system. An example of this is the recently reported anti-CRISPR proteins 
identified by Bondy-Denomy et al. [245] in temperate phage of P. aeruginosa. Bondy-Denomy 
et al. have identified 5 proteins produced by the aforementioned phage that inhibit the Type 1 
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subtype I-F CRISPR/Cas system found in P. aeruginosa strains (although not the closely 
related subtype I-E systems); these anti-CRISPR proteins have been shown not to protect 
specific DNA sequences or to impact on the expression of the CRISPR loci or cas genes, but 
to exert their inhibitory effect at a stage after the formation of the crRNA-Cas complex [245].  
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1.9      Aims and Objectives  
The primary aim of this study is to: 1) perform genetic analyses of P. tolaasii NCPPB 2192T 
and P. agarici NCPPB 2472 in order to better understand how they colonise and cause disease 
symptoms on Agaricus bisporus mushrooms, and; 2) to isolate and characterise bacteriophage 
that are capable of infecting these bacteria. Characterisation and genomic sequencing of the 
identified bacteriophage should elucidate the interactions between the phage and the host 
bacterium, with the potential for the whole phage or phage proteins to be used as a future 
treatment of P. tolaasii or P. agarici infections. These aims will be achieved by working 
through the following objectives:  
1. Extract and sequence genomic DNA of both P. tolaasii NCPPB 2192T and P. agarici 
NCPPB 2472. Perform assemblies and genome mining for potential virulence factors 
and phage susceptibility or resistance factors. 
2. Isolate, identify and characterise bacteriophage capable of infecting P. tolaasii NCPPB 
2192T and P. agarici NCPPB 2472, including full genome sequencing. This will 
provide the basis for analysis into the interactions between phage and host bacterium 
and allow the identification of phage proteins with the potential for use in treatment of 
P. tolaasii and P. agarici infections.  
3. Investigate the genetic basis of phage/host interactions. Full genomic sequencing and 
characterisation of both the phage and bacterial host achieved in the previous objectives 
should allow for the analysis of phage/host interactions at a genetic and transcriptomic 
level using RNA sequencing (RNA-seq).  
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Chapter 2: 
 Materials and Methods 
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2.1         Bacterial strains, phage preparations and growth conditions  
2.1.1      Bacterial strains  
Bacterial strains used in this study are outlined below in Table 2.1.  
Table 2.1. Bacterial strains used in this study. (R.W.J.: Gift from Professor Robert Jackson) 
 
Strain: Source 
P. tolaasii NCPPB 2192T R.W.J. 
P. agarici NCPPB 2472 R.W.J. 
P. sp NS1 Agaricus bisporus mushroom surface. This study 
P. syringae pv. morsprunorum R1 5244 R.W.J. 
P. syringae pv. syringae 9097 R.W.J. 
P. syringae pv. morsprunorum R2 5255 R.W.J. 
P. fluorescens Pfo-1 R.W.J. 
P. aeruginosa 14207 R.W.J. 
Bl21-AI™ One Shot® Chemically 
Competent E. coli 
Invitrogen 
One Shot® TOP10 Chemically 
Competent E. coli 
Invitrogen 
 
 
2.1.2      Proof of pathogenicity 
 
In order to demonstrate that the bacteria P. tolaasii 2192T and P. agarici 2472 were capable 
of causing the symptoms of disease associated with brown blotch and drippy gill respectively 
on Agaricus bisporus mushrooms, a series of inoculations were performed on excised ‘button’ 
(immature, unopened) mushroom caps sourced from a local supermarket, that showed no prior 
signs of browning or lesions.  
 
A single non-fluorescent colony of either P. tolaasii NCPPB 2192T or P. agarici NCPPB 2472 
was taken from a streak plate on KB agar and used to inoculate 10 ml of KB, before overnight 
incubation at 28°C with shaking. This overnight culture was then pelleted at 1,500 g for 30 
minutes and the pellet resuspended in 2ml Phosphate Buffered Saline (PBS) (NaCl 8 gL-1; KCl 
0.2 gL-1; Na2HPO4 1.44 gL-1; KH2PO4 0.24 gL-1). 10 µl of the bacterial suspension was then 
applied to either the mushroom cap for P. tolaasii or for P. agarici the mushroom hymenial 
tissue was removed and the suspension applied to the exposed gill tissue. Care was taken to 
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avoid damaging the tissue during pipetting. The inoculated mushrooms were then placed into 
sterile beakers which were sealed with cling-film before being incubated at 28°C until disease 
symptoms appeared.  
 
2.1.3      Sampling and sample preparation for phage isolation 
 
Samples of water were taken from several environmental sources including the River Thames, 
sampling locations shown in Figure 2.1, and un-treated sewage. 10 ml of these samples was 
combined with an equal volume of overnight culture of either P. tolaasii NCPPB 2192T or P. 
agarici NCPPB 2472, followed by overnight incubation at 28°C with 220 rpm shaking. Post-
incubation the bacteria were pelleted by centrifugation at 1,500 g and the supernatant was 
removed and filtered with a 0.45 µm pore-size syringe injection filter (Millipore) and stored at 
4°C. 
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Figure 2.1. Map of South-West London with bacteriophage sampling locations marked (red) 
© OpenStreetMap contributors. 
 
 
Environmental samples were taken from locations around the University of Reading campus 
that correspond to likely habitats for wild mushroom growth for example, partially or fully 
shaded leaf litter and soil, sampling locations shown in Figure 2.2.  
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Figure 2.2. Map of the University of Reading Campus with bacteriophage sampling locations 
marked (red) © OpenStreetMap contributors. 
 
 
 
The environmental samples were suspended in Nanopure water to a total volume of 50 ml in a 
50 ml falcon tube before being centrifuged for 10 min at 1,500 g. The supernatant was then 
decanted into a new 50 ml falcon tube before being passed through a 0.45 µm pore-size syringe 
injection filter (Millipore). The filtered samples were then pooled to a total volume of 1 ml 
which was then added to 5 ml KB cultures of P. agarici NCPPB 2472 and P. tolaasii NCPPB 
2192T then incubated overnight at 28°C. The overnight cultures were then centrifuged at 1,500 
g for 30 min to pellet the bacterial cells and the supernatant was either used immediately for 
phage isolation or stored at 4°C. 
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2.1.4      Phage isolation  
 
100 µl of the supernatant from the environmental sample preparations outlined in Section 2.1.3, 
were serially diluted eightfold in PBS. 100 µl of each serial dilution was then plated on KB 
agar plates and overlaid with 0.7% agar containing either P. agarici NCPPB 2472 or P. tolaasii 
NCPPB 2192T. The plates were then incubated overnight at 28°C and observed for the 
presence of visible plaques. 
 
If visible plaques were present, a new overnight culture of either P. tolaasii or P. agarici was 
inoculated with a stab of an isolated phage plaque before being incubated overnight at 28°C. 
The overnight culture was then spun at 1,500 g for 30 minutes to pellet cells and the supernatant 
filtered with a 0.45 µm pore-size syringe injection filter and 100 µl of filtered supernatant was 
eightfold serially diluted and each dilution plated of KB agar and overlaid with 0.7% agarose 
containing either P. agarici or P. tolaasii before incubation at 28°C overnight. The plates were 
then checked for uniform plaque morphology and if there was variable plaque morphology the 
process was repeated with each distinct plaque morphology until a uniform morphology was 
attained for each inoculation. 
 
 
2.1.5      Plaque assay protocols 
 
Plaque Assay  
Standard plaque assay procedure involved the addition of 1 ml of diluted phage sample in PBS 
or phage stock to 5 ml of 0.7% agar cooled to approximately 37°C in a sterile 50 ml falcon 
tube, this was then mixed by gently inverting the tube several times. The phage/agar mix was 
then poured onto a pre-prepared hard KB or LB agar plate and allowed to solidify at room 
temperature in a laminar flow cabinet before being inverted and incubated at 28°C overnight.  
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Droplet Assay 
Droplet assays procedure involved preparing a 10ml KB culture of either P. tolaasii or P. 
agarici which was then incubated overnight at 28°C with 220 rpm shaking. 5 ml of the 
overnight culture was then combined with 45 ml of molten overlay agar in a 50 ml falcon tube 
and mixed by inverting the tube several times. 5 ml of the culture/overlay agar mix was poured 
on to a pre-prepared hard KB or LB agar plate, which was allowed to solidify in a laminar flow 
cabinet at room temperature. A phage sample or stock was then passed through an eightfold 
serial dilution in sterile PBS, with mixing by vortexing between each dilution stage. 10 µl of 
each dilution was then pipetted on to the surface of the solidified plates and returned to the 
laminar flow cabinet to allow the droplets to dry, followed by inversion and overnight 
incubation at 28°C. 
 
 
2.1.6      Phage stocks  
 
Low titre phage stock 
Standard, low titre (<1x1010 pfu/ml) phage stocks were created by addition of 1ml of previous 
phage stock to 1ml of overnight bacterial culture in 10 ml of KB broth, before incubation 
overnight at 28°C with 200 rpm shaking. The bacterial cells were then pelleted out by 
centrifugation at 1,500 g for 30 minutes, and the phage containing supernatant clarified by 
filtration through a 0.45 µm pore-size syringe filter. The filtered phage supernatant was then 
stored at 4°C. 
 
High titre phage stocks 
The standard phage stock was serially diluted eightfold and each dilution used to create 3 repeat 
plaque assay plates and the plates then incubated for 24 hours at 28°C. After incubation 5 ml 
of PBS was added to the surface of the dilution plates in triplicate with almost confluent lysis 
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and the plates left for 90 minutes at room temperature with agitation every 15 minutes. 
Following this the PBS from all 3 plates was combined together and filtered through a 0.45 µm 
pore-size syringe filter.  
 
2.1.7      Phage host range assay  
 
Phage host range assays were performed using the plaque assay protocol and 1ml of undiluted 
low titre phage stock on Pseudomonas species shown in Table 2.2. 
 
Table 2.2. Bacterial strains used in phage host range assay. (R.W.J.: Gift from Professor 
Robert Jackson) 
 
 
Strain: Source 
P. tolaasii NCPPB 2192T R.W.J. 
P. agarici NCPPB 2472 R.W.J. 
P. sp NS1 Agaricus bisporus mushroom surface. This study 
P. syringae pv. morsprunorum R1 5244 R.W.J. 
P. syringae pv. syringae 9097 R.W.J. 
P. syringae pv. morsprunorum R2 5255 R.W.J. 
P. fluorescens Pfo-1 R.W.J. 
P. aeruginosa 14207 R.W.J. 
 
 
2.1.8      Chloroform sensitivity assay  
 
A 100 µl sample of phage culture of known concentration (1x108 pfu/ml) was incubated with 
5 µl of chloroform. The phage culture containing chloroform was then eightfold serially diluted 
with PBS and 10 µl drops of each dilution was spotted on to a pre-prepared soft agar overlay 
plate of P. agarici or P. tolaasii and incubated for 24 hours at 28°C and observed for plaque 
formation. 
 
2.1.9      Single step growth curve 
 
A 10 ml culture of P. agarici in KB was incubated overnight at 28°C with shaking at 220 rpm. 
1 ml of the stationary overnight culture was taken and transferred to a fresh 10 ml of KB and 
incubated at 28°C with shaking for 2 hours. The OD 600 was measured and the culture diluted 
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to a concentration of 1x108 cfu/ml (~0.028 Abs). 2.5 ml of P. agarici at 1x108 cfu/ml was then 
combined with 25 µl of ϕNV3 stock (1x109 pfu/ml) to give a MOI of 0.1.  
The mixture of P. agarici and ϕNV3 was then mixed by vortexing and incubated for 10 minutes 
on ice to allow for adequate phage adsorption, before being added to 247.5 ml of KB for a final 
volume of 250 ml to sufficiently dilute the culture and prevent further adsorption events. The 
culture was then transferred to a water bath at 28°C with frequent shaking. A 1 ml sample was 
transferred to a 1.5 ml Eppendorf every 1.5 minutes for 15 minutes then every 5 minutes for a 
further 75 minutes. These 1 ml samples were centrifuged at 10,000 g for 2 minutes to pellet 
any P. agarici cells that may otherwise form infective centres and 100 µl of the phage-
containing supernatant transferred to an Eppendorf containing 900 µl PBS, on ice. The samples 
were then passed down a threefold serial dilution in PBS and placed back on ice. 10 µl droplets 
from each time point were placed on pre-made soft agar plates of P. agarici and repeated in 
duplicate and allowed to dry at room temperature before incubation for 24 hours at 28°C to 
allow plaques to form.  
 
2.1.10      Adsorption assay  
 
A 10 ml inoculation of a single plate colony of P. agarici in KB was incubated overnight at 
28°C with shaking at 220 rpm, 1 ml of the stationary phase overnight culture was taken and 
transferred to a fresh 10 ml of KB and incubated at 28°C with shaking until cells reached mid 
log-phase (~0.4 Abs). Dilution tubes were prepared containing 1 ml of chloroform saturated 
PBS, which were placed on ice. The mid-log phase culture was then used to create a 50 ml 
culture in pre-warmed KB at 28°C containing 1x108 cfu/ml as determined by OD 600 (0.028 
Abs) to which 5x108 pfu of phage ϕNV3 was added and mixed by vortexing to give a final 
MOI of 0.1. The culture was then incubated at 28°C with regular mixing and at time intervals 
of 1 minute for 10 minutes, 1 ml of culture was taken from the ϕNV3/P.agarici culture and 
added to the chloroform saturated PBS.  
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The chloroform saturated samples were then fivefold serially diluted and 10 µl of appropriate 
dilutions of each time point were spotted in triplicate on to a pre-prepared P. agarici containing 
soft agar overlay plate and incubated overnight at 28°C.   
 
2.1.11      Kill curve assay  
 
Kill curves were performed using either P. tolaasii 2192T or P. agarici NCPPB 2472 taken 
from stationary phase overnight cultures grown in 10 ml KB broth at 28°C. 1 ml of overnight 
culture was taken and added to a fresh tube of 10 ml KB broth and incubated at 28°C. After 2 
hours OD 600 was measured, and culture diluted to the appropriate starting OD 600 of 0.092 
Abs for P. tolaasii or 0.028 Abs for P. agarici, that is equal to approximately 1x108 cfu/ml.  
 
Phage stocks were then diluted to the appropriate starting concentrations to produce MOI’s of 
0.1, 0.01 and 0.001 (1x108, 1x107, 1x106 pfu/ml respectively) and 100 µl of these phage 
dilutions added to 1 ml of the 1x108 cfu/ml bacterial solutions in a 1.5 ml Eppendorf tube and 
vortexed to mix. These mixes were left to stand at room temperature for five minutes to allow 
adequate diffusion of the phage particles throughout the solution and then 100 µl aliquots were 
transferred to 10 individual wells in a 96 well Cellstar® Cell Culture Plate with one row per 
MOI. The plates were then transferred to a Tecan GENios microplate reader at 28°C, and OD 
595 readings taken ever 5 minutes over a period of 12 hours. Data was visualised using 
GraphPad Prism 5, Version 5.0b. 
 
2.1.12      Phage/host co-evolution assay 
 
The phage/host co-evolution assays in this study were performed using a method adapted from 
Betts et al. [246]. The initial phage/host incubation was performed in 6 ml of KB in a 30 ml 
universal tube with 5 µl of ancestral ϕNV3 phage (~5x105 pfu) with 10 µl of ancestral P. 
agarici (~2x106 cfu), which was incubated at 27°C for 24 hours. From this overnight 
phage/bacteria culture 100 µl was taken and transferred to a new universal containing 6 ml of 
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fresh KB and incubated for 24 hours at 27°C. This process was repeated for a total of 12 
sequential transfers. For each of the transfers 1 ml of bacteria/phage mixture was removed and 
stored in 40% glycerol at -80°C; phage was isolated from each transfer by adding 100 µl of 
chloroform to 900 µl of bacteria/phage culture, mixed by vortexing for several seconds 
followed by centrifugation for 4 minutes at 10,000 g before the supernatant of purified phage 
was removed and stored at -80°C. 
 
Phage infection capacity for bacterial transfers T1, T3, T5, T7 and T9 was measured by 
streaking of 16 arbitrarily sampled bacterial colonies from streak plates of each transfer that 
were incubated at 27°C for 72 hours on KB agar. Each bacterial transfer was tested against the 
ancestral, present and future phage transfers (T-1, T0, T+1). To each of the 16 arbitrarily 
sampled bacterial streaks 5 µl of purified phage was placed in the centre of each line. This 
process was repeated 5 times per phage time point (ancestral, present and future). After 
incubation for 72 hours at 28°C a bacterial colony was considered resistant if its growth 
continued uninterrupted by the addition of phage.  
 
2.1.13      Electron microscopy  
 
Copper coated carbon-formvar TEM grids were prepared via floating on 10 µl drops of filtered 
phage lysate solutions of roughly 106-108 pfu/ml for 10 minutes. Excess liquid was removed 
by touching the side of the grid to filter paper. 10 µl of 1.5% (w/v) uranyl acetate stain was 
then spotted on to the grid for 20-30 seconds, excess stain was removed by touching the side 
of the grid to filter paper and the grids were left to dry at room temperature in a fume hood 
before being stored at room temperature in a grid box. Grids were then viewed under a Phillips 
CM200 Transmission Electron Microscope (TEM) operated at 80 kV.  
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2.2      Growth and microbiological media  
 
P. agarici and P. tolaasii were routinely cultured in both Kings B (KB) broth (Proteose peptone 
#3 20 gL-1; K2HPO4 1.5 gL-1; MgSO4 7H2O 1.5 gL-1; Glycerol 0.01% (v/v)) and Lysogeny 
Broth (LB) (Tryptone 10 gL-1; Yeast Extract 5 gL-1; NaCl 10 gL-1). For plating, bacteriological 
agar was added to broth media at a concentration of 15 gL-1. 
 
2.3      Antibiotics  
 
All stock antibiotics used were dissolved in nanopure water before filter sterilisation through 
a 0.22 µm filter and storage at -20°C. Working concentrations for ampicillin was 100 µg.ml-1 
and kanamycin was 50 µg.ml-1.  
 
2.4      Molecular biological techniques  
2.4.1   Phage DNA extraction and purification 
Phage genomic DNA was isolated and purified from 1 ml of 0.45 µm filtered phage lysate 
containing between 1x109 pfu/ml-1x1010 pfu/ml using a Norgen Biotek Phage DNA Isolation 
Kit using the standard manufacturers protocol, supplemented with a 30 minute incubation with 
4 µl of Proteinase K (20 mg/ml) at 50°C. DNA concentration was measured using a 
NanoDrop 2000, using standard manufacturers protocol (ThermoFisher Scientific). 
 
 
2.4.2      Bacterial genomic DNA extraction and purification 
 
Bacterial genomic DNA was isolated and purified with a Sigma-Aldrich GenElute™ Bacterial 
Genomic DNA Kit from 1.5 ml aliquots of 10 ml cultures of either P. agarici, P. tolaasii or 
Pseudomonas sp. NS1 grown overnight in KB at 28°C with shaking and eluted in nanopure 
water. DNA concentrations were quantified by NanoDrop 2000 (ThermoFisher Scientific).  
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2.4.3      PCR protocols 
 
Polymerase chain reaction (PCR) was used to amplify specific target regions of DNA for 
cloning and sequencing. Primers were designed using ApE v2.0.47 
(http://biologylabs.utah.edu/jorgensen/wayned/ape/) and manufactured by Integrated DNA 
Technologies, all primers were diluted with nuclease-free water to a stock concentration of 
100 pmol/µl. Standard PCR was performed with GoTaq Green Master Mix manufactured 
by Promega in 20 µl total reaction volumes (1 µl forward primer, 1 µl reverse primer, 3 µl 
template DNA, 7 µl nuclease-free water, 10 µl GoTaq Green Master Mix); reaction 
conditions were as follows: Denaturation at 95°C for 2 min; Cycle 30x at 95°C for 30 
seconds, 58°C for 45 seconds, 72°C for 1 min/kb of predicted product; Final elongation at 
72°C for 5 min.  
 
Colony PCR protocol reaction conditions were as per standard PCR protocol, with extended 
initial denaturation (5 min) and 3 µl of liquid culture/stock or 3 µl nanopure water with 
colony scraping to replace template DNA.  
 
Self-priming primer PCR protocol was as per standard PCR, with 2 µl of a single primer and 
8 µl of nuclease-free water.  
 
2.4.4      Agarose gel electrophoresis  
 
PCR products were separated by agarose gel electrophoresis. Agarose powder was dissolved 
to the required concentration (1.5% (w/v) for PCR products <1000 bp, 1% (w/v) for PCR 
products >1000 bp or unknown size and 0.7% (w/v) for agarose gel extraction) in 0.5X 
Tris/Borate/EDTA (TBE) buffer (5X TBE stock contains: Tris base 54 gL-1; Boric acid 27.5 
gL-1; 0.02% (v/v) EDTA). 1 µl of 10,000X Biotium GelRed was added to 100 ml 
agarose/TBE solution for nucleic acid staining. 1 µl of sample DNA was mixed with 1 µl of 
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5X Bioline Sample Loading Buffer and 3 µl of nanopure water. The sample mix and ladder 
(Bioline HyperLadder™ 1) were loaded into the pre-cast gel and run at 80-120V for the desired 
time (45-90 min). Completed gels were imaged using a Syngene G:BOX Chemi.  
 
2.4.5      DNA gel recovery  
 
DNA was extracted from 0.7% agarose gels using a Qiagen QIAquick Gel Extraction Kit as 
per manufacturers protocol.  Final elution was performed using 50 µl of Qiagen EB buffer. 
 
2.4.6      Genomic DNA sequencing  
 
De novo paired-end sequencing was performed by Source Bioscience on a single lane of an 
Illumina MiSeq with a read length of 50 bp. Whole genome sequencing libraries were 
generated by Source Bioscience using an Illumina TruSeq DNA Nano kit. The forward 
adapter sequence was: AGATCGGAAGAGCACACGTCTGAACTCCAGTCA and the 
reverse adapter sequence was: AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT. 
Returned data was adapter and quality trimmed using Skewer v0.1 [247] and trimmed reads 
were assembled into contigs with SPAdes v3.6.2 [248].  
 
The phage ΦNV3 genomic sequence was confirmed with extensive primer walking (Primer 
sequences available in Appendix 2, Tables Ap2.3 and Ap2.4) combined with Sanger 
Sequencing performed by Source Bioscience.  
 
2.4.7      P. agarici contig stitching  
 
Mapped contig junctions were assigned a numerical reaction number and primers were 
designed to allow for PCRs to amplify the unknown junction region as shown in Figure 2.3, a 
full list of primers used is available in Appendix 2 Tables Ap2.1 and Ap2.2.  
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Figure 2.3. Diagram of the primer design process for contig junction stitching.  
 
For contig stitching reactions related to predictions of contig order and orientation produced 
by alignment of P. agarici NCPPB 2472 sequenced contigs to P. fluorescens A506 outlined in 
Section 2.5.1 see Table 2.6. 
 
 
Table 2.6. Reaction list for contig junctions generated from mapping P. agarici NCPPB 2472 
sequenced contigs with P. fluorescens A506 (GCA_000262325.2). 
 
Reaction 
Number: 
Contig 1: Contig 2: 
Primer 1: Primer 2: 
1 C3 C21 Seq 6 Seq 33 
2 C21 C38 Seq 34 Seq 66 
3 C38 C26 Seq 65 Seq 42 
4 C26 C35 Seq 41 Seq 59 
5 C35 C16 Seq 60 Seq 23 
6 C16 C17 Seq 24 Seq 25 
7 C17 C59 Seq 26 Seq 98 
8 C59 C14 Seq 97 Seq 19 
9 C14 C10 Seq 20 Seq 11 
10 C10 C1 Seq 12 Seq 2 
11 C1 C33 Seq 1 Seq 56 
12 C33 C27 Seq 55 Seq 43 
13 C27 C34 Seq 44 Seq 57 
14 C34 C28 Seq 58 Seq 45 
15 C28 C2 Seq 46 Seq 4 
16 C2 C39 Seq 3 Seq 67 
17 C39 C11 Seq 68 Seq 13 
18 C11 C9 Seq 14 Seq 9 
19 C9 C42 Seq 10 Seq 74 
20 C42 C18 Seq 73 Seq 27 
21 C18 C32 Seq 28 Seq 53 
22 C32 C29 Seq 54 Seq 47 
23 C29 C6 Seq 48 Seq 7 
24 C6 C30 Seq 8 Seq 49 
25 C30 C24 Seq 50 Seq 40 
26 C24 C15 Seq 39 Seq 22 
27 C15 C13 Seq 21 Seq 17 
28 C13 C46 Seq 18 Seq 81 
29 C46 C12 Seq 82 Seq 16 
30 C12 C23 Seq 15 Seq 38 
 
Con g	1	 Con g	2	Junc on	
Primer	1	 Primer	2	
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For contig stitching reactions related to predictions of contig order and orientation produced 
by alignment of P. agarici sequenced contigs to P. agarici NCPPB 2289, outlined in Section 
2.5.1, see Table 2.7. 
 
Table 2.7. Reaction list for contig junctions generated from mapping P. agarici NCPPB 2472 
sequenced contigs with P. agarici NCPPB 2289.  
 
Reaction 
Number: 
Contig 1: Contig 2: 
Primer 1: Primer 2: 
Rb1 C46 C73 Seq 82 Seq 108 
Rb2 C73 C44 Seq 107 Seq 77 
Rb3 C44 C12 Seq 78 Seq 15 
Rb4 C12 C49 Seq 16 Seq 87 
Rb5 C49 C58 Seq 88 Seq 95 
Rb6 C58 C13 Seq 96 Seq 18 
Rb7 C13 C57 Rseq 17 Seq 93 
Rb8 C57 C53 Seq 94 Seq 113 
Rb9 C53 C52 Seq 114 Seq 91 
Rb10 C52 C62 Seq 92 Seq 102 
Rb11 C62 C23 Seq 101 Seq 38 
Rb12 C23 C35 Seq 37 Seq 59 
Rb13 C35 C22 Seq 60 Seq 35 
Rb14 C22 C37 Seq 36 Seq 63 
Rb15 C37 C1 Seq 64 Seq 1 
Rb16 C1 C65 Seq 2 Seq 104 
Rb17 C65 C19 Seq 103 Rseq 30 
Rb18 C19 C15 Rseq 29 Rseq 21 
Rb19 C15 C24 Seq 22 Seq 39 
Rb20 C24 C10 Rseq 40 Seq 11 
Rb21 C10 C28 Seq 12  Rseq 45 
Rb22 C28 C11 Rseq 46 Seq 14 
Rb23 C11 C42 Seq 13  Rseq 74 
Rb24 C42 C26 Seq 73 Rseq 42 
Rb25 C26 C2 Seq 41 Rseq 3 
Rb26 C2 C16 Rseq 4 Rseq 23 
Rb27 C16 C27 Rseq 24 Rseq 43 
Rb28 C27 C3 Seq 44 Rseq 6 
Rb29 C3 C33 Seq 5 Rseq 55 
Rb30 C33 C21 Rseq 56 Seq 34 
Rb31 C21 C18 Rseq 33 Rseq 28 
Rb32 C18 C38 Seq 27 Rseq 65 
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Rb33 C38 C14 Seq 66 Seq 20  
Rb34 C14 C29 Seq 19 Seq 47 
Rb35 C29 C6 Seq 48 Seq 7 
Rb36 C6 C32 Seq 8 Rseq 53 
Rb37 C32 C20 Seq 54 Seq 31 
Rb38 C20 C34 Seq 32 Seq 57 
Rb39 C34 C61 Rseq 58 Seq 99  
Rb40 C61 C39 Seq 100  Seq 68 
Rb41 C39 C59 Seq 67 Rseq 97 
Rb42 C59 C9 Seq 98 Seq 9  
Rb43 C9 C47 Rseq 10  Seq 84 
Rb44 C47 C17 Seq 83 Seq 26 
Rb45 C17 C30 Rseq25 Rseq50 
Rb46 C30 C31 Seq 49  Seq 52 
 
All designed primers were first run using the Self Priming Primer PCR protocol to check for 
multiple bands and self-priming due to inverted repeat regions in the unknown inter-contig 
sequence, if signs of self-priming were evident the primers were re-designed and moved ~500 
bp back from their previous position and re-run using the Self Priming Primer PCR until a 
single band was achieved.  
 
PCRs were then run on a 1% agarose gel, and those showing a single band the reactions were 
then repeated 2x in 160 l volumes before being gel extracted and purified as per the described 
protocol in 2.4.6. The DNA concentrations were then analysed using a NanoDrop 2000, any 
samples below the required concentration for Sanger sequencing were then concentrated via 
rotary evaporator at 40°C for 90 min.  
 
The samples were then sent for Sanger sequencing by Source Bioscience and the returned reads 
were analysed, aligned and assembled into a single sequence with ApE v2.0.47.  
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2.4.8      Vectors, cloning and plasmid construction  
 
The DNA vectors and plasmids used for cloning phage and bacterial genes for expression and 
knockout creation are listed below in Table 2.8.  
 
Table 2.8. Vectors and plasmids used in this study. (R.W.J: Gift from Professor Robert 
Jackson, UoR) 
 
Plasmid Features Source 
pEXP5-
CT/TOPO® 
T7 promoter, T7 forward binding site, Ribosome 
binding site, TOPO® Cloning site, C-terminal 
polyhistidine (6xHis) tag, T7 transcription 
terminator, T7 reverse priming site, bla promoter, 
Ampicillin resistance gene (ß-lactamase), pUC 
origin of replication (ori) 
Invitrogen 
pCR™2.1- TOPO® 
LacZα fragment, M13 reverse priming site, Multiple 
cloning site, T7 promoter/priming site, M13 
Forward (-20) priming site, f1 origin, Kanamycin 
resistance ORF, Ampicillin resistance ORF, pUC 
origin 
Invitrogen 
pBBR1MCS-2 
 
pBBR1 oriV, pBBR1 Rep, LacZα promoter, 
NeoR/KanR, M13 Forward priming site, M13 
Reverse priming site, Multiple cloning site. 
R.W.J. 
 
 
 
Endolysin constructs 
To allow for expression of the NV1 cell lysis proteins, two constructs were created using the 
primers in Table 2.9 that contain the native stop codon and the vector pEXP5-CT/TOPO® 
(Table 2.8). PCR amplification of the desired genes was performed using phage colony PCR 
and the product checked by agarose gel electrophoresis. The band corresponding to the desired 
product was extracted using the DNA gel recovery method and sent for Sanger Sequencing by 
Source Bioscience using the stock T7-promoter forward and reverse primers. After the returned 
sequence was confirmed to be the desired product by alignment in ApE v2.0.47, the products 
were TOPO® cloned into the pEXP5-CT/TOPO® vector as per the manufacturer’s protocol 
using 4 µl of DNA. Following the cloning reaction, 2 µl of the products were transformed in 
to One Shot® TOP10 Chemically Competent E. coli, as per the manufacturer’s protocol, and 
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plated on to selective LB agar plates containing ampicillin (100 µg/ml), then incubated at 37°C 
overnight.  
 
Colonies that grew on the overnight plates were checked for the presence of the respective NV1 
holin and lysozyme genes via colony PCR with a negative control containing water instead of 
bacterial cells and a positive control of NV1 DNA, with the products visualised via agarose gel 
electrophoresis.  
 
The colonies that were determined to contain the required inserts were then used to inoculate 
universals containing 10ml of ampicillin (100 µg/ml) infused LB broth and incubated for 24 
hours at 37°C. The constructs were then purified form the cultures using a QIAprep Spin 
Miniprep kit and the concentrations of the returned DNA analysed by Nanodrop™ 2000 
(ThermoFisher Scientific). The sequence of the products was then confirmed by Sanger-
Sequencing (Source Bioscience) with stock T7 forward primers supplied by Source Bioscience. 
 
Table 2.9. Primers used in phage NV1 lysis protein constructs. 
 
Name: Length: Tm: Sequence:  
NV1HolinF 21 54 ATGGTATTCTTTGCTGCGTAC 
NV1HolinR 21 54 TCATTTGGTTGCTCTCCATTC 
NV1LysoF 19 55 ATGTCGCGGATCTCACTAC 
NV1LysoR 26 54 TTATCCTTTATAAAGGTCGTACAGTG 
 
 
The method for producing the constructs for the ϕNV3 lysis proteins was the same as for the 
NV1 constructs, however instead using the primers in Table 2.10, 5 separate constructs were 
created. Each of the lysis proteins was cloned separately in to pEXP5-CT/TOPO® (pinholin, 
lysozyme, Rzl-like protein), as well as one construct containing both the pinholin and lysozyme 
from a DNA fragment produced from primer pair Nv3aPin-F and 3aLys_ex_R, and one 
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construct containing all the lysis proteins from a DNA fragment produced from the primer pair 
Nv3aPin-F and 3aRz1_ex_R. 
 
Table 2.10. Primers used in ϕNV3 lysis protein constructs.  
 
Name: Length: Tm: Sequence: 
Nv3aPin-F 22 61 ATGCAACTAGACACCACGAGCG 
Nv1Lyso_ex_F 24 61 ATGTCGCGGATCTCACTACTGAGG 
Nv3aRzl-F 22 62 ATGCGCTACGCCATCATTGCTG 
3aLys_ex_R 23 60 ATCCAGCAATAGTGGCGAGTACG 
3aPin_ex_R 22 61 TTCCTTAGGTTCATCCGCAGCC 
3aRz1_ex_R 26 61 ATCCTCCAGTGGGTATCCATTAAGGG 
 
 
A full table of all lysis protein constructs used in this study are outlined in Table 2.11. 
 
 
Table 2.11: Table of all lysis protein constructs used in this study. 
 
Name: Contains:  
pEXP5-NV1Hol Phage NV1 Holin  
pEXP5-NV1Lys Phage NV1 Lysozyme 
pEXP5-NV3Pin Phage ϕNV3 Pinholin 
pEXP5-NV3Lys Phage ϕNV3 Endolysin 
pEXP5-NV3Rzl Phage ϕNV3 Rzl/Rzl-like protein 
PEXP5-NV3PinLys Phage ϕNV3 Pinholin and Endolysin 
pEXP5-NV3Full  Phage ϕNV3 Pinholin, Endolysin and Rzl/Rzl-like protein.  
 
 
 
2.4.9      Protein expression  
 
Expression of the phage lysis proteins was performed by first transforming the 5-10 ng of lysis 
protein constructs, outlined in Table 2.8, in a volume of 1-5 µl into BL21-AI™ One Shot® 
Chemically Competent E. coli using the manufacturers basic protocol using 5-10 ng of DNA 
in a volume of 1-5 µl; all growth media was supplemented with 0.1% (w/v) glucose due to the 
toxic nature of the proteins encoded by the constructs. Following incubation of the 
transformation plates at 37°C overnight, colonies were picked from the plates and cultured 
overnight at 37°C in 10 ml LB supplemented with 0.1% glucose and ampicillin. Each overnight 
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culture was aliquoted in to 10, 1 ml volumes in 2 ml Eppendorf tubes and supplemented with 
300 µl of 40% (v/v) glycerol solution and immediately frozen at -80°C. One of each aliquot 
was analysed by PCR using the appropriate primers from Table 2.6 and Table 2.7 
corresponding to the relevant lysis proteins, including a negative control containing water and 
a positive control of the corresponding phage DNA. Bands corresponding to the desired 
product were excised from the gels using the gel extraction protocol and sent for Sanger 
Sequencing by Source Bioscience with the appropriate primers from Table 2.6 and Table 2.7 
corresponding to the relevant lysis proteins. Any aliquots that did not contain the required 
phage sequence were discarded. 
  
For the protein expression assay, 1 ml of the required -80°C aliquots of BL21-AI cells 
containing phage lysis protein sequences was pipetted in to 10 ml of 0.1% glucose 
supplemented ampicillin infused LB broth and incubated at 37°C with 220 rpm shaking until 
the OD 600 reached approximately 0.4 Abs. 100 µl of each culture was then pipetted into 12 
wells of a Cellstar® 96 well cell culture plate. To 6 of each of the culture containing wells, 2 µl 
of 10% L-Arabinose solution was added to induce protein expression and the plate immediately 
transferred to a Tecan GENios microplate reader pre-warmed to 37°C and maintained at 37°C 
while OD 595 readings were taken every 5 minutes for 150 cycles with rotary shaking between 
readings.  
 
 
2.4.10      P. agarici knockout vector construction and competent cell preparation  
 
The vector used in the creation of the knockout construct was Invitrogen pCR2.1-TOPO 
TA, containing both ampicillin and kanamycin resistance markers. The gene fragment used 
was from the P. agarici NCPPB 2472 Type IV pilus assembly ATPase PilB gene (Locus Tag: 
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AWM79_RS16250), amplified by PCR using the primers P.ag-IVPiliF and P.ag-IVPili-R to 
create an insert of 840 bp in length with an ‘A’ overhang for TOPO cloning.  
A map of the completed construct is shown below (Figure 2.4). 
 
 
Figure 2.4. Map of the pCR2.1/TypeIV pilus construct indicating the location of the AmpR 
and KanR resistance markers. Generated using ApE v2.0.47.  
 
 
The insert was then purified by gel extraction and imaged on an agarose gel, the concentration 
of the insert was determined to be 43.2 ng/l via NanoDrop 2000 (ThermoFisher Scientific). 
The insert was then cloned in to the pCR2.1-TOPO TA vector using the method outlined 
in the manufacturers recommendations as follows: 4 l of insert and 1 l of pCR2.1-TOPO 
TA vector were combined in a TOPO cloning reaction with 1 l of salt solution (1.2 M NaCl; 
0.06 M MgCl2), followed by transformation of 2 l of the TOPO cloning reaction into 
chemically competent One Shot TOP10 and plating on to selective agar containing 
ampicillin. After overnight incubation at 37°C, 6 colonies were selected and analysed by 
colony PCR for the presence of the gene insert, these reactions were separated on a 1% agarose 
gel by gel electrophoresis and imaged using a Syngene G:BOX Chemi. The colonies that were 
demonstrated to contain the insert were then inoculated into 10ml LB supplemented with 
ampicillin and incubated overnight at 37°C, 220 rpm. Following overnight incubation, plasmid 
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DNA was purified from all cultures and sent for Sanger sequencing (Souce Bioscience) using 
T7 forward and reverse sequencing primers, to analyse the quality of the DNA insert.  
The next step was to create competent P. agarici NCPPB 2472 cells for transformation of the 
knockout plasmid. A positive control plasmid, pBBR1MCS-2, containing a kanamycin 
resistance marker (Figure 2.5), was used to determine the competency of the P. agarici cells. 
 
Figure 2.5. Map of the control plasmid pBBR1MCS-2 indicating the location of the 
Kan/neoR resistance marker. Generated using ApE v2.0.47. 
 
 
The method for preparing electrocompetent Pseudomonas cells was adapted from the method 
described by Choi et al. [249]. Six millilitres of overnight P. agarici culture grown in LB 
medium was split into three 2ml microcentrifuge tube and were centrifuged at 10,000 g for 4 
min at room temperature. The cell pellet was then washed with 2 ml room temperature 300mM 
sucrose, then centrifuged at 10,000 g for 4 min. The wash was step repeated and the excess 
sucrose solution was removed by pipette following centrifugation and the resultant cell pellet 
was resuspended in 100 l 300mM sucrose solution.  
 
For electroporation, 2 l of 246 ng/l pCR2.1-TOPO Pili construct or 2.7 l of 183ng/l 
pBBR1MCS-2 positive control vector was used. DNA was mixed with 100 l of fresh 
electrocompetent cells was transferred to the electroporation cuvette. The cells were pulsed 
(settings: 25F; 200, 2.5kV) before 1 ml of room temperature LB medium was added and 
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the tube was transferred to a 28C incubator for 2 hours. The cells were then centrifuged at 
10,000 g for 4 minutes and the supernatant was discarded. The cells were then resuspended in 
100 l LB medium and plated on to a LB agar containing kanamycin and incubated at 28C 
for 48 hours. A negative control of competent P. agarici was also performed, without 
electroporation. 
 
The protocol for preparation of chemically competent Pseudomonas cells was adapted from 
Chuanchuen et al. [250]. 10 ml P. agarici cells were grown overnight in LB medium until they 
reached saturation. A 2 ml microcentrifuge was pre-chilled on ice for ~20min, then 2 ml of 
overnight culture was transferred to the tube followed by 1 minute centrifugation at 10,000 g. 
The cell pellet was resuspended in 2 ml 0.1M MgCl2 at 4C. The cell suspension was then 
centrifuged again at 10,000 g for 1 minute. The supernatant was removed, and the cell pellets 
were resuspended in 1 ml transformation salts with glycerol solution (75mM CaCl2, 6mM 
MgCl2, 15% glycerol) at 4C. The cell suspension was then incubated on ice for 10 min then 
centrifuged at 10,000 g for 1 min. After decanting the supernatant, the cell pellets were then 
resuspended in 200 l transformation salts solution at 4C with glycerol and flash frozen in 
liquid nitrogen before being transferred to -80C freezer for storage.  
 
For transformation, 2 l of 246 ng/l PCR2.1-TOPO Pili construct or 2.7 l of 183 ng/l 
pBBR1MCS-2 was used as a positive control. The DNA and competent cells were combined 
in a 2 ml microcentrifuge tube, a negative control using nanopure water was also performed. 
The cell/DNA suspension was then incubated on ice for 15 min, followed by a 2 min heat-
shock at 37C, after which 500 l LB broth was immediately added to the tubes. The tubes 
were then incubated at 28C for two hours. After incubation, 200 l was taken of each 
transformation and plated on to LB agar containing kanamycin. 
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2.4.11      RNA Extraction, purification and sequencing 
 
P. agarici NCPPB 2472 was inoculated in triplicate in 10 ml KB and incubated at 28°C 
overnight, then subcultured 1:10 in fresh KB for ~2 hours until cells reached mid log phase 
(0.4 Abs at 600 nm). Each culture was diluted to 0.28 Abs (approximately 1x109 cfu) and two 
1 ml aliquots of cells per culture were transferred to 2 ml reaction tubes. To 3 of the 6 reaction 
tubes 100 µl of 1x1010 pfu/ml ϕNV3a in PBS was added, to the remaining 3 reaction tubes 100 
µl of PBS was added. The reaction tubes were incubated at room temperature for 5 mins before 
being transferred to a 28°C shaking incubator at 220 rpm for 40 min. Following incubation, the 
tubes were spun at 10,000 g for 5 minutes and the resultant cell pellet was resuspended in 2 ml 
RNAlater® before being stored at 4°C.  
 
RNA was extracted from the samples stored in RNAlater® using an Ambion® PureLink® RNA 
Mini Kit. Homogenisation of the bacterial cells was achieved using MP Biomedical Lysing 
Matrix B 2 ml tubes in a MP Biomedical FastPrep®-24 benchtop homogeniser at maximum 
speed for 45 seconds and immediately placed on ice. RNA was extracted using a PureLink 
RNA Mini Kit. DNA was removed from the samples by on-column DNase treatment using the 
PureLink DNase Set. The extracted RNA was concentrated using a Thermo Scientific 
GeneJET RNA Cleanup and Concentration Micro Kit and stored at -80°C. 
 
Initial RNA concentration was determined by NanoDrop 2000 (ThermoFisher Scientific), 
RNA integrity and concentration were analysed using an Agilent RNA 6000 Nano Kit in an 
Agilent 2100 Bioanalyzer.  
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Sequencing was performed by Source Bioscience using a NextSeq® 500 v2 using one Mid-
output flow cell at 75 bp paired-end reads, library preparation was performed using a TruSeq 
Stranded mRNA kit with Ribo-Zero™. 
 
2.5      Bioinformatic techniques 
2.5.1   Contig mapping and scaffold construction  
P. agarici NCPPB 2472  
Mapping of P. agarici contigs provided by Source Bioscience was performed using both P. 
fluorescens A506 (GCA_000262325.2) and P. agarici 2289 (GCA_000280785.1) as a 
reference sequence using CONTIGuator 2.7.4 [251]. 
 
P. tolaasii NCPPB 2192T  
Mapping of the P. tolaasii contigs provided by Source Bioscience was performed using P. 
tolaasii PMS117 as a reference genome, CONTIGuator 2.7.4 [251] was unable to return any 
results and mapping was instead performed using MeDuSa v1.6 [252].  
 
Pseudomonas sp. NS1 
Mapping of Pseudomonas sp NS1 contigs provided by Source Bioscience was performed using 
the Pseudomonas strain that had been identified as sharing the highest nucleotide identity by 
BLASTN [253] analysis of all provided contigs, Pseudomonas azotoformans S4 
(GCA_001579805.1), as a reference sequence using CONTIGuator 2.7.4 [251].  
 
2.5.2      Phage phylogeny  
For analysis of phage phylogeny of NV1 and ϕNV3, the evolutionary history was inferred 
using the Maximum Parsimony method over the entire genome sequence [254]. For NV1 a 
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total of 19 genomic sequences were analysed, which are shown in Table 2.12, based on analysis 
previously performed by Monique Eller et al. [108].  
 
The phage genomic sequences were first aligned using ClustalW [255], then the Maximum 
Parsimony tree was calculated using Mega6.06 [256] with 500 Bootstrap Test replicates [257] 
, the MP tree was obtained using the Subtree-Pruning-Regrafting algorithm [258] with search 
level 1 in which the initial trees were obtained by the random addition of sequences (10 
replicates), all codon positions were included (1st, 2nd,3rd and Noncoding) and all positions 
containing gaps and missing data were eliminated. The final tree was rooted to Enterobacteria 
phage T7. 
 
 
Table 2.12. Phage strain sequences used in NV1 phylogenetic relationship analysis.  
 
Strain:  Accession: 
Enterobacteria phage T7 NC_001604.1 
Pseudomonas aeruginosa phage PaP3 NC_004466.2 
Pseudomonas phage DL54 KR054029.1 
Pseudomonas phage gh-1 NC_004665.1 
Pseudomonas phage LUZ7  NC_013691.1 
Pseudomonas phage LUZ24 NC_010325.1 
Pseudomonas phage MR299-2 JN254801.1 
Pseudomonas phage PaP4 KC294142.1 
Pseudomonas phage phi-2 NC_013638.1 
Pseudomonas phage PhiCHU KP233880.1 
Pseudomonas phage phiIBB-PAA2 KF856712.1 
Pseudomonas phage phiIBB-PF7A NC_015264.1 
Pseudomonas phage ϕKMV NC_005045.1 
Pseudomonas phage tf NC_017971.2 
Pseudomonas phage TL  HG518155.1 
Pseudomonas phage UFV-P2 JX863101.2 
Pseudomonas phage vB PaeP C1-14 Or HE983844.1 
Pseudomonas phage vB PaeP p2-10 Or1 HF543949.1 
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The same method of Maximum Parsimony analysis was performed on ϕNV3 using 18 phage 
genomic sequences of Autographivirinae and Podoviridae members, shown in Table 2.13, 
including NV1 and ϕNV3 (not included in Table 2.13). The final tree was rooted to 
Enterobacteria phage K1E.  
 
Table 2.13. Phage strain sequences used in ϕNV3 phylogenetic relationship analysis. 
Strain:  Accession: 
Enterobacteria phage K1-5 AY370674.1 
Enterobacteria phage K1E NC_007637.1 
Enterobacteria phage SP6 AY370673.1 
Erwinia amylovora phage Era103 NC_009014.1 
Kluyvera phage Kvp1 NC_011534.1 
Pseudomonas phage ϕKMV NC_005045.1 
Pseudomonas phage DL62 KR054031.1 
Pseudomonas phage gh-1 NC_004665.1 
Pseudomonas phage LKA1 NC_009936.1 
Pseudomonas phage LKD16 NC_009935.1 
Pseudomonas phage LUZ19 AM910651.1 
Pseudomonas phage MPK7 JX501340.1 
Pseudomonas phage phikF77 FN263372.1 
Pseudomonas phage phiNFS KU743887.1 
Pseudomonas phage PT2 NC_011107.1 
Pseudomonas phage UFV-P2 JX863101.2 
 
 
2.5.3     Bacterial phylogeny 
 
Bacterial phylogeny was inferred using multi locus sequence analysis (MLSA) of 5 genes, 23s 
rlmJ, 16s rDNA fragments, rpoD, gyrB, rpoB. 
The 16S Fragment were generated by identifying the region of DNA between the pseudomonas 
specific primers PA-GS-F and PA-GS-R [259] PA-GS-F (5′-
GACGGGTGAGTAATGCCTA3-′) and PA-GS-R (5′-CACTGGTGTTCCTTCCTATA-3′) in 
silico with Artemis v16.0.0.1 genome browser.  
All genes were aligned individually for all bacterial strains using MUSCLE [260] and the 
alignments then transferred to Mega6.06 [256], where the gaps were removed and the 
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alignments for all the genes were then concatenated into a single alignment session for 
phylogenetic analysis.  
 
 
Table 2.14. Pseudomonas strain sequences used for phylogenetic relationship analysis.  
 
Strain: Accession: 
P. azotoformans LMG 21611 NZ_LT629702.1 
P. azotoformans F77 NZ_CP019856.1 
P. azotoformans S4 NZ_CP014546.1 
P. fluorescens F113 NC_016830.1 
P. fluorescens L228 NZ_CP015639.1 
P. tolaasii 2192T NZ_CP020369.1 
P. tolaasii PMS117 NZ_AJXG01000263.1 
P. tolaasii 6264 NZ_AKYY00000000.1 
P. protegens CHA0 NC_021237.1 
P. cedrina BS2981 LT629753.1 
P. fulva 12-X NC_015556.1 
P. putida KT2440 NC_007005.1 
P. syringae B728a NC_002516.2 
P. aeruginosa PA01 NC_002516.2 
P. chloroaphis PA23 NZ_CP008696.1 
P. agarici NCPPB 2472 NZ_CP014135.1 
P. agarici NCPPB 2289 NZ_JH730872.1 
P. agarici LMG2112 NZ_FOAR01000001.1 
E. coli K-12 subset MG1655 NC_000913.3 
 
 
Phylogenetic relationships between 15 of the strains in Table 2.14, chosen to most accurately 
place each of P. agarici NCPPB 2472, P. tolaasii NCPPB 2192T and P. sp NS1, were 
calculated using the Maximum Likelihood method based on the Tamura-Nei model [261]. The 
initial tree for the heuristic search was obtained automatically by applying Neighbor-Join and 
BioNJ algorithms to a matrix of pairwise distances estimated using the Maximum Composite 
Likelihood approach and then selecting the topology with superior log likelihood value.  
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2.5.4      Bacterial secondary metabolite and NRPS prediction 
 
Putative biosynthetic gene clusters were predicted from the full genomic sequence files of P. 
tolaasii, P. agarici and Pseudomonas sp. NS1 using antiSMASH 3.0 [262]. These putative 
clusters were then checked manually using both BLASTN and BLASTP [253] and checked for 
predicted function.  
 
In order to identify ORF’s potentially encoding large NRPS’s all ORF’s over 1000 aa in length 
were identified in Artemis and analysed with BLASTP [253]. ORFs identified as potentially 
encoding NRPSs were then analysed using InterPro v65.0 [263] for the presence of 
condensation, adenylation and thiolation domains.  
 
 
 
2.5.5      RNA sequencing analysis  
 
The returned RNA sequencing reads of P. agarici samples were aligned to the partially 
assembled P. agarici NCPPB 7472 genome sequence using Burrows-Wheeler Aligner 
(Illumina Basespace). The resulting alignment files in BAM format were imported into the 
Bioconductor v3.6 [264, 265] package in RStudio (Version 1.0.143) running R version 3.4.0, 
for further analysis. The gene annotation model (gff) used for read counting was created from 
genomic feature file (gff3) produced by the NCBI Prokaryotic Pipeline for P. agarici NCPPB 
2472. 
 
Read counting in Bioconductor v3.6 [264, 265] was performed using the summarizeOverlaps 
function of the GenomicAlignments package [266], reads were only counted once to each gene 
with settings for paired-end reads and non-strand specific reads. Non-phage treated samples 
(P4, P5, P6) were used as the reference level in DESeq2 [267]. The count matrix was filtered 
to remove results with counts <10.  
 91 
 
Scatterplots were created using log2, regularized-logarithm transformation (rlog) [267] and the 
variance stabilizing transformation (vst) for negative binomial data with a dispersion-mean 
trend [267]. Euclidean distances were created using the rlog-transformed values to ensure equal 
contribution from all genes. Distances were visualised in a heat map created with the 
‘pheatmap’ package, colour was added using the RColorBrewer package. Poisson Distance 
was calculated with the PoiClaClu package [268] to take in to account the variance structure 
of counts using the non-normalized count matrix, and imaged again with pheatmap and 
RColorBrewer. The PCA plot data was generated for the rlog-transformed values using 
plotPCA function in the DESeq2 package and plotted using the ggplot2 package [269]. 
 
 
 
2.5.6      Phage terminal repeat identification 
 
Identification and analysis of putative phage terminal repeats was performed using PhageTerm 
v1.0.11  [270] on the Galaxy web platform [271]. The seed length was set as 20, the peak 
surrounding region as 20 and the coverage limit as 250.  
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Chapter 3:  
Comparative genomics of Agaricus bisporus 
pathogenic Pseudomonas strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 93 
3.1      Introduction 
Agaricus bisporus are an important agricultural crop, with 8-9x105 tonnes are cultivated in 
Europe alone, worth an approximate 2 billion Euros annually [1]. In this study I will be 
isolating, characterising and comparing the genomes of two Agaricus bisporus pathogenic 
Pseudomonas species, Pseudomonas tolaasii NCPPB 2192T, Pseudomonas agarici NCPPB 
2472 and a third non-pathogenic species recently identified which I have provisionally named 
Pseudomonas sp. NS1(2017); with the aim of identifying potential virulence factors and phage 
resistance/susceptibility factors.  
 
P. tolaasii is the causal organism of the mushroom blotch disease “brown blotch disease”, the 
symptoms of which commence as small (1-4 mm) brown or cream lesions on the pileus and 
stipe of the mushroom that become darker and more sunken as the damage progresses [1]. 
Mushroom loss due to brown blotch disease caused by P. tolaasii is economically significant 
as it has been estimated to be responsible for a 5-10% crop loss in the U.K and a further 
downgrading of 10% of mushrooms produced [11]. 
 
P. agarici is the causal agent of the disease ‘drippy gill’ in A. bisporus mushrooms, a disease 
characterised by cloudy white droplets of bacteria on the gill tissue of mushrooms, that can 
progress to cause total destruction of the affected tissue [24]. The majority of the large U.K 
based outbreaks were reported before 1980, although outbreaks of P. agarici have also been 
reported in New Zealand in 1991 [26] and in Serbia as recently as 2008 [32], which indicates 
that P. agarici has the potential to cause economic loss to cultivated mushroom farmers.  
 
While other members of the P. fluorescens group have been well characterised at the genome 
level, such as the type strains P. fluorescens and P. tolaasii; P. agarici has not been the subject 
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of in depth characterisation and analysis, with only two partial genomes published (P. agarici 
strain NCPPB 2289 and P. agarici strain LMG2112). To date no scientific literature has 
described the genome of P. agarici NCPPB 2472 and this study aims to address this shortfall. 
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3.2      Pseudomonas tolaasii 2192T 
3.2.1   Proof of pathogenicity  
In order to determine whether the provided P. tolaasii 2192T strain was capable of producing 
brown blotch disease symptoms on the host A. bisporus cap surface, a pathogenicity assay was 
performed. After 72 hours, the mushrooms infected with P. tolaasii 2192T begun to display 
darkening of the tissue and pitting of the surface, as shown in Figure 3.1 confirming the ability 
of the P. tolaasii strain to cause brown blotch disease.  
 
 
Figure 3.1. A. bisporus mushroom cap showing brown discolouration and pitting associated 
with brown blotch disease caused by P. tolaasii infection.  
 
3.2.2      Phylogeny  
 
To infer the phylogenetic relationship of P. tolaasii NCPPB 2192T among the fluorescent 
Pseudomonads a Maximum-Likelihood analysis was performed on the DNA sequence returned 
from whole-genome sequencing using 5 housekeeping genes (RlmJ, rrs, RpoD, GyrB and 
RpoB) using the Tamura-Nei model [261].  
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Figure 3.2. Molecular phylogenetic analysis of P. tolaasii 2192T (highlighted) by Maximum 
Likelihood method. The tree is drawn to scale, with branch lengths measured in the number 
of substitutions per site. The analysis involved 15 nucleotide sequences. Codon positions 
included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing data were 
eliminated. There were a total of 8768 positions in the final dataset. Evolutionary analyses 
were conducted in MEGA6.06 
 
The results of this analysis shown in Figure 3.2 agree with the phylogeny reported by 
Yamamoto et al. [272]; with P. tolaasii 2192T clustering with the closely related P. 
azotoformans and P. fluorescens which are all members of the Pseudomonas intragenic cluster 
II,  P. fluorescens complex, P. fluorescens lineage. However, it is unusual that P. tolaasii 
2192T is located on a separate branch to P. tolaasii 6264 and PMS117, indicating that it may 
have diverged from the other members of the P. tolaasii species.  
 
 
 
 
 
 
 
 
 
 97 
3.2.3      Sequencing and genome organisation  
 
For the whole-genome sequencing of P. tolaasii, a total of 150 µl of genomic DNA at a 
concentration of 79 ng/µl (11.85 µg total) was sent to Source Bioscience, who prepared a 
whole-genome sequencing library using an Illumina TruSeq Nano kit, before paired end 
sequencing was performed on an Illumina MiSeq with a read length of 50 bp. 
 
In total, the sequencing run returned 536.3 Mbases of sequence, with an average coverage of 
approximately 40-fold. The reads were initially assembled in to 262 contigs by Source 
Bioscience, with a total sequence length of 6,808,027 bp. These contigs were then aligned to 
Pseudomonas tolaasii PMS117 with the MeDuSa v1.6 software, which returned a single 
scaffold, and the resulting sequence was annotated using the NCBI Prokaryotic Genome 
Annotation Pipeline. The full genome is available under the accession code NZ_CP020369. 
 
Of the 6,286 ORFs identified, of which 6,065 were identified as being protein coding sequences 
and 63 RNA encoding genes were identified including 56 tRNAs, 3 complete rRNAs (5S, 16S, 
23S) and 4 ncRNAs. The total gene count is lower than that of the closely related P. tolaasii 
PMS117 which is predicted to encode 6,482 genes, but higher than P. tolaasii 6264 which is 
predicted to encode 6,093 genes; a full comparison is shown in Table 3.1. 
 
Table 3.1. Comparison of the genomes and predicted genes of P. tolaasii strains 2192T, 
PMS117 and 6264.  
 
Strain  Total 
(bp) 
ORFs Encoding Genes 
(RNA) 
tRNA rRNA ncRNA GC 
(%) 
2192T 6,856,683 6,286 6,065 63 56 3 4 60.5 
PMS117 7,007,821 6,482 6,011 60 53 3 4 60.2 
6264 6,233,813 6,093 5,265 63 54 5 4 61 
 
A full circular map illustrating the genome of P. tolaasii 2192T including G+C content, 
location of the tRNA genes and gene orientation is shown in Figure 3.3. 
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Figure 3.3. Circular map of the P. tolaasii NCPPB 2192T genome with the genes encoded on 
the positive strand in the first lane (grey), the negative strand in the second lane (blue) and the 
tRNA genes in the third lane (green). The deviation in GC content from the total average is 
illustrated in the centre circle with yellow bars denoting an above average content and purple 
bars, a below average GC content. Figure generated using DNAPlotter function of the Artemis 
v16.0.0.1 genome browser. 
 
 
3.2.4      Secondary metabolites and NRPSs  
The genome of P. tolaasii NCPPB 2192T was mined for potential biosynthetic gene clusters, 
which revealed a total of 17 complete and incomplete putative NRPS encoding ORFs. These 
ranged from 21,173 bp to 675 bp in length. Six putative NRPSs were identified that showed 
both amino acid and nucleotide similarity to a reported tolaasin biosynthetic cluster of P. 
costantinii [50] as shown in Table 3.2. The ORF RS02650 predicted by the NCBI prokaryotic 
pipeline to encode a frameshifted single protein was identified as to be comprised of the C-
terminus of a NRPS, between bases 531441 and 534953 on the leading strand, with amino acid 
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and nucleotide similarity to the P. costantinii taaC gene and associated protein product; and a 
complete ORF between bases 535013 and 545227 on the leading strand, with amino acid and 
nucleotide similarity to the P. costantinii taaD gene and associated protein product.   
 
Table 3.2.  Predicted NRPS of P. tolaasii 2192T with similarity to the tolaasin biosynthesis 
cluster of P. costantinii as identified by BLASTP [253], Predicted function of the gene product 
in P. tolaasii 2192T and the associated protein in P. costantinii, including the locus tag of the 
encoding gene are shown.  
 
Locus 
Tag:  
Predicted 
Function:  
P. costantinii 
Protein Locus Tag: Cover: Ident: 
RS30620 NRPS TaaA CCJ67636.1 97% 85% 
RS22935 NRPS TaaB CCJ67637.1 99% 72% 
RS23980 NRPS TaaC (N) CCJ67638.1 99% 86% 
RS02650 NRPS TaaC (C) CCJ67638.1 87% 82% 
RS02650 NRPS TaaD CCJ67639.1 98% 77% 
RS24725 NRPS TaaE CCJ67640.1 100% 85% 
 
 
Within the tolaasin biosynthetic cluster of P. costantinii that the gene encoding the protein 
TaaE is upstream of genes encoding two further proteins, a macrolide-specific efflux protein 
MacA and macrolide export ATP-binding/permease protein MacB (CCJ67641.1 and 
CCJ67642.1), it was observed that the gene encoding the predicted protein in P. tolaasii 2192T 
with amino acid identity to TaaE (RS24725) was likewise upstream of genes predicted to 
encode both a macrolide-specific efflux protein macA and macrolide export ATP-
binding/permease protein MacB (RS24720 and RS24715). Similarly, the gene encoding the 
protein TaaA in P. costantinii was found to be preceded by a cyclic peptide transporter family 
protein (CCJ67635.1), it was also observed that the gene encoding the predicted protein in P. 
tolaasii 2192T with amino acid identity to TaaA (RS30620) was likewise preceded by a gene 
predicted to encode a cyclic peptide export ABC transporter (RS30625).  
 
Two of the further NRPSs identified in silico were also predicted to be incorrectly separated 
parts of a single large NRPS, with similarity to a known biosynthesis gene, these were RS16165 
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and RS16170 (1527 aa and 224 aa in size respectively), which were found to show moderate 
amino acid identity by BLASTP [253] to the known pyoverdine synthesis genes PvdI of 
Pseudomonas syringae pv. daphniphylli (57% identity) Accession: KPX09284.1 and the 
pyoverdine sidechain peptide synthetase of P. fluorescens (68% identity) Accession: 
WP_003191936.1, respectively. These genes were also found to be upstream of a further 
incomplete NRPS, RS16160, that showed 63% amino acid identity to pyoverdine synthesis 
protein PvdJ of P. aeruginosa 62 (Accession: ERX81199.1) and downstream of a TonB-
dependent siderophore receptor (RS16175). 
 
Similarly, a 1948 aa NRPS was identified (RS12420) that is also hypothesised to be involved 
in siderophore synthesis, due to its location downstream of a gene predicted to encode a 
siderophore synthetase (RS12390), MFS transporter (RS12395) and TonB-dependent receptor 
(RS12400); as well as being located upstream from a TonB-dependent siderophore receptor 
(RS12430). 
 
Phage tail-like bacteriocin 
A biosynthetic gene cluster hypothesised to be involved in the synthesis of a phage tail-like 
bacteriocin (PTLB) was identified, shown in Table 3.3.  
 
Table 3.3. Predicted PTLB gene cluster of P. tolaasii 2192T. 
 
Predicted Function: Start: End: Locus Tag: Protein Id: 
pyocin R2, holin 3523422 3523766 RS16310 WP_016970764.1 
hypothetical protein 3523787 3524302 RS16315 WP_016970765.1 
phage baseplate 
assembly protein V 3524306 3524914 RS16320 WP_016970766.1 
phage baseplate 
protein 3524927 3525259 RS16325 WP_016970767.1 
baseplate J protein 3525256 3526251 RS16330 WP_016970768.1 
phage tail protein I 3526248 3526976 RS16335 WP_016970769.1 
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tail fiber protein 3526973 3527506 RS16340 WP_016970770.1 
hypothetical protein 3527533 3528171 RS16345 WP_016970771.1 
hypothetical protein 3528233 3528439 RS16350 WP_020372583.1 
tail protein 3528700 3529866 RS16355 WP_016970774.1 
phage tail protein 3529866 3530372 RS16360 WP_016970775.1 
 
Downstream of the predicted PTLB gene cluster, a further protein (RS16305) was later 
identified, which was initially classified as an XRE family transcriptional regulator, however 
it was then noted that it showed 100% amino acid identity to the repressor protein PrtR of P. 
fluorescens Strain: PCL1751 and is therefore likely to be involved in transcriptional regulation 
of the above identified PTLB in tandem with another protein, the pyocin activator protein PrtN 
(RS06590), identified in the genome of P. tolaasii 2192T. 
 
3.2.5      Phage resistance systems  
 
No CRISPR-associated repeats or proteins were identified in the P. tolaasii 2192T genome or 
within those of P. tolaasii PMS117 or 6264. However, multiple restriction endonuclease 
proteins, another well documented system by which bacteria are able to resist phage infection 
[203], were identified within the genome of P. tolaasii 2192T, shown in Table 3.4.  
 
The first predicted ‘restriction endonuclease’ (RS17360) contains an McrB conserved domain, 
which is associated with the GTP-binding regulatory subunit [273]. The RS17360 predicted 
restriction endonuclease gene is upstream of a ‘hypothetical protein’ (RS17355) that contains 
a PDDEXK_7 conserved domain, which is a domain of the PD-(D/E)XK nuclease family and 
it is speculated that it could function as a methylation-dependent restriction enzyme [274]; 
therefore it is likely that both RS17360 and RS17355 are two subunits of a single 
uncharacterised Type IV methylation-dependent restriction endonuclease system. 
 
 
 
 102 
Table 3.4. Predicted restriction endonuclease proteins of P. tolaasii 2192T. 
 
Protein: Start: End: Locus Tag: 
Restriction endonuclease 3766583 3768847 RS17360 
Restriction endonuclease subunit R 3783281 3786340 RS17410 
Restriction endonuclease subunit M <5750878 5751093 RS26390 
Restriction endonuclease subunit M  <6602607 6602822 RS30090 
Restriction endonuclease subunit M 6602929 >6603507 RS30095 
 
 
The second predicted restriction endonuclease (RS17410) is predicted to be a Type III 
restriction endonuclease and is directly downstream of a site-specific DNA-methyltransferase 
(RS17420), with a second site-specific DNA-methyltransferase (RS17440) approximately 
7,700 bp upstream of the first.  
The incomplete methyltransferase encoded by RS26390, predicted as a ‘restriction 
endonuclease subunit M’ shows significant amino acid identity to a known prophage (Prophage 
PSPPH02) adenine modification methyltransferase and therefore has no associated restriction 
endonuclease. Likewise, the incomplete methyltransferases encoded by RS30090 and 
RS30095 are likely to be of phage origin; the protein encoded by RS30090 shows 100% amino 
acid identity to a protein of the prophage PSPPHO2 (as predicted by BLASTP [253]) and the 
protein encoded by RS30095 shows a high degree of similarity to prophage PSPPH06 (95% 
Ident as predicted by BLASTP [253]). Furthermore, there are several ORFs downstream of 
both these genes that encode phage related proteins, including RS30070 (baseplate assembly 
protein) and RS30080 (microvirus H family protein).  
 
A biosynthetic operon comprised of 15 genes (Table 3.5) was identified in the genome of P. 
tolaasii 2192T, hypothesised to be involved in the production of alginate due to the presence 
of a gene encoding the alginate biosynthesis protein Alg44 (RS11530), which has been 
demonstrated to be required for alginate biosynthesis in Pseudomonas aeruginosa [275] and 
AlgE, also reported to be involved alginate biosynthesis in Pseudomonas [276]. 
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Table 3.5. Predicted alginate biosynthesis proteins of P. tolaasii 2192T 
.  
Predicted Protein Function  Locus Tag: 
Nucleotide sugar dehydrogenase RS11545 
Glycosyl transferase RS11540 
Alginate biosynthesis protein Alg44 RS11530 
Sel1 repeat family protein RS11525 
Alginate biosynthesis protein AlgE RS11520 
Right-handed parallel beta-helix repeat-containing protein RS11515 
Alginate O-acetyltransferase RS11510 
Mannuronate-specific alginate lyase RS11505 
MBOAT family protein RS11500 
Alginate O-acetyltransferase RS11495 
Alginate O-acetyltransferase RS11490 
Mannose-1-phosphate guanylyltransferase/mannose-6-
Phosphate isomerase RS11485 
DUF3077 domain-containing protein RS11480 
Hypothetical protein RS11475 
Short-chain dehydrogenase RS11470 
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3.3      Pseudomonas agarici NCPPB 2472 
3.3.1   Proof of pathogenicity 
 
In order to determine the pathogenicity of P. agarici NCPPB 2472, the gill tissue of previously 
un-opened and disease-free Agaricus bisporus was inoculated with bacterial culture.  
 
 
Figure 3.4. Gill tissue of Agaricus bisporus inoculated with P. agarici NCPPB 2472 showing 
characteristic symptoms of ‘drippy gill’ disease.  
 
After 72 hours of incubation at 28°C, cloudy-white bacterial droplets appeared on the 
mushroom gill tissue, as shown in Figure 3.4. This shows that P. agarici NCPPB 2472 is 
capable of infecting and causing drippy gill disease symptoms on Agaricus bisporus mushroom 
gill tissue.  
 
3.3.2      Phylogeny  
 
To infer the phylogenetic relationship of P. agarici NCPPB 2472 among the fluorescent 
Pseudomonads a Maximum-Likelihood analysis was performed on the DNA sequence returned 
from whole-genome sequencing using 5 housekeeping genes ( RlmJ, rrs, RpoD, GyrB and 
RpoB) using the Tamura-Nei model [261].  
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Figure 3.5. Molecular phylogenetic analysis of P. agarici NCPPB 2472 (highlighted) by 
Maximum Likelihood method. The tree is drawn to scale, with branch lengths measured in the 
number of substitutions per site. The analysis involved 15 nucleotide sequences. Codon 
positions included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing 
data were eliminated. There were a total of 9117 positions in the final dataset. Evolutionary 
analyses were conducted in MEGA6.06. 
 
The results in Figure 3.5 show that P. agarici 2472 clusters significantly in a tight 
monophyletic branch with other strains of P. agarici, which indicates that they are likely to be 
closely related. This confirms the results reported by Yamamoto et al.[272] who also reported 
that the P. agarici strains used in their study formed a tight monophyletic branch. Similarly, 
the results in Figure 3.5 show that the P. agarici branch is closer to the branch containing P. 
chloroaphis than to that containing P. fluorescens, which again is similar to the results reported 
by Yamamoto et al. [272], who suggest that P. agarici forms part of the P. chloroaphis lineage 
within the P. fluorescens complex of the Pseudomonas intrageneric cluster II, while P. tolaasii 
forms part of the P. fluorescens lineage. 
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3.3.3      Sequencing and genome organisation 
 
Sequencing of the genome of P. agarici by Source Bioscience returned 5,618,560 bp in a total 
of 232 contigs with an average contig length of 24,218 bp, a maximum contig length of 607,529 
bp and a minimum of 211 bp. These contigs were then mapped to two related Pseudomonas 
strains, Pseudomonas fluorescens A506 and Pseudomonas agarici NCPPB 2289 using 
CONTIGuator 2.7.4 [251], in order to orient the returned contigs correctly and allow a genome 
scaffold to be created that would minimise the number of contig junctions that require stitching. 
Mapping of the contigs to P. fluorescens A506 reduced the number of contigs from 232 to 32 
and the total sequence length to 5,314,908 bp. Primers were then created for each contig 
junction to allow PCR amplification of the unknown region between them. The ACT 
comparison of the genome of P. fluorescens A506 and the 32 aligned contigs of the sequenced 
P. agarici is shown in Figure 3.6, the total degree of nucleotide similarity between the two is 
not high however there are several large regions of similarity that allow a confident prediction 
of contig orientation and ordering.  
 
 
Figure 3.6. Alignment map of P. agarici NCPPB 2472 contigs (B.) mapped against the genome 
of P. fluorescens A506 (A.) generated using WebACT. Red bars indicate collinear regions of 
similarity between the mapped sequences.  
 
The returned P. agarici NCPPB 2472 contigs were also mapped to the genome sequence of P. 
agarici NCPPB 2289 and this reduced the number of contigs from 232 to 48 and the total 
sequence to 5,501,881 bp. The ACT comparison of the genome of P. agarici NCPPB 2289 and 
the 48 aligned contigs is shown in Figure 3.7, the total degree of nucleotide between the two is 
very high, with large regions of collinear similarity that would indicate a very confident 
prediction of contig orientation and ordering.  
A.
B.
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Figure 3.7. Alignment map of P. agarici NCPPB 2472 contigs (B.) mapped against the genome 
of P. agarici NCPPB 2289 (A.) generated using WebACT. Red bars indicate collinear regions 
of similarity between the mapped sequences.   
 
The P. agarici NCPPB 2472 contigs mapped to the genome sequence of P. agarici NCPPB 
2289 were then annotated using the NCBI Prokaryotic Genome Annotation Pipeline, the results 
are available with the accession code NZ_CP014135.  
Of the 4,901 ORFs identified, 4,673 were identified as being protein coding and 67 RNA 
encoding genes; including 59 tRNAs, 4 complete rRNAs (5S, 16S, 23S) and 4 ncRNAs. The 
total gene count is lower than the counts for both the closely related strains P. agarici NCPPB 
2289 and LMG 2112, a full comparison is shown in Table 3.6. 
 
Table 3.6. Comparison of the genomes and predicted genes of P. agarici strains NCPPB 2472, 
2289 and LMG 2112.  
 
Strain  Total 
(bp) 
ORFs Encoding Genes 
(RNA) 
tRNA rRNA ncRNA GC 
(%) 
2472 5,502,003 4,901 4,673 67 59 4 4 58.89 
2289 5,511,390 5,009 4,414 62 54 4 4 59 
LMG 
2112 5,508,100 5,002 4,738 68 58 6 4 59 
 
A full circular genome map was created using the DNAPlotter function of Artemis v16.0.0.1 
in order to visualise the returned data and is shown in Figure 3.8. 
A.
B.
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Figure 3.8. Circular map of the P. agarici NCPPB 2472 genome with the genes encoded on 
the positive strand in the first lane (grey), the negative strand in the second lane (blue) and the 
tRNA genes in the third lane (green). The deviation in GC content from the total average is 
illustrated in the centre circle with yellow bars denoting an above average content and purple 
bars, a below average GC content. Figure generated using DNAPlotter function of the Artemis 
v16.0.0.1 genome browser. 
 
 
 
3.3.4      Contig stitching 
 
Contig stitching using PCR amplification of the regions between contigs was performed in 
order to both confirm the bioinformatic predictions of genome organisation and to identify and 
sequence any regions not covered by the initial sequencing run. 125 PCRs were performed 
corresponding to the reactions previously outlined in Table 2.6 and Table 2.7. Of the 30 
reactions that were performed based on the alignment of P. agarici and P. fluorescens A506 
that are shown in the agarose gel image of Figure 3.9, 8 returned products that were 
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successfully sequenced and allowed stitching of their associated contigs (Figure 3.9, lanes 1, 
2, 18, 19, 23, 26, 28 and 30). These successful reactions varied considerably in number of bases 
they added, from a maximum of 5366 bp, to a minimum of 737 bp, the full results are outlined 
in Table 3.7 and the returned sequences are available in Appendix 1.  
 
 
Figure 3.9. Agarose gel image of all PCR products from Table 2.6 from contig junctions 
generated from mapping of P. agarici NCPPB 2472 with P. fluorescens A506, lane numbers 
(1-30) correspond to respective reaction numbers (R1-R30).  
 
Of the 46 reactions that were performed based on the alignment of P. agarici 2472 and P. 
agarici 2289 shown in Table 2.7, only 3 returned products that were successfully sequenced 
and allowed stitching of their associated contigs, Rb13, Rb19, Rb40, lanes 13,19 and 40 of 
Figure 3.10 respectively. Of these three products, two corresponded to regions of overlap 
between the contigs and only one product returned novel sequence.  
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Figure 3.10. Gel image of all PCRs from Table 2.7 from contig junctions generated from 
mapping of P. agarici NCPPB 2472 with P. agarici NCPPB 2289, lane numbers (1-50) 
correspond to the respective reaction numbers (Rb1-Rb50). 
 
The large discrepancy in reactions that returned products from which sequence data was 
obtained would appear to show that the genome organisation of P. agarici NCPPB 2472 is 
more similar to that of P. fluorescens A506 than P. agarici NCPPB 2289, despite the 
significantly larger degree of collinear similarity between the genomes of P. agarici NCPPB 
2472 and P. agarici NCPPB 2289. However due to limitations of Sanger sequencing several 
of the products returned from the PCRs of contig alignments of P. agarici NCPPB 2472 and 
P. agarici NCPPB 2289 were not able to be successfully sequenced and with other methods 
may in fact contain valid sequence. 
 
 
 
 
 
 
 
 
 111 
 
 
Table 3.7. Table of all completed contig junction stitches and associated sequence additions 
or overlaps.  
 
Reaction: Contig 1: Contig 2: Bp Added: Overlap: GC% 
R1 3 21 5366 No 52 
R2 21 38 847 No 58 
R18 11 9 737 No 63 
R19 9 42 3203 No 64 
R23 29 6 983 No 60 
R26 24 15 849 No 58 
R28 13 46 882 No 57 
R30 12 23 1597 No 59 
Rb13 22 35 N/A Yes N/A 
Rb19 15 24 848 No 58 
Rb40 61 39 N/A Yes N/A 
 
 
3.3.5      Secondary metabolites and NRPSs  
 
The genome of P. agarici was mined for potential biosynthetic gene clusters and NRPSs. 
In total 10 NRPS/PKSs were predicted in three distinct biosynthetic clusters; however, it was 
identified that two of these identified (RS0070/RS10745) were in fact part of larger NRPSs 
(RS12925 and RS00065 respectively) that had been split due to assembly errors of the full 
genome sequence data. The first cluster is comprised of 5 NRPS proteins, as shown in Table 
3.8.  
 
Table 3.8. Predicted NRPS proteins of P. agarici NCPPB 2472. 
 
No. Predicted Function: Locus: Tag 
1 non-ribosomal peptide synthetase RS12910 
2 non-ribosomal peptide synthetase RS12915 
3 non-ribosomal peptide synthetase RS12920 
4 non-ribosomal peptide synthetase RS12925 
5 non-ribosomal peptide synthetase  RS00065 
6 non-ribosomal peptide synthetase (part of RS12925) RS00070 
7 non-ribosomal peptide synthetase (part of RS00065) RS10745 
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The second is comprised of a single NRPS (RS20800) and a polyketide synthase (RS20810); 
the final biosynthetic cluster appears to possess only a single NRPS (RS10630). While all the 
NRPS showed a high degree of conservation with other NRPSs of the Pseudomonas, it was not 
possible to predict the function of the three biosynthetic clusters from in silico analysis.  
 
Phage tail-like bacteriocin 
A biosynthetic gene cluster hypothesised to be involved in the synthesis of a phage tail-like 
bacteriocin was identified, shown in Table 3.9.  
 
Table 3.9. Predicted potential pyocin proteins of P. agarici NCPPB 2472. 
 
Predicted Function: Start: End: Locus Tag: Protein Id: 
pyocin R2, holin 2500773 2501108 AWM79_10925 WP_060782816.1 
hypothetical protein 2501271 2501855 AWM79_10930 WP_060782817.1 
DUF2635 domain-containing 
protein 2501852 2502034 AWM79_10935 WP_060782818.1 
phage tail protein 2502034 2503530 AWM79_10940 WP_060782819.1 
tail protein 2503597 2503944 AWM79_10945 WP_017131070.1 
hypothetical protein 2503941 2504237 AWM79_10950 WP_017131069.1 
phage tail protein 2504368 2505999 AWM79_10955 N/A 
hydroxyacid dehydrogenase 2505980 2507245 AWM79_10960 WP_060782820.1 
baseplate protein 2507249 2508295 AWM79_10965 WP_060782821.1 
hypothetical protein 2508348 2508857 AWM79_10970 WP_060782822.1 
hypothetical protein 2508857 2509255 AWM79_10975 WP_060782823.1 
baseplate J protein 2509245 2510285 AWM79_10980 WP_017131062.1 
phage tail protein 2510273 2510872 AWM79_10985 WP_017131061.1 
hypothetical protein 2510884 2512029 AWM79_10990 WP_017131060.1 
acyltransferase 2512800 2514725 AWM79_10995 WP_060782824.1 
pyocin R, lytic enzyme 2515164 2515727 AWM79_11000 WP_017131058.1 
lysozyme 2515709 2516245 AWM79_11005 WP_017131057.1 
 
Similar to the PTLB cluster identified in P. tolaasii 2192T an XRE family transcriptional 
regulator was identified downstream of the PTLB gene cluster (AWM79_10920) which may 
function in a role similar to the PrtR protein as well as an incomplete gene predicted to encode 
the pyocin activator protein PrtN (AWM79_18570) which may be involved in transcriptional 
regulation of the PTLB cluster.  
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Siderophore Biosynthesis  
 
A biosynthetic cluster was identified that is predicted to produce the siderophore 
achromobactin, shown in Table 3.10.  
 
Table 3.10. Predicted achromobactin biosynthesis proteins of P. agarici NCPPB 2472.  
 
No. Predicted Function  Locus Tag: 
1 RNA polymerase sigma factor RS04660 
2 sugar ABC transporter substrate-binding protein RS04665 
3 TonB-dependent siderophore receptor RS04670 
4 aspartate aminotransferase family protein RS04675 
5 AcsD protein RS04680 
6 diaminopimelate decarboxylase RS04685 
7 MFS transporter RS04690 
8 AcsC protein RS04695 
9 siderophore biosynthesis protein SbnG RS04700 
10 AcsA protein RS04705 
 
Three proteins (RS04680, RS04695 and RS04705) showed high amino acid identity to the 
proteins AcsD, AcsC and AcsA respectively, which have been demonstrated by Berti and 
Thomas [61] to be involved in the biosynthesis of achromobactin by P. syringae pv. syringae 
B728a. A fourth protein (RS04685), which is predicted to function as a diaminopimelate 
decarboxylase, I hypothesise to perform the function of the P. syringae pv. syringae B728a 
protein AcsE.  
The gene cluster also shows significant similarities in ORF organisation to the achromobactin 
biosynthesis cluster of P. syringae pv. syringae B728a, as is illustrated in Figure 3.11. All 
ORFs show high (72-91%) amino acid identity to the corresponding ORFSs of P. syringae pv. 
syringae B728a, a full table of results including BLASTP [253] amino acid identity is available 
in Appendix 4, Table Ap4.5. The predicted function of this cluster in the production of a 
siderophore is further confirmed by the presence of a predicted TonB-dependent siderophore 
receptor (RS04670) and predicted siderophore biosynthesis protein SbnG (RS04700). 
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Figure 3.11. Comparison of the achromobactin biosynthetic cluster of (A) P. syringae pv. 
syringae B728a, including gene nomenclature proposed by Berti and Thomas [61] and (B) 
putative achromobactin biosynthetic cluster of P. agarici NCPPB 2472. Gene labels are 
adjacent to their respective ORFs. Figure generated using Microsoft PowerPoint.  
 
 
3.3.6      Phage resistance systems  
 
The genome of P. agarici was found to contain a single CRISPR-associated repeat region, 
between 1180063-1181413 bp on the positive strand. The P. agarici CRISPR/Cas system was 
identified as comprising of a cluster of 6 Type I-F CRISPR-associated proteins located 
downstream of the repeat region, outlined in Table 3.11.  
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Table 3.11. Predicted CRISPR-associated proteins of P. agarici NCPPB 2472. 
 
Location: Locus Tag: Gene:  Protein ID: 
1171497-1172474 RS05180 Type I-F CRISPR-associated 
endonuclease Cas1 
WP_060782314.1 
 
1172471-1175881 RS05185 
 
Type I-F CRISPR-associated 
helicase Cas3 
WP_060782315.1 
 
1175960-1177330 
 
RS05190 
 
Type I-F CRISPR-associated 
protein Csy1 
WP_060782316.1 
 
1177323-1178306 
 
RS05195 
 
Type I-F CRISPR-associated 
protein Csy2 
WP_060782317.1 
 
1178340-1179365 
 
RS05200 
 
Type I-F CRISPR-associated 
protein Cas7f/Csy3 
WP_060782318.1 
 
1179369-1179932 
 
RS05205 
 
Type I-F CRISPR-associated 
endoribonuclease Cas6/Csy4 
WP_060782319.1 
 
 
 
The Cas proteins identified in Table 3.11 are characteristic of a Type 1 Subtype I-F CRISPR 
system, similar to that reported in Pseudomonas aeruginosa PA14 by Rollins et al. [239], 
which require a CRISPR RNA-guided surveillance complex (also known as a Csy complex), 
in this case formed of the proteins RS05190-RS05205, to recruit the Cas2/3 (RS05185) trans-
acting nuclease for degradation of the target DNA.  
 
The repeat consensus sequence associated with the CRISPR region was identified as being 
28bp in length composed of the sequence: GTTCACTGCCGTATAGGCAGCTCAGAAA.  
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In total 34 spacer regions were identified of 32bp in length which are shown in Table 3.12.   
 
Table 3.12. CRISPR-associated repeat region spacer sequences of P. agarici NCPPB 2472. 
 
No (5’-3’): Sequence 
1 TCGCGGATTGGATGGATTAGCGGTAGACGCCC 
2 TGCCGTCAGCGCTAACACCATTCAGAACGCGT 
3 ACTTGAGCCCGGCGAAATTGTGCACCACAAAA 
4 ATGCCGCGGTCTGAACCAGCGTTGCTTGAAGG 
5 TGCCAGTAATCGGCTAAGCGGTAGTGCATCGG 
6 TACTACCGGCGACCCAGTAACCGATGGTATCC 
7 GGTTAAAAGGATGATCCTTTTGATCTTGGTAT 
8 TCCTTGCGAATCGCGGGTTGGAGTACCACACG 
9 ATAAATCCAGCAACACCAGAAGGCCCGGCTCT 
10 TATCTGCGCGAGGAAAGCAGCTATACGCAGCC 
11 TGCTGGAGATTAAATAATGACTGGTAATAACT 
12 TCAACGTCGCCGGCTTCTTCATGAATGCCGAC 
13 TTGGTGGTGTCCAGTGGGATGCGCAACTGTTG 
14 TTCAGGCGGGGCGCCAAACGCTGACGCCCTAC 
15 GCATCGCCTACTTTGCGCACGGCGGTCAATAC 
16 ACCACGTTCAAGAGCTGTTGCAGGGCGTCTCG 
17 TTGTCGACGAACCACATTTGCCCCCACAGATC 
18 ATACGGCGGACTTCGCTGCCCATTCCGGTTGC 
19 GCCGAGAGCATCGACATTATTGAAGCACTGGG 
20 TGAACGCCGCAGCCAAGTCGATGAAGCTCATG 
21 GCGAAGGCCGCAGGCGAGATAGTCATGTGGCAT 
22 TTTGCACTGGCTTGAGATACTCCTGCCAAACC 
23 GGAGTACACGCAGGACGCTGTGGTCACGACTGA 
24 TTCACCTCAAACTCGCCCTGGATCTCATCCAT 
25 TTCCGTCGGCTCCGGACATCCCTACGGACTCGA 
26 TTCACCGCTCAGTCGGTCAAGGCTCTGACCAA 
27 TGGCCGACGGCTCGTCATCGTCGCCTGGAAGG 
28 AGGCCATGAACAAGAAAAACGTTCAACTCAAG 
29 AAGAAAGGCAAGAAGGGCAAGAAGGGTGGACG 
30 GTCGGGCTCAGCGATCAAAACAACTTCAGGAC 
31 TGGGATCGCGAGATTGAAGCGCACGCCTTCAC 
32 GAAACGAAGCGCGATTTGTCTGGCATGAGCCT 
33 GTGATGGTTGAGCCGGCACGACCGCGCTGACC 
34 TCGGGTGCGCGGGGTGGTGAAGCTACCCCACA 
 
 
Only one spacer sequence, No. 34, showed any nucleotide identity to a known sequence as 
identified by BLASTN [253], although a single base substitution was present of the first G to 
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an A in the matched sequences. Three matches were found corresponding to plasmid 
sequences; a plasmid present in P. frederiksbergensis strain AS1, P. fluorescens strain PC20 
(plasmid pNAH20) and P. putida NCIB 9816-4 (plasmid pDTG1) and the single base pair 
substitution was conserved in all matches. These plasmids were found to encode naphthalene 
degrading enzymes, including the plasmid originating from P. frederiksbergensis strain AS1 
which has been demonstrated to be a naphthalene-degrading bacterium [277]. None of the 
spacer regions showed similarity to the sequences of the phage identified during this study.  
 
Restriction Endonuclease Systems  
 
In total 7 ORFs that were predicted to encode restriction endonucleases were identified within 
the P. agarici 2472 genome. These are outlined in Table 3.13.  
 
Table 3.13. Predicted restriction endonuclease proteins of P. agarici NCPPB 2472.  
 
Protein:  Start: End: Locus Tag: 
Restriction endonuclease <1266141 
 
1266375 
 
RS05570 
 
Restriction endonuclease subunit R 1277574 
 
1280486 
 
RS05645 
 
Restriction endonuclease 4212986 
 
4213897 
 
RS18565 
 
Type I restriction endonuclease subunit R 4213907 
 
4217116 
 
RS18570 
 
Restriction endonuclease subunit S 4217117 
 
4217992 
 
RS24540 
 
Restriction endonuclease subunit S 4239877 
 
4241145 
 
RS18660 
 
Type I restriction endonuclease subunit R 4242778 
 
4245888 
 
RS18670 
 
 
 
Of these 7 ORFs, 3 were predicted to encode the restriction (R) subunits (RS05645, RS18570, 
RS18670) and 2 to encode the specificity (S) subunits (RS24540, RS18670).  
Two SAM-dependent DNA methyltransferase encoding ORFs were identified that are 
associated with 4 of the restriction endonuclease ORFs identified, one (RS18580) which is 
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associated with the restriction endonuclease subunits RS18565 and RS18570, and a second 
(RS18665) which is located between the S and R restriction endonuclease subunits RS18660 
and RS18670.  
 
 
Alginate 
 
I have identified an operon comprised of 12 genes within the genome of P. agarici 2472, shown 
in Table 3.14, hypothesised to be involved in the production of alginate.  
All 12 ORFS within this operon are orthologous to the 12 proteins (AlgD, Alg8, Alg44, AlgK, 
AlgE, AlgG, AlgX, AlgL, AlgI, AlgJ, AlgF, and AlgA) required for alginate production and 
export in Pseudomonas [276].  
 
Table 3.14. Predicted alginate biosynthesis proteins of P. agarici NCPPB 2472. 
 
ORF 
No. 
Predicted Function: Locus Tag: Ortholog: 
1 GDP-mannose 6-dehydrogenase RS03600 AlgD 
2 glycosyl transferase RS03595 Alg8 
3 alginate biosynthesis protein Alg44 RS03590 Alg44 
4 alginate biosynthesis protein RS03585 AlgK 
5 alginate biosynthesis protein AlgE RS03580 AlgE 
6 poly(beta-D-mannuronate) C5 epimerase RS03575 AlgG 
7 alginate O-acetyltransferase RS03570 AlgX 
8 mannuronate-specific alginate lyase RS03565 algL 
9 poly(beta-D-mannuronate) O-acetylase RS03560 AlgI 
10 alginate O-acetyltransferase RS03555 AlgJ 
11 alginate O-acetyltransferase RS03550 AlgF 
12 
mannose-1-phosphate guanylyltransferase/mannose-
6-phosphate isomerase RS03545 AlgA 
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3.4      Pseudomonas sp. NS1(2017)  
 
The strain that I have provisionally named ‘Pseudomonas sp. NS1(2017)’ was first identified 
from plate counts of P. tolaasii washed from the surface of Agaricus bisporus mushrooms 
showing no previous symptoms of disease, where it was found to both bear a strikingly similar 
colony morphology to P. tolaasii and to rapidly outgrow P. tolaasii NCPPB 2192T cultures on 
KB agar, further analysis revealed it to also be Gram negative.   
 
 
Figure 3.12. Streak plate of Pseudomonas sp. NS1 on KB agar after 72 hours at 28C.  
 
 
Pseudomonas sp. NS1 was observed to produce a fluorescent pigment on KB agar similar to 
that of P. tolaasii, as shown in Figure 3.12. It was hypothesised from the plaque morphology 
and Gram staining results that P. sp NS1 may be a member of the fluorescent Pseudomonads 
or potentially a faster growing strain of P. tolaasii and so further investigation was undertaken.  
 
3.4.1      Phylogeny  
 
To infer the phylogenetic relationship of Pseudomonas sp. NS1 among the Pseudomonas genus 
and assist in taxonomic placement, a Maximum-Likelihood analysis was performed on the 
DNA sequence returned from whole-genome sequencing using 5 housekeeping genes (23s 
rlmJ, 16S rrs, rpoD, gyrB and rpoB) of 14 Pseudomonas strains, as well as E. coli K12 for 
 120 
rooting the phylogenetic tree, using the Tamura-Nei model [261]. The final tree with the 
highest log likelihood (-55462.6960) is shown in Figure 3.13.  
 
 
Figure 3.13. Molecular phylogenetic analysis of Pseudomonas sp. NS1 (highlighted) by 
Maximum Likelihood method. The percentage of trees in which the associated taxa clustered 
together is shown next to the branches. The tree is drawn to scale, with branch lengths measured 
in the number of substitutions per site. The analysis involved 15 nucleotide sequences. Codon 
positions included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing 
data were eliminated. There were a total of 9210 positions in the final dataset. Evolutionary 
analyses were conducted in MEGA6.06. 
 
As shown in Figure 3.13, Pseudomonas sp. NS1 is clustered among members Pseudomonas 
azotoformans species, however it is on a separate branch to the closely related P. azotoformans 
S4. It is therefore likely that P. sp NS1 forms part of the P. fluorescens lineage of the P. 
fluorescens complex of the Pseudomonas intrageneric cluster II as reported by Yamamoto et 
al. [272]. 
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3.4.2      Sequencing and genome organisation 
 
In total, the Illumina MiSeq full genome sequencing run performed by Source Bioscience of 
P. sp NS1 returned 527.6 Mbases with a coverage of approximately 75 fold. The reads were 
assembled in to 546 contigs by Source Bioscience, with a total sequence length of 7,069,489 
bp. The contigs returned by Source Bioscience were mapped to the genome of Pseudomonas 
azotoformans S4 using CONTIGuator 2.7.4 [251] which returned 83 contigs, containing a total 
of 6,702,516 bp. The final mapped contigs were aligned to the genome using ACT, the results 
are shown in Figure 3.14.  
 
 
Figure 3.14. Alignment of Pseudomonas sp NS1 contigs (B.) to the genomic sequence of 
Pseudomonas azotoformans S4 (A.), figure generated by CONTIGuator 2.7.4 [251]. 
 
 
As is evident in Figure 3.14, the mapped contigs of P. sp NS1 and P. azotoformans S4 show 
large areas of collinear similarity, as indicated by red bars, this is borne out by the total 
nucleotide identity as determined by BLASTN [253] of 98% over 84% of the total assembled 
genome.  
 
The returned contigs, in a single scaffold, were annotated using the NCBI Prokaryotic Genome 
Annotation Pipeline, the full results are available under the accession code CP022960.  
Of the 6,241 ORFs identified, 6,073 were identified as being protein coding and 72 RNA 
encoding genes were identified; including 60 tRNAs, 8 complete rRNAs (5S, 16S, 23S) and 4 
ncRNAs. The total gene count is lower than the count of the closely related P. azotoformans 
S4 (6,241 vs. 6,324) and P. fluorescens LMG 5329 (6,241 vs. 6,429), correlating with the lower 
overall genome size.  
A.
B.
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Table 3.15. Comparison of the genomes and predicted genes of P. sp NS1, P. azotoformans 
S4 and P. fluorescens LMG 5329. 
 
Strain  Total 
(bp) 
ORFs Encoding Genes 
(RNA) 
tRNA rRNA ncRNA GC 
(%) 
NS1(2017)  6,702,516 6,241 6,073 72 60 8 4 61.08 
S4 6,859,618 6,324 5,991 94 70 19 5 60 
LMG 5329 6,870,020 6,429 6,216 63 57 2 4 60.5 
 
 
A full circular genome map was created using the DNAPlotter function of Artemis v16.0.0.1 
in order to visualise the returned data and is shown in Figure 3.15. 
 
To further aid in taxonomic classification and to calculate the probability that P. sp NS1 was a 
strain of either P. azotoformans or P. fluorescens the full draft genome was analysed using the 
JSpecies [278] work package. The results of the pairwise comparison of the draft genome of 
P. sp NS1 using average nucleotide identity showed that it was most closely related to P. 
fluorescens LMG 5329 and P. azotoformans S4 with scores of 93.43% and 93.32% respectively 
(TETRA score 0.99858 and 0.99892 respectively). Full results of all analysis conducted are 
available in Appendix 4 Tables Ap4.2 and Ap4.3.  
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Figure 3.15. Circular map of the Pseudomonas sp. NS1 genome with the genes encoded on 
the positive strand in the first lane (grey), the negative strand in the second lane (blue) and the 
tRNA genes in the third lane (green). The deviation in GC content from the total average is 
illustrated in the centre circle with yellow bars denoting an above average content and purple 
bars, a below average GC content. Figure generated using DNAPlotter function of the Artemis 
v16.0.0.1 genome browser. 
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3.4.3      Secondary metabolites and NRPSs 
 
In total 10 complete or partial NRPSs were identified within the genome of P. sp NS1, with 8 
of these located in two distinct clusters. A NRPS containing biosynthetic gene cluster 
containing 6 whole and partial NRPSs as shown in Table 3.16, was predicted by antiSMASH 
v3.0 [262] to potentially produce the lipopeptide poaeamide. 
 
Table 3.16. Predicted proteins of the WLIP production cluster 2 of P. sp. NS1.  
 
ORF 
No. Predicted Function:  Locus Tag: 
1 MATE family efflux transporter CI807_19185 
2 TetR/AcrR family transcriptional regulator CI807_19190 
3 MFS transporter CI807_19195 
4 toxin-antitoxin system HicB family antitoxin CI807_19200 
5 type II toxin-antitoxin system HicA family toxin CI807_19205 
6 non-ribosomal peptide synthetase CI807_19210 
7 peptide synthase CI807_19215 
8 non-ribosomal peptide synthetase CI807_19220 
9 non-ribosomal peptide synthetase CI807_19225 
10 non-ribosomal peptide synthetase CI807_19230 
11 TonB-dependent siderophore receptor CI807_19235 
12 cyclic peptide transporter CI807_19240 
13 N(5)-hydroxyornithine transformylase PvdF CI807_19245 
14 chromophore maturation protein PvdO CI807_19250 
15 aminotransferase CI807_19255 
16 peptidase M19 CI807_19260 
17 PvdJ/PvdD/PvdP-like protein CI807_19265 
18 non-ribosomal peptide synthetase CI807_19270 
19 non-ribosomal peptide synthetase CI807_19275 
20 macrolide transporter subunit MacA CI807_19280 
21 MacB family efflux pump subunit CI807_19285 
22 LuxR family transcriptional regulator CI807_19290 
23 methionine gamma-lyase CI807_19295 
24 Lrp/AsnC family transcriptional regulator CI807_19300 
 
However, BLASTN [253] analysis of the NRPSs within the cluster showed that it has a 
significantly higher nucleotide identity to the lipopeptide production system gene cluster for 
white line-inducing principle (WLIP) of Pseudomonas fluorescens strain LMG 5329 cluster 2. 
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This would indicate that it is more likely this gene cluster encodes the WLIP, a lipopeptide of 
the viscosin group, than poaeamide [279].  
 
A second NRPS (CI807_26350) similarly identified by antiSMASH v3.0, when analysed by 
BLASTN [253] showed significant nucleotide identity to the WLIP production cluster 1 of 
Pseudomonas fluorescens LMG 5329. However, small amino acid differences in the sequence 
of the NRPSs can confer significant changes in function of the final peptide, therefore sequence 
alone is not enough to conclude that these NRPS clusters produce WLIP [279].  
 
Further in silico analysis showed that the NRPSs in the initial cluster, as shown in Table 3.16, 
not only showed nucleotide identity, but also a conserved pattern of gene encoding ORFS when 
compared to the WLIP production cluster 2 of Pseudomonas fluorescens strain LMG 5329. A 
direct visual comparison of gene organisation in the identified cluster of Pseudomonas sp. NS1 
and the WLIP production cluster 2 of Pseudomonas fluorescens strain LMG 5329 is shown in 
Figure 3.16. 
 
 
 
Figure 3.16. Diagram of gene organisation of WLIP production cluster 2 of A) Pseudomonas 
sp. NS1 and B) Pseudomonas fluorescens strain LMG 5329; NRPSs illustrated in grey, 
‘Nx100’ regions illustrated in red, ORFS 1-5 of P. sp NS1 illustrated in green, ORFS 11-17  of 
P. sp NS1 in blue and ORFS 20-24 of P. sp NS1 in orange with their corresponding orthologs 
in B) highlighted using the same colour scheme. Figure generated using Microsoft PowerPoint.  
 
The first NRPSs within the cluster (ORFS 6-10) are incomplete due to regions of 100 N’s 
inserted during the assembly of the contigs are shown in Figure 3.16, line A. as red bars and 
appear to be fragmented parts of the 3 large NRPSs found in P. fluorescens LMG5329 in Figure 
3.16 B.  
A.
B.
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The ORFS 18 and 19 in Table 3.16, was predicted to putatively encode the WLIP synthetase 
B and C respectively. ORF 18 (CI807_19270) shows 97% amino acid identity to the WLIP 
synthetase B NRPS of P. fluorescens LMG 5329 and ORF 19 (CI807_19275) shows 96% 
amino acid identity to WLIP synthetase C NRPS of P. fluorescens LMG 5329. As shown in, 
Figure 3.16, ORFS 18 and 19 are flanked by pyoverdine synthesis genes upstream (illustrated 
in blue) and macrolide transporters downstream (illustrated in orange) an organisation pattern 
which has been identified by Rokni-Zadeh et al. [279] to be conserved in both the WLIP NRPS 
system of P. fluorescens strain LMG 5329 and the viscosin system of Pseudomonas fluorescens 
SBW25. 
 
In order to determine if Pseudomonas sp. NS1 produced WLIP, P. sp NS1 was cultured 
alongside P. tolaasii 2192T; a distinct white precipitate formed within the agar, shown in 
Figure 3.17, which confirms that the biosynthetic gene clusters identified most likely encode 
the NRPS system for WLIP production rather than any other of the viscosin-related 
nonapeptides.  
 
Figure 3.17. Co-culturing of P. tolaasii NCPPB 2192T, left of image, and Pseudomonas sp. 
NS1, right of image, on KB agar after 72 hours showing white co-precipitate of tolaasin and 
WLIP. 
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3.4.4      Phage resistance systems 
 
Alginate  
 
Similar to both P. tolaasii 2192T and P. agarici 2472, an operon predicted to encode the genes 
required for alginate biosynthesis was identified within the genome of P. sp. NS1 that could 
possibly act to mask cell surface receptors from phage. In comparison to the operon in P. 
agarici which contained predicted proteins orthologous to the 12 proteins required for alginate 
synthesis, the operon in P. sp. NS1 contains 13 predicted proteins, shown in Table 3.17, and 
lacks a protein orthologous to AlgE but also contains an additional hypothetical protein in ORF 
position 12.  
 
Table 3.17. Predicted alginate biosynthesis proteins of P. sp. NS1. 
 
ORF 
No. 
Predicted Function: Locus Tag: Ortholog: 
1 nucleotide sugar dehydrogenase CI807_11825 AlgD 
2 glycosyl transferase CI807_11820 Alg8 
3 hemolysin D CI807_11810 Alg44 
4 alginate biosynthesis protein CI807_11805 AlgK 
5 transcriptional regulator CI807_11800 / 
6 poly(beta-D-mannuronate) C5 epimerase CI807_11795 AlgG 
7 alginate O-acetyltransferase CI807_11790 AlgX 
8 mannuronate-specific alginate lyase CI807_11785 AlgL 
9 MBOAT family protein CI807_11780 AlgI 
10 alginate O-acetyltransferase CI807_11775 AlgJ 
11 alginate O-acetyltransferase CI807_11770 AlgF 
12 hypothetical protein CI807_11765 / 
13 mannose-1-phosphate 
guanylyltransferase/mannose-6-phosphate 
isomerase CI807_11760 AlgA 
 
 
 
Restriction Endonuclease Systems  
 
No CRISPR-associated repeats or proteins were identified in within the genome of P. sp. NS1, 
however 4 predicted restriction endonuclease proteins were identified, as shown in Table 3.18. 
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Table 3.18.  Predicted restriction endonuclease proteins of P. sp. NS1.  
 
Protein:  Start: End: Locus Tag: 
restriction endonuclease subunit M 3169222 3170016 CI807_15035 
restriction endonuclease subunit S 4531120 4531992 CI807_21265 
restriction endonuclease (McrC) 5903408 5904724 CI807_27500 
restriction endonuclease (McrB) 5904721 5906754 CI807_27505 
 
The third and fourth proteins (CI807_27500 and CI807_27505) contain McrC and McrB 
conserved domains respectively, the McrB conserved domain is associated with the GTP-
binding regulatory subunit of the methylcytosine specific McrBC restriction endonuclease of 
E. coli K-12 [273]. As the McrBC restriction endonuclease cleaves foreign methylated DNA, 
it does not possess an associated methyltransferase [280].  
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3.5      Discussion 
 
The Pseudomonas genus is large, complex, and rapidly expanding, with a current total of 238 
species and 18 subspecies recognised and published in the List of Prokaryotic Names with 
Standing in Nomenclature [281]; a significant increase from 144 species and 10 subspecies 
recognised in 2014 [282]. Since the genus was first described in 1894 [283] based on 
morphology and metabolism, the taxonomic status has undergone many revisions with the 
advent of new technologies, such as the use of nucleic acid homologies [284] and 16S rRNA 
gene sequences [13, 23].  
 
The use of 16S rDNA (rrs gene) alone to resolve phylogenetic relationships, however, is 
limited for a variety of reasons. These include the intraspecies heterogeneity of rrs sequences 
frequently resulting from multiple copies of the rrs gene within a genome [285], which can 
impact the accuracy of sequencing; and also the lack of rrs sequence diversity within closely 
related strains or even species due to the slow evolution of the rrs gene [286].  
 
Instead, a multilocus sequence analysis (MLSA) method using several genes of varying rates 
of evolution, including protein encoding genes that are reported to evolve faster than rRNA 
[287], can be used to infer phylogeny. It has previously been demonstrated that the 
housekeeping genes rrs, gyrB and rpoD are suitable candidates for accurate phylogenetic and 
taxonomic analysis for both Pseudomonads and other bacterial genus [272, 288, 289].  
 
For this study, a single concatenated sequence comprised of a single rRNA gene, rrs, as well 
as the rpoD, rpoB, RlmJ and gyrB genes was used to provide both a slow-evolving rDNA 
sequence and fast-evolving protein-encoding DNA sequence to most accurately analyse the 
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phylogenetic relationship of P. tolaasii 2192T both among the Pseudomonas genus and within 
other closely related P. tolaasii strains. 
 
The gyrB gene encodes one of two subunits (gyrA/gyrB) of the prokaryotic DNA gyrase 
protein, which is responsible for general DNA supercoiling as well as chromosome partitioning 
and is ubiquitous among bacteria [290]. The rpoD gene encodes the RNA polymerase σ70 
factor, that allows promoter-specific transcription initiation of RNA polymerase [291]. The 
rpoB gene encodes the β-subunit of the DNA dependent RNA polymerase [292]. The RlmJ 
gene encodes the methyltransferase RlmJ which catalyses the methylation of 23S rRNA during 
ribosome biogenesis and is ubiquitous among bacteria [293].  
 
In the case of P. tolaasii 2192T, the results of the phylogenetic analysis shown in Figure 3.2 
agree with the phylogeny reported by Yamamoto et al. [272] which utilised a more limited 
gene selection (gyrB and rpoD alone); with P. tolaasii 2192T clustering with the closely related 
P. azotoformans and P. fluorescens which are all members of the Pseudomonas intragenic 
cluster II,  P. fluorescens complex, P. fluorescens lineage. However, it is unusual that P. 
tolaasii 2192T is located on a separate branch to P. tolaasii 6264 and PMS117 indicating, as 
previously mentioned, that it may have diverged earlier from the other members of the P. 
tolaasii species. Likewise, with P. agarici NCPPB 2472 the phylogenetic results attained in 
this study, shown in Figure 3.5, confirm the previous work on phylogenetic relationships of P. 
agarici strains by Yamamoto et al. [272]; with P. agarici NCPPB 2472 showing tight 
clustering with P. agarici strains NCPPB 2280 and LMG 2112 in a monophyletic branch within 
the P. chloroaphis lineage, itself within the P. fluorescens complex of the Pseudomonas 
intrageneric cluster II. 
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The agreement of the results of the phylogenetic analysis in this study of both P. tolaasii 2192T 
and P. agarici NCPPB 2472 with the results previously published by Yamamoto et al. [272] 
increases confidence in the results of the analysis performed on P. sp. NS1, shown in Figure 
3.13, which show that P. sp. NS1 clusters with members of the P. azotoformans species, within 
part of the P. fluorescens lineage of the P. fluorescens complex of the Pseudomonas 
intrageneric cluster II as reported by Yamamoto et al. [272]. To further aid in taxonomic 
classification and to calculate the probability that P. sp. NS1 was a strain of either P. 
azotoformans or P. fluorescens the full draft genome was analysed using the JSpecies [278] 
work package, a form of in silico DNA-DNA hybridisation, which identified that P. sp. NS1 
was most closely related to P. fluorescens LMG 5329 and P. azotoformans S4, with scores of 
93.43% and 93.32% respectively (TETRA score 0.99858 and 0.99892 respectively). From this 
we can deduce that it is likely that P. sp. NS1 is a novel strain of either the P. azotoformans or 
P. fluorescens species.  
 
In order to fully characterise the Pseudomonas species used in this study at the genetic level, 
full genome sequencing was performed, and the returned sequences assembled in to scaffolds 
based on mapping of the contigs returned by Source Bioscience to closely related species. In 
the case of P. agarici NCPPB 2472, contig mapping was performed utilising both P. agarici 
NCPPB 2289 and P. fluorescens A506, to provide two data sets from which to design PCRs in 
order to confirm contig ordering and ‘stitch’ the remaining contig junctions with sequence from 
amplified inter-contig regions. The initial contig mapping to both P. fluorescens A506 and P. 
agarici NCPPB 2289, illustrated in Figures 3.6 and 3.7 shows that P. agarici NCPPB 2472 
shares significantly larger areas of collinear similarity with P. agarici NCPPB 2289. However, 
during the process of stitching these contigs via PCR and Sanger sequencing the resultant 
products, the results of which are shown in Figures 3.9 and 3.10, it was clear that the reactions 
 132 
based on contig mapping to P. fluorescens A506 returned a larger number of significantly 
clearer bands on agarose gel than the reactions based on the contig mapping to P. agarici 
NCPPB 2289. This is further evident in the number of the reactions that returned valid 
sequencing data, with the reactions based on mapping to P. fluorescens A506 returning 8 
sequenced products from 30 reactions (26%), compared to 3 sequenced products from the 46 
reactions based on alignment to P. agarici NCPPB 2289 (7%). Difficulties were encountered 
due to a large number of self-priming primers during the contig stitching PCRs, possibly due 
to the presence of inverted repeats within the contig junction sequence. The results of the contig 
stitching PCRs would appear to show that the genome arrangement of P. agarici NCPPB 2472 
is more similar to that of P. fluorescens A506 than to the closely related strain P. agarici 
NCPPB 2289, despite the larger regions of collinear similarity.  
 
The assembled genomic sequences of P. tolaasii 2192T, P. agarici NCPPB 2472 and P. sp. 
NS1 were then mined for potential biosynthetic gene clusters involved in the production of 
virulence factors, including toxins such as tolaasin [44], or siderophores such as pyoverdines 
[33]. Likewise, the genomic sequences were analysed for phage resistance mechanisms that 
may impede the use of bacteriophage as a potential treatment of infections of Agaricus bisporus 
mushrooms caused by either P. tolaasii or P. agarici.   
 
Within the genome of P. tolaasii NCPPB 2192T I identified 6 ORFS, shown in Table 3.2, with 
significant amino acid identity (72-86%) to the proteins TaaA-TaaE of P. costantinii which 
have been demonstrated by Scherlach et al. [50] to be involved in the production of Tolaasin 
I. P. tolaasii NCPPB 2192T has been reported to produce Tol I Tol II and Tol A-E by Bassalero 
et al. [47], therefore we can conclude that based on the amino acid identity and the similarities 
in gene organisation outlined that is likely the NRPSs identified in Table 3.2 are involved in 
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the production of Tolaasin I. However, the biosynthetic cluster identified by Scherlach et al. 
[50] occurs as a single cluster whereas the NRPSs identified in this study are located 
sporadically throughout the genome of P. tolaasii 2192T and also include at least one NRPS 
that has been incorrectly assembled (RS02650); it is likely that this is due to errors in the initial 
contig assembly stage of the full genome sequencing caused by the repetitive nature of NRPS 
sequence and that the NRPSs identified should occur as a single cluster.  
Similarly, two of the further NRPSs identified within the genome of P. tolaasii 2192T, 
RS16165 and RS16170 were initially split during in silico assembly of the returned contigs but 
were found to be likely to instead consist of a single large NRPS. This larger NRPS of 
approximately 1751 aa in total showed amino acid identity, as identified by BLASTP [253], to 
the known pyoverdine biosynthesis genes PvdJ of Pseudomonas syringae pv. daphniphylli and 
the pyoverdine sidechain peptide synthetase of P. fluorescens. Likewise, an ORF downstream 
of these NRPSs was also found to show amino acid identity to the PvdJ protein of P. aeruginosa 
62. Pyoverdines are fluorescent siderophores that are important virulence factors in many 
fluorescent Pseudomonas species [33, 294]. The presence of a TonB-dependent siderophore 
upstream of these putative NRPSs and their similarity to known pyoverdine synthesis proteins 
indicates this cluster is likely to be involved in the synthesis of pyoverdine or related 
chromophore.  
 
Within the genome of P. agarici NCPPB 2472 I identified the presence of multiple clusters of 
NRPSs, including a single large cluster comprised of 5 NRPSs outlined in Table 3.8, as well 
as two smaller clusters composed of a single NRPS each. However, it was not possible to 
predict the function of the NRPS containing biosynthetic gene clusters via in silico analysis of 
the nucleotide or amino acid composition, although it is likely that they produce a siderophore. 
However, a large biosynthetic cluster was identified within the genome of P. agarici NCPPB 
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2472, shown in Table 3.10, that is predicted to encode the proteins involved in the synthesis of 
the siderophore achromobactin. Achromobactin production was first identified by Munzinger 
et al. [295] in the bacterium formally known as Erwinia chrysanthemi (now Dickeya dadantii 
[296]), as a siderophore derived from the precursor citrate. Berti and Thomas [61] reported in 
2009 that P. syringae pv. syringae B728a is capable of achromobactin synthesis and that it is 
produced via NRPS-independent synthetases; demonstrating that the enzymes AcsD, AcsA and 
AcsC are capable of converting citrate to achromobactin. They have likewise demonstrated 
that a 12 ORF region of the P. syringae pv. syringae B728a genome is responsible for the 
biosynthesis of achromobactin [61]. I have identified a biosynthetic gene cluster in P. agarici 
NCPPR 2472, as shown in Table 3.10, that is predicted to encode the enzymes required for 
achromobactin synthesis (AcsD, AcsA and AcsC). This gene cluster shows striking similarity 
in ORF organisation to the cluster of P. syringae pv. syringae B728a, as shown in Figure 3.11, 
as well as a high degree of amino acid identity between the predicted gene products, ranging 
from 72-91% (by comparison the amino acid identity between the achromobactin synthesis 
proteins of P. syringae pv. syringae B728a and Dickeya dadantii is reported as between 64-
72% [61]). I therefore suggest that P. agarici NCPPB is likely to produce the siderophore 
achromobactin under iron-limited conditions. Both Dickeya dadantii and P. syringae pv. 
syringae B728a produce a second siderophore in addition to achromobactin, in the case of 
Dickeya dadantii this is chrysobactin and for P. syringae pv. syringae B728a it is pyoverdine 
[61, 295, 297]. It has been suggested that in both cases that the primary siderophore, 
achromobactin, is required for epiphytical growth and that their secondary siderophores are 
reserved for active infection [61, 298, 299]. It is therefore possible that one of the identified 
NRPS clusters of P. agarici NCPPB 2472 is involved in production of a siderophore, such as 
pyoverdine, utilised in active infection of Agaricus bisporus and that the predicted 
achromobactin siderophore is utilised during non-infective growth in the environment.  
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Within the genome of P. sp NS1 I identified 10 complete or partial NRPSs, 8 of which reside 
in two distinct clusters. A single cluster containing 6 NRPSs was identified, shown in Table 
3.16, which showed nucleotide identity to the WLIP production cluster 2 of Pseudomonas 
fluorescens strain LMG 5329. WLIP, a subtype of the viscosin-related nonapeptides [41], 
produces a precipitate in agar medium when a WLIP producing Pseudomonas strain is co-
cultured alongside a strain of tolaasin producing Pseudomonas tolaasii; however minor 
differences in amino acid sequence can confer significantly differing biological properties, for 
example viscosin, which differs from WLIP in only one amino acid residue fails to produce a 
precipitate when co-cultured alongside P. tolaasii [42].  
A second, ORFan, NRPS (CI807_26350) was identified that showed nucleotide identity to 
WLIP production cluster 1 of Pseudomonas fluorescens LMG 5329. It was then further 
identified that the 6 NRPS containing cluster with similarity to the WLIP production cluster 2 
of Pseudomonas fluorescens strain LMG 5329 also shared a conserved gene organisation, as 
illustrated in Figure 3.16, which has been identified by Rokni-Zadeh et al. [279] to be 
conserved in both the WLIP NRPS system of P. fluorescens strain LMG 5329 and the viscosin 
system of Pseudomonas fluorescens SBW25. 
 
The conserved gene organisation and further amino acid identity analysis which identified high 
levels of similarity between the NRPSs within the P. sp. NS1 cluster and the WLIP synthetases 
of P. fluorescens LMG 5329 led to the hypothesis that the identified gene cluster was likely to 
encode the proteins required for WLIP synthesis. This hypothesis was tested by co-culturing 
P. sp. NS1 alongside P. tolaasii 2192T, revealing a white precipitate as illustrated in Figure 
3.17, confirming that P. sp. NS1 is capable of WLIP production and that is most likely 
produced by the NRPSs and associated proteins identified in Table 3.16.  
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Although a wide variety of secondary metabolites involved in host colonisation and invasion 
by Pseudomonas species are produced by NRPS’s, many are produced by more traditional 
assembly routes; therefore, further biosynthetic clusters that may confer advantages on the host 
surface were identified and characterised, including putative phage tail-like bacteriocin (PTLB) 
encoding genes. PTLBs are bacteriocins of which there are three broad types, F, R and S [68]. 
Both the F and R type PTLBs resemble bacteriophage tail proteins, with the R type being most 
similar to contractile phage tails [300, 301] and the F type being flexible non-contractile rods 
similar to flexible phage tails [302] and are likely both of phage origin [303]. PTLBs are very 
common in Pseudomonas strains, with 90% P. aeruginosa strains being reported to produce 
either the F or R type [304]. Putative PTLB encoding operons were identified in both P. tolaasii 
2192T and P. agarici NCPPB 2472, shown in Table 3.3 and 3.9 respectively, with the operon 
for P. agarici NCPPB 2472 consisting of a total of 19 ORFs and the smaller operon for P. 
tolaasii NCPPB 2192T consisting of only 13 ORFs in comparison.  
 
As previously mentioned the genomes of P. tolaasii NCPPB 2192T, P. agarici NCPPB 2472 
and P. sp. NS1 were also mined for the presence of phage resistance genes that may prevent or 
hinder the possible use of bacteriophage in the treatment of Agaricus bisporus mushrooms.  
 
Within the genome of P. agarici NCPPB 2472 I have identified multiple phage resistance 
systems, including a complete CRISPR/Cas system. No confirmed CRISPRs or CRISPR-
associated proteins were identified in the genomes of the closely related P. agarici NCPPB 
2289, P. agarici LMG 2112 or within either of the genome sequences of P. tolaasii NCPPB 
2192T or P. sp. NS1. The Cas proteins of P. agarici NCPPB 2472 are characteristic of a Type 
1 Subtype I-F CRISPR system, Subtype I-F CRISPR systems have also been documented in 
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Pseudomonas aeruginosa PA14 [239], Pseudomonas aeruginosa strain UCBPP-PA14 [305], 
Pectobacterium atrosepticum [237] as well as certain strains of E. coli, where it was reported 
to be more frequently found in strains susceptible to antimicrobials, possibly due to interference 
in resistance plasmid acquisition [306]. The repeat consensus identified in P. agarici NCPPB 
2472 was 28bp in length and a total of 33 spacer regions were associated with the identified 
repeats. Of the 34 spacer sequences, only a single sequence showed any similarity to known 
sequence, as identified by BLASTN [253], with a single base pair substitution. This sequence 
corresponded to 3 plasmid sequences present in the Pseudomonas strains: P. frederiksbergensis 
strain AS1, P. fluorescens strain PC20 (plasmid pNAH20) and P. putida NCIB 9816-4 
(plasmid pDTG1). The identified plasmid sequences were found to encode naphthalene 
degrading enzymes, including the plasmid that was identified from P. frederiksbergensis strain 
AS1, which been demonstrated to be a naphthalene-degrading bacterium [277]. None of the 
spacer regions showed any nucleotide identity to the genomic sequences of any of the phage 
used in the course of our study.  
 
While only P. agarici NCPPB 2472 was identified as possessing a CRISPR/Cas system, all of 
the Pseudomonas strains I have sequenced and mined possessed restriction endonuclease 
systems, which are a well-documented method by which bacteria are able to resist phage 
infection [203].  
Within the genome of P. tolaasii 2192T several resistance endonucleases were identified, as 
shown in Table 3.4. The restriction endonucleases identified included a probable methylation-
dependent restriction endonuclease, RS17360, and a Type III restriction endonuclease, 
RS17410. This shows that P. tolaasii 2192T possesses defence mechanisms against phage 
infection, including by phages with previously methylated nucleotides. Similarly, within the 
genome of P. sp. NS1, two restriction endonuclease proteins (CI807_27500 and 
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CI807_27505), shown in Figure 3.18, were identified as containing McrC and McrB conserved 
domains respectively which are associated with the methylcytosine specific McrBC restriction 
endonuclease of E. coli K-12 [273]; indicating that similar to P. tolaasii NCPPB 2192T, P. sp 
NS1 is capable of cleaving previously methylated nucleotides. In comparison while multiple 
restriction endonucleases were identified within the genome of P. agarici NCPPB 2472, shown 
in Table 3.13, including two Type I restriction endonuclease R subunits (RS18570 and 
RS18670), no methylation-dependent restriction endonucleases were identified.  
 
A second potential phage resistance system was likewise identified in all three Pseudomonas 
species in this study, alginate. As previously mentioned, while not a specific phage resistance 
system, alginate can act to mask host receptors from phage and therefore can offer an advantage 
to the producing bacterium [200]. For P. tolaasii NCPPB 2192T a complete operon of 15 genes, 
shown in Table 3.5, was identified that was predicted to be involved in the production of 
alginate due to the presence of a gene encoding the alginate biosynthesis protein Alg44 
(RS11530), which has been demonstrated to be required for alginate biosynthesis in 
Pseudomonas aeruginosa [275] and AlgE, also reported to be involved alginate biosynthesis 
in Pseudomonas [276]. Within the genome of P. agarici NCPPB 2472 I have identified a 12 
ORF operon which is comprised of proteins orthologous to the 12 proteins (AlgD, Alg8, Alg44, 
AlgK, AlgE, AlgG, AlgX, AlgL, AlgI, AlgJ, AlgF, and AlgA) required for alginate production 
and export in Pseudomonas [276]. Therefore, it is highly likely that P. agarici NCPPB 2472 is 
capable of producing alginate. Similar to the operon of P. agarici NCPPB 2472, a cluster of 
13 genes was identified in the genome of P. sp NS1 that contains proteins orthologous to AlgD, 
Alg8, Alg44, AlgK, AlgG, AlgX, AlgL, AlgI, AlgJ, AlgF and AlgA, which are required for 
alginate production and export in Pseudomonas [276]; although unlike the operon identified in 
P. agarici NCPPB 2472, it lacks a protein orthologous to AlgE and also contains an additional 
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hypothetical protein in ORF position 12. However, the presence of 11 out of the 12 genes 
required for alginate production and export indicates this cluster is highly likely to be involved 
in the production of alginate in P. sp. NS1. 
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Chapter 4: 
Isolation and Identification of Bacteriophage 
Infecting P. agarici and P. tolaasii 
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4.1      Introduction 
 
While the previous chapter has characterised the P. tolaasii NCPPB 2192T and P. agarici 
NCPPB 2472 genomes, including the presence of multiple phage resistance mechanisms, this 
chapter will focus on the identification and characterisation of bacteriophage capable of 
overcoming these resistance factors and utilising the bacteria as hosts; with the aim of 
elucidating the genetic and molecular basis of phage and host interaction and the possible use 
of the whole phage or phage proteins in the treatment of Pseudomonas infections of Agaricus 
bisporus mushrooms.  
 
While the majority of phage research involving Pseudomonas species revolves around the 
human pathogen P. aeruginosa [34], some research has been performed on bacteriophage 
capable of infecting P. tolaasii, for example recently Kim et al. have isolated 21 environmental 
phage of P. tolaasii of varying lytic ability [74] . To date no research has been published on 
phage capable of infection P. agarici.  
 
To enable the characterisation of the interaction of the phage-host relationship it was first 
necessary to isolate phage capable of infecting the host bacterium from environmental sources. 
Water samples were taken from the River Thames at select locations, as well as environmental 
samples from locations within the University of Reading campus and untreated sewage water 
samples. From these samples, two bacteriophages capable of causing lysis on P. tolaasii 
NCPPB 2192T and P. agarici NCPPB 2472 plates were identified; the first, named 
Pseudomonas phage NV1 was capable of infecting P. tolaasii 2192T and the second, named 
Pseudomonas phage ϕNV3, was capable of infecting P. agarici NCPPB 2472.  
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4.2      Isolation and characterisation of Pseudomonas phage NV1  
 
4.2.1   Phage morphology 
 
To aid in initial phage classification and guide future characterisation of phage NV1, a phage 
isolated from River Thames water, TEM imaging was performed, the resultant electron 
micrograph is shown below in Figure 4.1. TEM was performed on clarified phage lysates with 
negative staining using uranyl acetate. 
 
 
Figure 4.1. Electron micrograph at 80 kV of phage NV1 virion morphology, showing the 
icosahedral head and short tail (arrow) characteristic of the Podoviridae.  
 
TEM was performed on clarified phage lysates with negative staining using uranyl acetate. 
From the presence of a tail in Figure 4.1 we can confidently identify phage NV1 as a member 
of the Caudovirales. The head of NV1 is approximately 58 nm (  0.76 SD) in diameter and 
the short tail is approximately 26 nm (2.6 SD) in length, no tail fibers were visible on any TEM 
images returned. The presence of the short stubby tail and icosahedral head suggest that phage 
NV1 is a member of the Podoviridae family of the Caudovirales order. 
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Phage NV1 plaque morphology on P. tolaasii plaque assay plates show very small zones of 
lysis (< 2 mm) with a hazy appearance. The host range of NV1 is narrow, as shown in Table 
4.1, being capable of only infecting P. tolaasii NCPPB 2192T of the 8 Pseudomonas strains 
tested.  
 
Table 4.1. Host range assay results of phage NV1. 
 
Strain:  NV1 
Infection 
P. tolaasii NCPPB 2192T + 
P. agarici NCPPB 2472 / 
P. sp NS1 / 
P. syringae pv. morsprunorum R1 5244 / 
P. syringae pv. syringae 9097 / 
P. syringae pv. morsprunorum R2 5255 / 
P. fluorescens Pfo-1 / 
P. aeruginosa 14207 / 
 
 
4.2.2      Sequencing and genome organisation 
 
The results of the TEM imaging of phage NV1 indicated that it belonged to the Podoviridae, 
a family of phage within Group I of the Baltimore classification scheme, and therefore most 
likely possessed a dsDNA genome. The genetic material of phage NV1 was extracted using a 
Norgen Biotek Phage DNA Isolation Kit, returning 75 l of DNA at a concentration 128.9 
ng/l as determined by NanoDrop 2000. The genomic DNA was sent for sequencing by 
Source Bioscience on an Illumina MiSeq, with paired-end reads of 300 bp. The returned 
sequence for NV1 was a single contig of 45,059 bp in length, with a coverage of 55.8x, 
BLASTN [253] analysis of the returned sequence showed NV1 was closely related to the 
Pseudomonas fluorescens phage UFV-P2 (84% Identity across 86% of the genome), which is 
illustrated in the dot matrix shown in Figure 4.2, and so the genome of NV1 was oriented to 
be collinear to that of UFV-P2. The complete genome of phage NV1 is available on GenBank 
with the accession code: MG845684.1. 
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Figure 4.2. Dot matrix view identifying regions of similarity based upon the BLASTN [253] 
alignment. Phage NV1 sequence is represented on the X-axis and the numbers represent the 
bases of the genome sequence. Phage UFV-P2 is represented on the Y-axis. Alignments are 
shown in the plot as lines. Positive strand and protein matches are slanted from the bottom left 
to the upper right corner, negative strand matches are slanted from the upper left to the lower 
right. The number of lines shown in the plot is the same as the number of alignments identified 
by BLASTN[253]. 
 
The dsDNA genome of NV1 is approximately 45,059 bp in length, which is slightly smaller 
than that of the closely related UFV-P2, at 45,517 bp, consequently NV1 encodes 64 predicted 
ORFs compared to the larger 75 of UFV-P2 [108]. 57 of the 64 encoding ORFs (89%) found 
in NV1 show significant amino acid identity to encoding ORFs identified in UFV-P2. The 
genome of NV1 has a slightly higher GC content at 52.87% than is reported for UFV-P2 at 
51.5% [108], however it shares a similar bidirectional organization, illustrated graphically in 
Figure 4.3 with the early host conversion genes as well as the viral DNA replication genes 
being located within the positive strand, with the exception of the putative phage holin. The 
putative late stage genes encoding proteins involved in virion structure and assembly are 
encoded in the negative strand. 
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Figure 4.3. Graphical plot of the genome structure of Pseudomonas phage NV1, with the early 
host conversion genes in green, the DNA replication genes in light blue, the virion structure 
genes in dark blue, hypothetical proteins in grey and the cell lysis proteins in purple. The 
deviation in GC content from the total average is illustrated in the centre circle with yellow 
bars denoting an above average content and purple bars illustrating a below average GC 
content. Figure generated using DNAPlotter function of the Artemis v16.0.0.1 genome 
browser. 
 
 
Of the 64 predicted ORF’s, only 25 showed amino acid similarity to proteins of known or 
predicted function as identified by BLASTP [253], these are shown in Table 4.2. The majority 
of those with predicted functions are those that are involved in virion structure, assembly and 
DNA packaging which show high levels of amino acid sequence conservation among other 
closely related phage.  
 
Similarly, the ORF’s encoding for the replication genes at NV1_p21, p24, p25, p29 and p33 
putatively encoding an ATP-grasp enzyme, DNA primase/helicase, holin and two exons of the 
phage DNA polymerase respectively show, not only a high degree of amino acid sequence 
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conservation among closely related phage strains, but a very high nucleotide identity to UFV-
P2 (78-88% Ident) and unusual organisation of a putative holin located between the exons of 
the DNA polymerase [108]. 
 
The early host conversion genes, however, show the least conservation both among closely 
related phage strains and between phage NV1 and UFV-P2; consequently, the function of most 
is not deducible from the amino acid sequences, a full table of predicted NV1 ORF’S is 
available in Appendix 3, Table Ap3.1.  
 
Table 4.2. ORFs of phage NV1 with BLASTP [253] similarity to proteins of known or  
predicted function. 
 
Locus 
Tag 
Start 
Position 
Size 
(aa) 
Total 
GC (%) 
Predicted Function (putative): 
NV1_p11 5060 276 57.04 SPFH domain-containing protein 
NV1_p18 9913 384 54.46 Amidoligase 
NV1_p19 11098 489 53.5 Glutamine amidotransferase 
NV1_p21 12926 291 54.45 ATP-grasp enzyme 
NV1_p24 14445 584 51.51 DNA primase/helicase 
NV1_p25 16138 183 49.28 DNA polymerase part I 
NV1_p29 17588 85 51.4 Holin 
NV1_p33 18725 546 53.12 DNA polymerase Family A  
NV1_p38 22125 294 52.84 5’-3’ exonuclease 
NV1_p40 23888 120 52.06 Endonuclease 
NV1_p44 25881 295 53.48 Phage structural protein 
NV1_p45 26779 1057 53.64 Phage structural protein 
NV1_p46 29959 571 54.21 Phage structural protein 
NV1_p47 31676 134 52.08 Phage structural protein 
NV1_p48 32077 366 53.17 Phage particle protein  
NV1_p49 32699 93 54.6 Phage particle protein  
NV1_p52 34147 514 50.29 Phage particle protein  
NV1_p53 35699 211 51.41 Tail fiber protein 
NV1_p56 36755 209 50.32 Phage structural protein 
NV1_p58 37759 317 52.2 Major capsid protein 
NV1_p59 38730 333 51.7 Scaffolding protein 
NV1_p61 39969 712 50.16 Phage portal protein 
NV1_p62 42086 481 50.76 Terminase large subunit  
NV1_p63 43535 179 50.56 Lysozyme 
NV1_p64 43962 157 47.05 Phage structural protein 
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A common feature of the Luz24likeviruses is the reported presence of localized single-stranded 
breaks associated with the consensus sequence 5’-TACT/RTGMC-3’, for example the genome 
of Pseudomonas putida Phage tf contains 14 single-strand interruptions in the positive strand 
[307] and the genome of phage UFV-P2 contains 15 on the positive strand  [108]. 
In total, 13 potential single-strand nick sequences were identified in NV1, all in positive strand, 
with consensus sequence 5’-TACTRTGAC-3’; therefore, it is likely that the genome of NV1 
contains single-stranded nicks similar to other Luz24likeviruses.  
 
 
4.2.3      Phylogeny 
 
To analyse the phylogenetic clustering of NV1 within the LUZ24likevirus genus, the entire 
genomic nucleotide sequence was aligned by MUSCLE [260] and all gaps were removed from 
the sequence. A maximum parsimony analysis was chosen to predict evolutionary history due 
to the small number of sequences and likelihood of nucleotide conservation between them and 
run using Mega6.06. The resulting phylogenetic tree is shown in Figure 4.4.  
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Figure 4.4. Maximum parsimony analysis of Pseudomonas phage NV1 (•). The most parsimonious tree with length = 105449 is shown. The 
consistency index is (0.561417) the retention index is (0.693657), and the composite index is 0.392642 (0.389431) for all sites and parsimony-
informative (in parentheses). The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 
replicates) are shown next to the branches [257]. The MP tree was obtained using the Subtree-Pruning-Regrafting (SPR) algorithm [258] with 
search level 1 in which the initial trees were obtained by the random addition of sequences (10 replicates). The tree is drawn to scale, with 
branch lengths calculated using the average pathway method [258]and are in the units of the number of changes over the whole sequence. The 
analysis involved 19 nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing 
data were eliminated. There were a total of 24899 positions in the final dataset. Evolutionary analyses were conducted in MEGA6.06 [256].
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The phylogenetic tree in Figure 4.4 confirms that NV1 and UFV-P2 are closely related and 
possibly of the same species, clustered together on an off-shoot of the branch most closely 
related to other phage of the Luz24likevirus genus of the Podoviridae family. Two 
phiKMVvirus phage were included in the analysis, Pseudomonas phage phi-2 and 
Pseudomonas phage phiKMV, which are located in a branch separate from the Luz24viruses 
towards the lower end of the tree. Likewise, the T7virus phages, Pseudomonas phage gh-1, 
Pseudomonas phage philBB-PF7A are located in a single branch closest to Enterobacteria 
phage T7 which was used to root the phylogenetic tree. A further phylogenetic analysis 
utilising only the large terminase subunit gene is available in Appendix 4, Figure Ap4.6, which 
confirms the results shown in Figure 4.4, with NV1 clustering closely with UFV-P2 and other 
Luz24likevirus members.  
 
4.2.4      Growth characteristics  
To characterise the ability of phage NV1 to lyse P. tolaasii a variety of kill curves were 
performed at different starting MOIs and over either 150 minutes, as shown in Figure 4.5, or 
700 minutes, as shown in Figure 4.6.  
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Figure 4.5. Growth curve of P. tolaasii infected with NV1 at a starting bacterial concentration 
of ~1x108 cfu/ml, incubated at 28C. Phage NV1 was added to the cultures at T=0 at an MOI 
of 1, 0.1, 0.01. Mean values of 10 replicates, error bars = +/- SEM.  
 
 
At an MOI of 1 after 50 minutes the OD dropped from 0.018 Abs to 0.011 Abs at 70-75 
minutes, a difference of 0.007 Abs, in comparison across the same time points at a MOI of 0.1 
there is a drop in OD of only 0.003 Abs. However, at a MOI of 0.01 the OD increases by a 
total of 0.007 Abs between 50 and 75 minutes. 
By 150 minutes the OD data in Figure 4.5 shows little change across all MOIs, however the 
final ODs vary greatly, at an MOI of 1 the final OD is 0.014 Abs, at an MOI of 0.1 the final 
OD is 0.025 Abs and at a MOI of 0.01 the final OD is 0.035 Abs; in comparison, the control 
OD at the final time point is significantly higher at 0.123 Abs. As OD is correlated with total 
bacterial cell count it is clear that the largest drop in bacterial cell count occurs at the highest 
MOI of 1 and that initial MOI correlates with the cell count at the final time point, with the 
largest MOIs demonstrating the lowest final ODs.  
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Figure 4.6. Growth curve of P. tolaasii infected with NV1 at a starting bacterial concentration 
of ~1x108 cfu/ml, incubated at 28C for 2 hours with a MOI of either 0.1, 0.001 or 0.001. OD 
at 595 nm was read every 5 minutes. Mean values of 10 replicates, error bars = +/- SEM. 
In order to determine the effectiveness of phage at lower MOI’s that would more accurately 
represent the conditions likely to occur on the surface of A. bisporus or within the casing soil 
layer a further set of kill curve experiments were performed as shown in Figure 4.6.  
At t=90 minutes the OD data for the MOI of 0.1 begins to deviate from the MOI of 0.001 which 
more closely matches the uninfected control in rate of OD increase. The rate of increase in OD 
of MOI of 0.1 begins to flatten at t=140 minutes at an OD of approximately 0.02 Abs, indicating 
that the rate of cell lysis is matching the rate of cell replication; the OD begins to once again 
rise beyond the t=250 minutes point and continues to rise before stabilising once again at 
around t=600 minutes, ending at an OD of approximately 0.18 Abs.  
The MOI of 0.01 roughly follows the rate of increase in OD of the control until t=160 minutes 
where it begins to flatten at an OD of approximately 0.03 Abs; similar to the MOI of 0.1, past 
t=250 minutes the OD begins to rise again, although it does not plateau towards the final time 
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point, it does however show a slowing in the rate of OD increase, ending at a final OD of 
approximately 0.35Abs.  
The lowest MOI of 0.001 only begins to flatten at t=195 minutes at an OD of approximately 
0.04 Abs, the largest OD of all MOI’s tested. However, past the t=250 time point, similar to 
both MOIs of 0.1 and 0.01 the OD begins to increase again across the remainder of the 
experiment, ending at a final OD of approximately 0.48 Abs.  
The uninfected control in contrast shows a steady rate of increase in OD until t=400 minutes 
where the rate of increase in OD begins to slow, ending at a final OD of 0.91 Abs. 
 
No single step growth curves or adsorption assays were performed with phage NV1 because 
of difficulties in getting accurate plaque counts due to the small size and hazy appearance of 
NV1 plaques.  
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4.3     Isolation and characterisation of Pseudomonas phage ϕNV3  
 
4.3.1   Phage morphology 
Pseudomonas phage ϕNV3 was initially identified from samples of untreated sewage where it 
was identified as causing plaques on plates of P. agarici NCPPB 2472 and was then imaged 
by TEM. TEM imaging of phage virion particles allows for a broad classification of the phage 
based on morphology. TEM was performed on clarified phage lysates with negative staining 
using uranyl acetate. From the presence of an extremely short tail in the electron micrograph 
in Figure 4.7, we can tentatively identify phage ϕNV3 as a member of the Caudovirales, similar 
to phage NV1. 
 
 
Figure 4.7. Electron micrograph at 80 kV, illustrating the virion morphology of ϕNV3, clearly 
visible are the icosahedral head and short tail characteristic of the Podoviridae. 
 
 
The head of ϕNV3 is approximately 43nm (1.5 SD) in diameter and an extremely short tail that 
is approximately 10 nm (3 SD) in length, with no tail fibers visible on any TEM images, similar 
to phage NV1. The presence of the short stubby tail and icosahedral head suggest that phage 
ϕNV3 is a member of the Podoviridae.  
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Figure 4.8. Plaque assay plate of phage ϕNV3 and P. agarici NCPPB 247 showing near-
confluent lysis. 
 
Phage ϕNV3 has a narrow host range, only infecting P. agarici NCPPB 2472, of all the 
Pseudomonas species tested, as shown in Table 4.4; on plaque assays of P. agarici, ϕNV3 
plaques show large clear plaques of approximately 3-5 mm in diameter, illustrated in Figure 
4.8.  
 
Table 4.4. Host range assay results of phage ϕNV3. 
 
Strain:  ΦNV3 
Infection 
P. tolaasii NCPPB 2192T - 
P. agarici NCPPB 2472 + 
P. sp NS1 - 
P. syringae pv. morsprunorum R1 5244 - 
P. syringae pv. syringae 9097 - 
P. syringae pv. morsprunorum R2 5255 - 
P. fluorescens Pfo-1 - 
P. aeruginosa 14207 - 
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4.3.2      Sequencing and genome organisation 
The results of the TEM imaging of phage ϕNV3 indicated that it belonged to the Podoviridae, 
a family of phage within Group I of the Baltimore classification scheme, and therefore most 
likely possessed a dsDNA genome. The genetic material of phage ϕNV3 was extracted using 
a Norgen Biotek Phage DNA Isolation Kit, returning 75 l of DNA at a concentration 126.4 
ng/l as determined by NanoDrop 2000. The genomic DNA was sent for sequencing by 
Source Bioscience on an Illumina MiSeq, with paired-end reads of 300 bp. Full genome 
sequencing of ϕNV3 returned a single contig of 43,184 bp in length with a coverage of 9.2x 
and an average GC content of 58.29%, which was confirmed with extensive primer walking 
combined with Sanger Sequencing. The complete genome of ϕNV3 was analysed by 
PhageTerm [270] for the presence of direct terminal repeats (DTRs), which identified a T7-
like packaging scheme with DTRs of 693bp in length. The completed sequence was uploaded 
to GenBank (Accession code: MG845683).  
 
ORFs over 100 bp in length were considered as potential genes and 49 ORFs were identified 
and predicted to encode proteins, all of the ORFs reside on the positive strand and the 
organisation of the genes shows significant similarities to that reported for ϕKMV [100] and is 
illustrated graphically in Figure 4.9; however the total nucleotide identity to any known phage 
is extremely low, with the largest as identified by BLASTN [253] to be 77% identity with only 
3% cover of the genome to phage ϕKMV. Of the 49 identified ORFs, 25 showed amino acid 
identity to phage proteins of known or predicted function as identified by BLASTP [253], these 
are shown in Table 4.5. A full table of all ORFs identified is available in Appendix 3, Table 
Ap3.2.  
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Figure 4.9. ϕNV3 genome organisation, green early host preparation genes, light blue is mid, 
dark blue late and structural, purple is lysis cassette, hypothetical proteins in grey, inner circle 
denotes GC usage with yellow being above average and purple being below average, genome 
is shown circular for illustrative purposes only. Figure generated using DNAPlotter function 
of the Artemis v16.0.0.1 genome browser. 
 
 
 
Similar to phage NV1 the majority of genes with identified functions in Table 4.5 are phage 
structural proteins and those involved in DNA replication. Notably, ϕNV3 encodes a single 
subunit RNA polymerase upstream of DNA replication genes, adjacent to the structural protein 
region of the genome. 
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Table 4.5. ORFS of phage ϕNV3 with BLASTP [253] similarity to proteins of known or 
predicted function.  
 
Locus Tag 
Start 
Position 
Size 
(aa) 
Total GC 
(%) 
Predicted Function (putative): 
phiNV3_p13 7159 278 57.46 DNA primase  
phiNV3_p14 8047 436 58.81 DNA helicase  
phiNV3_p16  9913 299 60.11 ATP-dependent DNA ligase 
phiNV3_p19  11583 786 58.83 DNA polymerase I  
phiNV3_p21 15008 319 58.64 Integrase 
phiNV3_p22 15948 158 54.92 DNA endonuclease VII  
phiNV3_p23 16432 406 59.04 DNA exonuclease 
phiNV3_p26  18414 818 58.4 RNA polymerase 
phiNV3_p29  21679 156 57.53 DNA endonuclease 
phiNV3_p30 22363 45 60.86 Virion structural protein 
phiNV3_p31 22510 512 57.24 Head-tail connector protein  
phiNV3_p32 24048 321 61.9 Scaffolding protein  
phiNV3_p33 25069 330 60.12 Capsid protein  
phiNV3_p34 26161 184 56.75 Tail tubular protein A 
phiNV3_p35 26712 823 59.54 Tail tubular protein B  
phiNV3_p36  29183 181 59.7 Internal virion protein A 
phiNV3_p37  
29721 886 59.9 
Baseplate hub subunit and tail 
lysozyme 
phiNV3_p38 32390 1310 60.56 Internal core protein  
phiNV3_p39  36323 788 54.79 T7-like tail protein  
phiNV3_p41 39215 110 57.7 DNA maturase A 
phiNV3_p42 39529 590 57.13 DNA maturase B 
phiNV3_p43 41303 79 60.41 Pinholin 
phiNV3_p44 41526 166 58.48 Lysozyme 
phiNV3_p45 41975 110 60.96 Rz-like protein 
phiNV3_p46 42165 81 62.6 Rzl-like protein 
 
 
phiNV3_p37, a protein composed of 886 amino acids, is predicted to encode the baseplate hub 
subunit and tail lysozyme. A 122 aa T4-like lysozyme conserved domain is located at the C-
terminus of the protein between residues 738-860. This C-terminus lysozyme domain is 
characteristic of the Autographivirinae including phage ϕKMV and SP6, the T7-like phage of 
the Podoviridae instead have this domain at the N-terminus [100, 308].  
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4.3.3      Phylogeny  
 
To analyse the phylogenetic clustering of ϕNV3 the entire genomic sequence was aligned by 
MUSCLE [260] to other members of the Autographivirinae and all gaps were removed from 
the sequence. A maximum parsimony analysis was chosen to predict and evolutionary history 
due to the small number of sequences and likelihood of nucleotide conservation between them 
and run using Mega6.06. The resulting phylogenetic tree is shown in Figure 4.10.  
 
 
Figure 4.10: Maximum Parsimony analysis of taxa: The evolutionary history of 
Pseudomonas phage ϕNV3 (•), was inferred using the Maximum Parsimony method. The 
most parsimonious tree with length = 95095 is shown. The consistency index is (0.613301), 
the retention index is 0.422029 (0.417186) for all sites and parsimony-informative sites (in 
parentheses). The percentage of replicate trees in which the associated taxa clustered together 
in the bootstrap test (500 replicates) are shown next to the branches [257]. The MP tree was 
obtained using the Subtree-Pruning-Regrafting algorithm [258] with search level 1 in which 
the initial trees were obtained by the random addition of sequences (10 replicates). The tree is 
drawn to scale, with branch lengths calculated using the average pathway method [258] and 
are in the units of the number of changes over the whole sequence. The analysis involved 18 
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nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All positions 
containing gaps and missing data were eliminated. There were a total of 26547 positions in 
the final dataset. Evolutionary analyses were conducted in MEGA6 [256].  
 
 
The results in Figure 4.10 show that phage ϕNV3 clusters with other members of the 
phiKMVviruses, although on a separate branch to the majority, indicating that it may have 
diverged earlier than other members, similar to phage LKA1. A further phylogenetic analysis 
utilising only the large terminase subunit gene is available in Appendix 4, Figure Ap4.6, which 
confirms the results shown in Figure 4.10, with ϕNV3 clustering with other members of the 
phiKMVviruses and other members of the Autographivirinae. 
 
 
4.3.4      Growth characteristics 
 
In order to further characterise the ϕNV3 life cycle several studies were performed. As the first 
stage of a phage life cycle is finding and adhering to its host, an adsorption assay was performed 
for ϕNV3, corresponding to typical growth parameters in vitro. The results of this adsorption 
(Figure 4.11), were used to calculate the adsorption constant of ϕNV3, which was found to be 
approximately ka=3.5x10-9 ml min-1 demonstrating ϕNV3 efficiently adsorbs to P. agarici 
cells.  
 
Figure 4.11. Adsorption curve at 28°C with 200 rpm shaking (dotted line is linear regression) 
Adsorption constant: 3.501x10-9 phage/cell/ml/min, error bars = +/- SEM.  
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Following adsorption, the phage genome must enter the host cell and undergo replication and 
transcription/translation to produce progeny phages. A single step growth curve was performed 
to determine duration of the phases of phage replication and burst size (defined as the number 
of progeny phage release after a single phage has infected a single bacterium) for ϕNV3. The 
results (Figure 4.12) show the latent period of phage ϕNV3 is approximately 45 minutes in 
length, followed by a steep rise period of approximately 10 minutes due to the lysis of infected 
cells and release of progeny phage, the calculated burst size was approximately 55 phage per 
cell for ϕNV3. This stage was rapidly followed by a sharp decrease in phage titre, which can 
be attributed to the attachment of progeny phages to new host cells.  
 
 
Figure 4.12. Single step growth curve of ϕNV3 with P. agarici NCPPB 2472. Latent period 
and rise periods are indicated with lines labelled L. and R. respectively. Mean values of 3 
replicates are plotted, error bars = +/- SEM. 
 
 
 
In order to characterise the ability of ϕNV3 to effectively control bacterial populations, kill 
curve assays were performed at high phage titres with MOIs of between 0.1 and 10, the results 
are shown in Figure 4.13.  
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Figure 4.13. High titre kill curves with ϕNV3 and P. agarici NCPPB 2472 at a starting 
bacterial concentration of 1x108cfu/ml at 28°C, mean values of 10 replicates are plotted, error 
bars = +/- SEM. 
 
 
With a high MOI of 10 there is a rapid drop in OD commencing at 25 minutes and stabilising 
at approximately 60 minutes. This would appear to correspond to a single infective cycle where 
all bacterial cells have been successfully infected with ϕNV3 resulting in total lysis of all 
bacterial cells within 60 minutes, which matches the infection cycle characterised in the single 
step growth curve in Figure 4.12. The total lysis of all cells is illustrated by the lack of any rise 
in the OD of the culture over the remaining duration of the experiment.  
 
However, when the MOI is 1 the time required for a similar drop in OD to commence increases 
over two times to approximately 65 minutes with the total lysis as indicated by a stabilising of 
OD at 110 minutes. Once again, the drop in OD appears to correspond to complete lysis of all 
the bacterial cells as no increase in OD is observed in the culture of the remaining duration of 
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the experiment after the initial drop in OD between 65-110 minutes. The time required for this 
drop in OD would be equivalent to two cycles of phage replication.  
 
 
 
Figure 4.14. Low MOI kill curves kill curves with ϕNV3 at a starting bacterial concentration 
of 1x108cfu/ml at 28°C. Mean values of 10 simultaneous replicates are plotted, error bars= +/-
SEM. 
 
 
In order to determine the effectiveness of phage at lower MOI’s that would more accurately 
represent the conditions likely to occur on the surface of A. bisporus or within the casing soil 
layer a further set of kill curve experiments were performed as shown in Figure 4.14. 
 
At higher MOIs the drop in OD occurs more rapidly than at lower MOIs, for example the drop 
in OD at an MOI of 0.1 occurs at t=140 (0.009 Abs) and reaches a minimum at t=240 (0.004 
Abs), whereas at an MOI of 0.01 the drop does not occur until t=185 (0.016 Abs) and reaches 
a minimum at t=250 (0.006 Abs). Likewise, the drop in OD for the lowest MOI of 0.001 does 
not occur until t=210 (0.023 Abs) and reaches a minimum at t=285 (0.006 Abs).  
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Interestingly the drop in OD expressed as a percentage of the maximum peak in OD shows that 
the largest percentage drop is at the lowest MOIs, at an MOI of 0.1 the drop in OD corresponds 
to a 55.6% drop, at an MOI of 0.01 it corresponds to a 62.5% drop and at the lowest MOI of 
0.001 the drop corresponds to 74% of the peak OD value.  
 
 
4.3.5      Phage/host co-evolution 
 
In order to investigate the effects of antagonistic co-evolution on the bacterial host a co-
evolution study was performed. This was performed using sequential transfers of 100 µl of 
phage/bacteria in 6 ml of KB followed by overnight incubation at 27°C. From this, samples of 
purified phage and bacteria were taken, before phage infection capacity was measured by 
streaking on plates of bacterial colonies of each transfer. The graphical results are shown in 
Figure 4.14 and full results are available in Appendix 4, Table Ap4.4.  
 
 
Figure 4.15. Results of co-evolution study between phage ϕNV3 and P. agarici NCPPB 2472. 
Percentage resistant bacteria was determined using 16 arbitrarily sampled bacterial colonies 
from streak plates of each bacterial transfer to which 5µl of either past/present/future phage 
was added, each point is the mean value of 5 replicates, error bars= +/- SEM. x axis labels 
indicate phage transfer number, each bacterial transfer number is illustrated by data point shape 
and outlined in the key.  
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From the results shown in Figure 4.15 there is evidence of a high degree of co-evolution 
between the phage and host. For bacterial Transfers 1, 3, 5 it is evident that ‘future phage’ from 
the next sequential transfer is more effective; however, at bacterial transfer 8 the ‘future phage’ 
is less effective and by bacterial Transfer 9 all bacteria are resistant to all phage tested.   
Over the course of the experiment escalatory evolution of bacterial resistance is evident in the 
gradual increase in percentage bacteria resistant across all past, present and future phage, 
resulting in the final total resistance of the bacteria to all phage and eventual phage extinction.  
The initial bacterial transfer (Transfer 1) shows that the ‘future phage’ (T2) are capable of 
overcoming the initial bacterial resistance mechanisms, a similar result is shown in transfers 4 
and 6.  
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4.3.6      Lysis cassette 
In order to characterise the process by which phage ϕNV3 is able to cause lysis of P. agarici 
NCPPB 2472, the lysis cassette was identified and investigated. 
The bacteriophage lysis cassette, which is comprised of the phage encoded proteins involved 
in lysing the host cell to allow progeny phage escape at the end of the phage replication cycle, 
such as the lysin and holin (S) [109], or in the case of SAR-endolysins, the pinholin, lysin and 
Rzl/Rz1-like proteins [102].  
 
 
Figure 4.16. Diagram representing the lysis cassette of ϕNV3, showing the ORF’s encoding 
the putative pinholin, endolysin, Rz and Rz1-like proteins and the high degree of overlap 
between each ORF’s. 
 
 
The lysis cassette of ϕNV3 comprises of four proteins, as shown in Figure 4.16. The presence 
of a predicted pinholin and Rz-like and Rz1-like proteins as well as the order of these genes 
indicate that ϕNV3 possesses a SAR-endolysin system conserved in all phiKMVviruses [102], 
rather than a canonical system such as that found in NV1 that is comprised of solely a holin 
and endolysin proteins.  
 
 
N-Region        H-Region                      Catalytic domain 
1  + +  9 10           23 24             39 
MNLRNKALA GTALSLALGGLVGL EGMSLPAYRDIAGVPT ϕNV3 
---MNKPLR GAALAAALAGLVAL EGSETTAYRDIAGVPT ϕKMV 
+  + 
 
Figure 4.17. Direct comparison of the N-terminal signal-arrest-release domains of ϕNV3 and 
ϕKMV. The positively charged N-region, the hydrophobic H-region and the catalytic domain 
are indicated with the conserved catalytic domains underlined, based on work published by 
Briers et al. [102]. 
 
Analysis of the amino acid terminal sequence of phiNV3_p44, a putative endolysin, shows that 
it is almost identical to that of ϕKMV. That is, the ϕNV3 N-region of 9 amino acid residues, 
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which is 3 residues longer than that of ϕKMV, has a net positive charge (identified in Figure 
4.17 by the + symbol), and thus acts as a positive anchor to the negatively charged inner site 
of the cytoplasmic membrane.  
 
The H-region shows a large degree of conservation with that of ϕKMV and is composed of 
hydrophobic residues, which tend to form an alpha α-helix, as tentatively confirmed by 
PSIPRED Figure 4.18). 
 
 
Figure 4.18. PSIPRED results of the H-region of the ϕNV3 signal-arrest-release domain 
illustrating the predictedα-helix. 
 
 
This α-helix enhances insertion of the signal peptide into the phospholipid double layer. The 
catalytic domain shows again a high degree of amino acid sequence conservation between 
ϕNV3 and ϕKMV with the catalytic residues (E24, D33, T39) being identical [102]. 
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4.3.7      Lysis cassette expression 
 
To confirm the function and lytic activity of the predicted lysis cassette, the three genes that 
encode pinholin, endolysin and Rzl/Rz1-like of ϕNV3 were cloned individually in to the 
pEXP5-CT/TOPO® vector containing a T7 promotor and transformed in to BL21-AI 
competent cells, which carry the T7 polymerase gene under control of an arabinose induced 
promotor (araBAD) allowing for control over T7 RNA polymerase expression. The effect of 
expression was tested by inducing expression in exponential phase cells at a starting OD of 0.4 
Abs by adding L-arabinose to a final concentration of 0.2% at T=0 in Figure 4.19. 
 
 
Figure 4.19. Effect of expression of individual lysis protein constructs containing either the 
ϕNV3 endolysin, pinholin or Rz/Rz1-like encoding genes on optical density of BL21-AI E. 
coli following induction with 0.2% L-arabinose at T=0. The control comprised of an uninduced 
BL21-AI containing the Rzl/Rz1-like construct. Mean values of 6 replicates are plotted, error 
bars= +/- SEM. 
 
 
The results of the expression assays in Figure 4.19 show the strongest decrease in optical 
density, corresponding to a drop in bacterial cell numbers, is with expression of the BL21-AI 
E. coli containing the endolysin construct. The OD of the BL21-AI containing the endolysin 
construct begins to decrease rapidly at t=50 minutes from a peak of 0.108 Abs to 0.062 Abs at 
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t=80 minutes, a 43% reduction; after t=80 minutes the OD continues to gradually decrease over 
the remaining 120 minutes at a reduced rate, ending on a final OD of 0.032 Abs, a total decrease 
of approximately 70% from the peak OD at 50 minutes.  
 
The OD of the pinholin expression assay continues to rise at a similar rate to the control until 
80 minutes, at an OD of 0.187 Abs, where the increase in OD stalls until 115 minutes post 
induction at an OD of 0.197 Abs (an increase of 0.01 Abs, compared to a difference of 0.08 
between 45 minutes and 80 minutes), it begins to rise after 115 minutes again, however at a 
lower rate; the final OD at 200 minutes is significantly higher than the endolysin expression, 
at 0.28 Abs.  
 
The Rz/Rzl-like expression OD follows the control almost exactly until 75 minutes, where it 
begins to deviate, rising at a reduced rate in comparison to the control ending at a final OD of 
0.305 Abs, higher than the 0.28 Abs of the pinholin expression, although significantly (P(T<=t) 
one-tail=2.9E-05) lower than the control which has a final OD at 200 minutes of 0.411 Abs.  
 
To determine the effects of pinholin and Rz/Rz1-like protein complementation on the ability 
of the endolysin protein to lyse the host cells, a further two constructs were created containing 
either the pinholin and endolysin or the full lysis cassette (pinholin, endolysin and Rzl/Rzl-like 
protein) and expressed in BL21-AI, the results are shown in Figure 4.20.  
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Figure 4.20. Complementation assay of lysis cassette proteins of ϕNV3 by expression of 
constructs containing either the ϕNV3 endolysin gene, pinholin and endolysin genes or the 
complete lysis cassette in BL21-AI E. coli following induction with 0.2% L-arabinose at T=0. 
The control comprised of an uninduced BL21-AI containing the Pin+Endolysin construct. 
Mean values of 6 replicates are plotted, error bars= +/- SEM. 
 
 
 
The endolysin alone expression shows the most rapid increase in OD across all induced 
constructs as illustrated in Figure 4.20. The increase in OD continues to a peak at t=50 minutes 
of 0.108 Abs followed by a rapid drop, indicative of cell lysis, that continues to t=75 minutes 
when it is at an OD of 0.064 Abs, a decrease of 41%; after this time point, the decrease in OD 
continues over the time course of the experiment, albeit at a reduced rate similar to the results 
in Figure 4.19.  
 
In contrast, the complete lysis cassette construct expression OD matches the rate of increase as 
the uninduced control until t=40 minutes, where the increase in OD is markedly more rapid 
than the control. The rapid increase continues to a peak at 85 minutes at an OD of 0.119 Abs, 
where it begins a rapid decrease to a minimum of 0.041 Abs at t=120 minutes, which 
corresponds to a decrease of ~66% compared to the maximum peak at 85 minutes. After this 
rapid decrease, the OD begins to rise slowly over the remaining time course of the experiment.   
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The construct containing both the pinholin and endolysin however matches the rate of increase 
in OD of the control up until t=105 minutes, where it begins to deviate with the OD showing 
no decrease, but instead a slower rate of increase, when compared to the uninduced control 
rate. By t=135 minutes the control OD is at 0.2005 Abs compared to 0.1598 Abs in the 
pinholin/endolysin expression. The pinholin/endolysin construct expression shows the largest 
standard error of the mean (SEM) of all constructs as indicated by the size of the SEM bars in 
Figure 4.20.  
 
4.3.8     P. agarici Type IV pili knockout  
 
Previous work by Chibeu et al. with the bacteriophage PhiKMV and its host Pseudomonas 
aeruginosa has demonstrated that the adsorption of PhiKMV requires Type IV pili [101]. 
Therefore, it was hypothesised that, as a member of the phiKMVlikeviruses it was possible 
phage ϕNV3 utilised Type IV pili as a binding receptor and to test this hypothesis it would be 
necessary to create a knockout of P. agarici NCPPB 2472 that was incapable of expressing the 
Type IV pili on its surface. It has been reported that mutations in the PilB gene results in 
nonpiliated cells [309], therefore it was chosen as the knockout gene to prevent Type IV pilus 
assembly in P. agarici. Two methods of generating competent P. agarici cells were attempted, 
chemical competency and electrocompetency.  
 
For chemically competent P. agarici reactions no colonies were observed on any plates, 
including on both the positive and negative controls.  
 
For the electrocompetent P. agarici cells no colonies were observed on any of the pCR2.1-
TOPO construct transformation plates, however multiple colonies were visible on the 
pBBR1MCS-2 positive control transformation plates. Six of these colonies were chosen to be 
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analysed using PCR for the presence of the M13-F and M13-R regions, all 6 colonies returned 
positive results indicating the presence of the pBBR1MCS-2 vector.  
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4.4      Phage NV6 
4.4.1   Host range 
  
Phage NV6 was isolated simultaneously with ϕNV3 from the same untreated sewage sample 
and was identified as being able to form plaques on plates of both P. tolaasii NCPPB 2192T 
and P. agarici NCPPB 2472, however the plaques formed on P. tolaasii plates were 
significantly smaller (~1mm) and cloudy compared to the larger and clear plaques it formed 
on P. agarici. Phage NV6 did not infect any other Pseudomonas strain tested, as shown in 
Table 4.7. 
 
Table 4.7. Host range assay of phage NV6. 
 
Strain:  NV6 
Infection 
P. tolaasii NCPPB 2192T + 
P. agarici NCPPB 2472 + 
P. sp NS1 - 
P. syringae pv. morsprunorum R1 5244 - 
P. syringae pv. syringae 9097 - 
P. syringae pv. morsprunorum R2 5255 - 
P. fluorescens Pfo-1 - 
P. aeruginosa 14207 - 
 
 
4.4.2      Growth characteristics  
 
As shown in Figure 4.21, the kill curve characteristics of phage NV6 are almost 
indistinguishable from those of ϕNV3 under similar conditions (See Figure 4.14 in Section 
4.2.4). At higher MOIs the drop in OD occurs faster, at an MOI of 0.1 the drop in OD begins 
at approximately t=150 minutes (approximately 3 standard phage replication cycles), 
decreasing from 0.007Abs to 0.003Abs by t=200 minutes. The corresponding drop in OD at 
the lower MOI’s occurs at 180 minutes (0.017 Abs at t=180 to 0.006 Abs at t=240) at an MOI 
of 0.01 and 210 minutes (0.02 Abs at t=210 to 0.005 Abs at t=275 minutes) at an MOI of 0.001.  
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Figure 4.21. Kill curves of NV6 with A., P. agarici 2472 and B. P. tolaasii 2192T, at a starting 
bacterial concentration of ~1x108 cfu/ml, incubated at 28°C for 12 hours with a MOI of either 
0.1, 0.01 or 0.001. OD at 595nm was read every 5 minutes. Mean values of 10 simultaneous 
replicates are plotted, error bars= +/-SEM. 
 
 
However, the kill curve of NV6 with P. tolaasii is considerably different from that of NV6 
with P. agarici, with only a small drop or stall in OD across all MOIs. At an MOI of 0.1there 
is a slight drop in OD between t=30 and t=45 minutes (0.012 Abs to 0.011 Abs), likewise at an 
MOI of 0.01 at t=50 to t=55 minutes, approximately equal to a single cycle of phage replication, 
there is a small drop in OD (0.014 Abs to 0.0138 Abs). However, the OD of all phage infected 
samples, independent of MOI are consistently lower across the entirety of the experiment than 
the uninfected control; with the final ODs correlating to the MOIs, with MOI of 0.1 final OD 
of 0.419 Abs, MOI of 0.01 final OD of 0.576 Abs, MOI of 0.001 final OD of 0.724 Abs and 
the uninfected control final OD of 0.805 Abs.  
 
4.4.3      Sequencing 
 
Initial PCR amplification identified NV6 to show striking resemblance genetically to ϕNV3 
and it was hypothesised that NV6 was either closely related to ϕNV3 or had acquired a mutation 
that allowed it to infect a broader host range. To identify the any nucleotide changes between 
ϕNV3 and NV6 the genomic DNA was extracted and purified, returning a concentration of 201 
ng/µl which was then sent for paired-end sequencing performed by Source Bioscience.  
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The sequencing results returned a single contig of 43,217 bp for NV6, with a coverage of 54.4x, 
when compared to the figure of 43,184 bp for ϕNV3, there was an addition of 33 bases. 
Alignment of the returned NV6 sequence to the genome of ϕNV3 by BLASTn [253] indicated 
that these 33 bases were in a single large addition. This 33 bp addition was identified to be 
within phiNV3_p40, a 2,367 bp gene predicted to encode a putative T7-like tail protein, an 
alignment of the nucleotide sequence is shown in Figure 4.22.  
 
1635 TAAAAACTTGCA----------------------------G-----GGGCATGCCTTTGGGCC 1664 
1635 TAAAAACTTGCATGGGCATGCCTTTGGGCCGGGCGTACGTGATATCGGGCATGCCTTTGGGCC 1697 
Figure 4.22. DNA sequence comparison of a section of the T7-like Tail Fiber Protein gene of 
top, ϕNV3 and below, NV6, showing the base additions highlighted in grey. 
 
 
The 33 bp addition maintained the single reading frame of the phiNV3_p40 tail protein and 
when the amino acid sequence was analysed in Jalview 2.9.0b2 it was shown to have added a 
sequence of 11 aa (-PGVRDIGHAFG-) towards the C-terminal, and two amino acid 
substitutions upstream and downstream of the addition region, which is illustrated in the amino 
acid alignment in Figure 4.23.   
 
 
Figure 4.23. Amino acid sequence comparison of a section of the T7-like tail fiber protein 
gene of top, ϕNV3 and below, NV6. 
 
 
4.5      Discussion 
The phage Pseudomonas phage NV1 was initially isolated from water samples taken from the 
River Thames and was identified as forming very small hazy plaques on lawns of lawns of P. 
tolaasii 2192T. Hazy plaque morphology is often associated either with temperate phage or 
with inefficient phage adsorption to the host[310], however it is worth noting that no genes 
associated with lysogeny were identified within the NV1 genome. NV1 was identified as 
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having a narrow host range after failing to show evidence of plaques on any further 
Pseudomonas strains tested. From the virion morphology, shown in Figure 4.1 I was able to 
identify NV1 as belonging to the Podoviridae family of the Caudovirales order, a large order 
to which ~96% of all phage examined by electron microscopy occupy [311].  
The genome of NV1 was isolated and sequenced by Source Bioscience, which comprised of 
45,059 bp containing 64 identified ORFS, of which only 25 (~40%) showed amino acid identity 
to proteins of known or predicted function. Analysis of the returned contig revealed a high 
degree of nucleotide identity with the Pseudomonas fluorescens phage UFV-P2 (84% Ident 
over 86% of the genome). The genome of NV1 was then oriented to be collinear with that of 
phage UFV-P2, annotated and submitted to GenBank (Accession code pending). The 
International Committee on Taxonomy of Viruses (ICTV) guidelines recommend DNA 
sequence identity of 95% as a threshold for species delineation, with phage NV1 showing a 
maximum nucleotide identity of 84%, it is below the species delineation threshold[312].  
The differing host specificity, GC content (52.87% NV1 to 51.5% UFV-P2) and genome size 
would indicate that phage NV1 is a new species, albeit with significant similarities in gene 
synteny and significant amino acid and nucleotide similarity of several predicted genes.  
 
Likewise, with full genome phylogenetic analysis as shown in Figure 4.4, phage NV1 shows 
tight clustering with the closely related UFV-P2, therefore I suggest that NV1 is a new species 
of “UFV-P2” like virus and that the genome and results of this study provide evidence for the 
potential creation of a “UFV-P2virus” genus, distinct from the Luz24likevirus genus to which 
UFV-P2 has previously been attributed [108].  
The results of the kill curve experiments in Figure 4.5 and 4.6 show that phage NV1 is capable 
of lysis of P. tolaasii 2192T in vitro, however the minimum MOI needed to cause a decrease 
in OD that would correspond to a decrease in total bacterial numbers in vitro is 1, which would 
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be difficult to achieve in a real-world setting. While at lower MOIs the time required to show 
a slowing in bacterial growth is increased and a drop in OD that would correspond to a drop in 
total bacterial cell counts is never observed, illustrating that lower MOIs of phage treatment 
may not suitable for use in phage therapy. 
As is also shown in the low MOI kill curve results, illustrated in Figure 4.6, P. tolaasii appears 
to be able to rapidly develop resistance to phage NV1 and it is possible this ability of P. tolaasii 
to gain resistance is related to a shift in phenotype (smooth/rough) [14]. Many phages, such as 
the phage LKA1 of P. aeruginosa, are dependent on the expression of particular LPS receptors 
that are related to phenotype [155] and it is possible that phage NV1 infection is dependent on 
a specific LPS phenotype. However, this change in phenotype can result in P. tolaasii shifting 
from pathogenic to non-pathogenic [21] and therefore the pressure of developing phage 
resistance may reduce its infective potential.  
Further tests in vivo would be required to determine if phage infection and subsequent P. 
tolaasii resistance development would reduce or prevent disease symptoms on Agaricus 
bisporus; similar to those performed by Kim et al. with phage hb1a, where they were able to 
suppress blotch formation on P. ostreatus, with the addition of phage simultaneously with P. 
tolaasii [74]. 
 
Pseudomonas phage ϕNV3 was initially isolated from untreated sewage water samples and 
identified as capable of forming large (5 mm), clear plaques on lawns of P. agarici NCPPB 
2472. It was identified as having a narrow host range after failing to show evidence of plaques 
on any further Pseudomonas strains tested. TEM imaging of the virion morphology, shown in 
Figure 4.7 allowed us to identify ϕNV3 as belonging to the Podoviridae family of the 
Caudovirales order, similar to phage NV1.  
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The genome of ϕNV3 was isolated and sequenced by Source Bioscience, and identified to be 
43,184bp in length; the genome of ϕNV3 was also identified as showing genome organisation 
similarities with the reported organisation of Pseudomonas phage ϕKMV [100], which was 
then used to orient the genome of ϕNV3 correctly. The genome sequence and orientation was 
then confirmed with extensive primer walking and Sanger Sequencing. The genome of ϕNV3 
has an average GC content of 58.29% which is significantly lower than ϕKMV (62.3%) [100], 
but closer to Pseudomonas phage LKA1 (60.9%) [308] and close to the host P. agarici NCPPB 
2472 GC content (60.55%). 
 
In total 50 potential gene encoding ORFs were identified in the genome of ϕNV3, of these only 
25 showed amino acid identity to phage proteins of known or predicted functions as identified 
by BLASTP [253], shown in Table 4.5, consequently 50% of the ORFs have no known or 
predicted function, 29 ORFs (58%) have orthologs found in phage ϕKMV; however, the 
genome of ϕNV3 shows very little nucleotide similarity to any known phage with a very low 
similarity to ϕKMV with a nucleotide identity of 77% over only 3% of the entire genome.  
 
Similar to phage NV1 the majority of genes with identified functions are phage structural 
proteins and those involved in DNA replication, such as the single subunit RNA polymerase 
upstream of DNA replication genes, adjacent to the structural protein region of the genome, 
which is characteristic of the Autographivirinae subfamily of bacteriophage and similar to 
phage ϕKMV and other ϕKMV-like phages [100, 308]. 
 
The results of the full genome phylogenetic analysis likewise show that ϕNV3 clusters with 
other members of other members of the phiKMVvirus genus, although on a separate branch to 
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the majority, indicating that it may have diverged earlier than other members, similar to phage 
LKA1.  
Current phage classification guidelines based on nucleotide identity state that the species 
demarcation is set at 95% identity and genus at >50% identity [312]. From the genome 
sequencing results including the apparent lack of nucleotide identity (77% identity over 3% of 
the genome to phage ϕKMV), the similarities of genome organisation to ϕKMV [100] and the 
results of the phylogenetic analysis I propose that ϕNV3 is most likely a new species of the 
phiKMVvirus genus, however it is possible due to the extremely low nucleotide identity that 
ϕNV3 represents a new bacteriophage genus within the Autographivirinae, closely related to 
the phiKMVviruses. 
 
The life cycle of phage ϕNV3 was characterised in order to identify whether it would represent 
a possible candidate for biocontrol applications and to understand its interactions with the host 
P. agarici NCPPB 2472. It was identified via adsorption assay that ϕNV3 is capable of efficient 
adsorption to host P. agarici NCPPB 2472 cells with an adsorption constant of ka=3.5x10-9 ml 
min-1. This adsorption rate is similar to that of the P. aeruginosa phage LKA1 (ka=3.9x10-9 ml 
min-1) although less than half of the value for Pantoea virus LIMEzero (8.29x10-9 ml min-1), 
while it has been reported that both phage LKD16 and ϕKMV failed to produce clear 
adsorption curves due to their inefficient adsorption [103, 308].   
 
Likewise, it was identified via single step growth profile that the latent period of ϕNV3 is 
approximately 45 minutes, with a rise period of 10 minutes. The lysis of host cells after 45 
minutes post infection is longer than the time required for cell lysis of other members of the 
ϕKMV-like phage such as LKD16, ϕKMV and LKA1 (25, 35 and 40 minutes respectively 
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[308]). The calculated burst size of approximately 55 phage per cell for ϕNV3, is identical to 
that of ϕKMV although lower than LKD16 and LKA1 (120 and 255 respectively) [308].  
 
The results of the kill curve assays in Figure 4.12 and 4.13 show that at high MOIs such as a 
MOI of 10 the total lysis of all host cells is rapid, occurring between 25 and 60 minutes, and 
that at MOI of 1 the time required for total cell lysis increases to 110 minutes. However, at 
MOIs lower than 1 total bacterial cell lysis is not seen and the emergence of resistance to ϕNV3 
is rapid indicating that for the use of ϕNV3 in biocontrol applications, a high phage titre would 
need to be used.  
 
This emergence of resistance is similarly displayed in the results of the co-evolution study 
illustrated in Figure 4.15, with up to 51% of bacteria resistant to the ‘current’ phage transfer 
within one 24-hour cycle. However, they appear to be less resistant to ‘future’ phage for 
bacterial transfer numbers 1, 3 and 5 which may indicate that the development of phage 
resistance by P. agarici at this stage comes at cost and may be due to phase variation, similar 
to C. jejuni which can alter the expression of the polysaccharide receptor required by phage 
F336, or a change in bacterial phenotype similar to that of P. tolaasii [14]. The resistance to 
‘present’ phage increases to 79% by Transfer 5 and by Transfer 9 the bacteria are resistant to 
all ‘past’ ‘present’ and ‘future’ phage; this complete resistance to all phage assayed in transfer 
9 may be due to the CRISPR/Cas system of P. agarici NCPPB 2472 identified in Section 3.3.6 
and the acquisition of a spacer region associated with ϕNV3. This hypothesis could be tested 
by PCR amplification of the CRISPR repeat region and sequencing of the resulting product to 
identify any newly acquired spacer regions.  
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While whole phage treatments of bacterial infections have been well documented in literature, 
phage lysis proteins have also been studied intensively, as potential enzybiotics treatments of 
bacterial infections [111, 112, 134] and have shown promise in vivo [135]. For this reason, the 
lysis cassette of ϕNV3 was characterised in detail.  
 
ϕNV3 possesses a SAR-endolysin system comprised of 4 proteins, the pinholin, endolysin, Rz 
and Rzl-like proteins, a system that is conserved in all phiKMVviruses [102] and differing from 
the canonical system putatively identified in phage NV1. As outlined in Section 4.3.6 the SAR-
endolysin system of ϕNV3 shows a great deal of conservation with that of ϕKMV, especially 
within the N-terminal signal-arrest-release domain of the endolysin protein as illustrated in 
Figure 4.16, as well as sharing conserved catalytic residues within the catalytic domain. This 
would indicate that the lysis cassette of ϕNV3 likely operates with a similar mechanism as that 
reported for ϕKMV by Briers et al. [102]. 
 
In order to confirm the predicted function of the endolysin proteins and associated proteins of 
the lysis cassette the proteins were cloned into the pEXP5-CT/TOPO® vector and transformed 
in to BL21-AI cells for expression. The results of these expression assays are shown in 
Figures 4.18 and 4.19 and confirm the lytic ability of the ϕNV3 endolysin protein, even without 
the presence of the pinholin and Rz/Rzl-like proteins, although the greatest drop in bacterial 
cell numbers is correlated with the full lysis cassette protein expression although the time 
required for this drop is longer in comparison to the endolysin protein expressed alone, 
however this may be attributed to the metabolic pressure of expressing multiple proteins 
simultaneously compared to a single endolysin protein.  
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Expression of the lysis proteins of NV1 were also performed, the results of which are available 
in Appendix 4, Figures Ap4.7 and Ap4.8; however, the results demonstrated limited differences 
in optical density between the induced and uninduced controls. This limited differences in 
induced versus uninduced in comparison to the distinct differences seen in the expression of 
the ϕNV3 lysis proteins may be due to the different lysis systems involved (canonical NV1 
system versus the SAR-endolysin system of ϕNV3) where we would expect the lysozyme of 
NV1 to accumulate in the cytosol as it would lack access to the cell wall, although noticeable 
differences would be expected with the holin protein expression due to the large pores formed 
in the cell membrane. The lack of OD reduction, especially in Figure Ap4.7 would appear to 
indicate that the proteins had not been expressed at all, as a small reduction due to the metabolic 
stress of protein production would be expected, which may account for the slight differences 
in OD visible towards the end of the experiment in Figure Ap4.8. However, further experiments 
would be required to confirm protein expression or the lack thereof in both construct 
expressions. 
 
The final phage characterised, NV6, was initially identified on mixed culture plates of P. 
tolaasii 2192T from untreated sewage and was originally thought to be a unique phage; 
however, it was swiftly noted to possess the ability to cause plaques on both P. tolaasii NCPPB 
2192T and P. agarici NCPPB 2472 and to bear striking similarities to phage ϕNV3. Kill curve 
assays, as illustrated in Figure 4.21 demonstrated that NV6 possessed a significantly greater 
ability to lyse host cells of P. agarici NCPPB 2472 than P. tolaasii 2192T, with only minimal 
changes in growth demonstrated with P. tolaasii. 
 
Consequently, the full genome of phage NV6 was isolated and sent for sequencing by Source 
Bioscience in order to determine if phage NV6 was a mutant of ϕNV3 and if so, whether there 
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was a genetic difference that may account for the broader host range. It was identified that the 
only difference between the genomes of NV6 and phiNV3 is a single addition of 33 bases, 
within phiNV3_p40, which encodes a putative T7 tail protein. It is therefore likely that this 
region within the T7-like tail protein of ϕNV3 is a determinant of host specificity potentially 
involved in receptor binding, as demonstrated by the broader host range of phiNV6. 
 
Interestingly while the full genome molecular phylogenetic analysis of phylogeny of both 
phage appears to correctly place both NV1 and ϕNV3 with members of the same phage 
families, similar to the further analysis performed using only the large terminase subunit gene, 
available in Appendix 4 Figure Ap4.6; the analysis only utilising the large terminase places 
members of the Myoviridae and Siphoviridae on branches alongside members of the 
Podoviridae. This may indicate that in future studies the approach of full genome phylogenetic 
analysis, while computationally heavy may yield significant increases in accuracy due to the 
much larger number of sites used for the analysis, 26,547 and 24,899 sites used to produce 
Figures 4.10 and 4.4 respectively in comparison to 804 sites used in Figure Ap4.6. 
 
Finally, while the attempts to create a P. agarici NCPPB 2472 Type-IV pili knockout using the 
pCR2.1-TOPO vector were unsuccessful, possibly be due to degradation by the identified 
Type 1 CRISPR system previously identified. It was however demonstrated that the method 
utilised in creating the electrocompetent cells was successful using the pBBR1MCS-2 vector, 
and so this cell preparation method could be used in further studies utilising other vectors. 
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Chapter 5: 
 RNA Sequencing of P. agarici and ϕNV3 infected P. 
agarici 
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5.1      Introduction 
Having successfully sequenced and assembled both the phage, ϕNV3 and the host, P. agarici 
NCPPB 2472 genomes, the next step was to analyse their interactions on a transcriptional level 
with the aim of potentially elucidating the mechanisms involved in developing phage 
resistance. In order to do this RNA sequencing and differential gene expression profiling was 
chosen in order to maximise the number of genes that could be analysed simultaneously.  
 
P. agarici NCPPB 2472 cells infected with phage ϕNV3 at an initial MOI of 1 to ensure that 
the majority of cells were infected to allow for the largest change in RNA transcription, while 
avoiding potential lysis from without that can occur at higher MOIs.  
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5.2      RNA isolation and purification 
 
In total 6 total RNA samples were prepared, 3 non-phage infected controls (P4-P6) and 3 phage 
infected samples (PN4-PN6). The RNA was extracted from homogenised cell cultures at 45 
minutes post phage infection, to correspond with mid to late log-phase phage growth (see single 
step growth curve, Section 4.3.4, Figure 4.12), which would allow the maximum bacterial 
response to infection at a transcriptional level.  
 
The RNA was then concentrated to a level appropriate for RNA sequencing and the resulting 
concentrations varied from a low of 96 ng/µl (P6) to a high of 358 ng/µl (P4) as ascertained by 
an Agilent 2100 Bioanalyzer, the full results including RNA Integrity Scores (RIN) are shown 
in Table 5.1. In addition to the RNA integrity scores, the bioanalyzer returned gel 
electrophoresis images of the RNA samples, which allowed visual interpretation of the RNA 
integrity as determined by the clarity of the 16S and 23S rRNA bands in the resulting gel image. 
The gel images are shown below in Figure 5.1.  
 
Figure 5.1. Gel images of RNA samples used for RNA sequencing.  
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As is shown in Figure 5.1 above, the samples with the darkest and most clear 16S and 23S 
bands, the dark bars located towards the top of the gel image, are samples PN5 and PN6. Both 
these samples also show minimal low molecular weight smearing which is most evident in 
sample P6. This is further confirmed by the RIN scores or 7.2 and 7 for PN5 and PN6 
respectively, in Table 5.1.  
 
Table 5.1: RNA sample concentration, RIN and total mapped reads for uninfected P. agarici 
NCPPB 2472 (P4,P5,P6) and ϕNV3 infected (PN4, PN5, PN6).  
 
Sample Concentration 
(ng/ul) 
RIN Aligned Reads 
P4 358 5.4 68734869 
P5 296 6.2 51438405 
P6 235 5.1 61971656 
PN4 242 5.9 60307697 
PN5 96 7.2 50277057 
PN6 194 7 70485550 
 
 
All passed quality control with FastQC, however both P5 and PN5 had a 50 bp sequence of 
‘G’ which accounted for 0.172% and 0.137% of the total reads respectively. The FastQ 
sequencing read files returned by Source Bioscience were aligned to a Fasta sequence file 
containing the concatenated genomes of P. agarici NCPPB 2472 and phage ϕNV3, the total 
number of aligned reads per sample is also shown in Table 5.1.  
 
The aligned read file was then used to create counts for each gene of P. agarici NCPPB 2472 
identified via the NCBI Prokaryotic Genome Annotation Pipeline, the total counts are 
illustrated in Table 5.2.  
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Table 5.2: Mean read counts for uninfected P. agarici NCPPB 2472 (P4,P5,P6) and ϕNV3 
infected (PN4, PN5, PN6).  
 
Sample   Read Count 
P4  30264541 
P5 21693870 
P6 27264739 
PN4 11884370 
PN5 10384432 
PN6 11550021 
 
 
The mean counts for the uninfected samples (P4-P6) in Table 5.2 is 26,407,717 however, for 
the phage infected (PN4-PN6) the mean counts is 57% lower at 11,272,941.  
 
A principal components analysis (PCA) plot was constructed from the regularized-logarithm 
transformed (rld) results in order to identify any clustering based on phage infection or bacterial 
cell line, the results are shown in Figure 5.2.  
 
 
Figure 5.2. PCA plot generated for the rlog-transformed values of mapped reads, using 
plotPCA function in the DESeq2 [267] package and plotted using the ggplot2 package [269]. 
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From the plot in Figure 5.2 we can see that while there is significant clustering of the untreated 
(uninfected) samples (P4-P6) in both the x and y axis; there is no apparent clustering of the 
infected samples which are spread across both axes, with both samples PN5 and PN4 located 
close to the untreated in the y axis and PN4 clustering with the uninfected samples both in the 
x and y axes.  
 
5.3      Phage gene expression  
To determine the level of phage infection per sample, as determined by the highest total level 
of phage gene transcription, the RPKM values were obtained for each phage gene per sample 
then a total calculated, as shown in Table 5.2. 
 
Table 5.2. Total RPKM values of phage infected P. agarici NCPPB 2472 samples. 
 
Sample: Total (RPKM): 
PN4  747046.571 
PN5 684582.436 
PN6 859655.397 
 
 
Total RPKM value for each sample, shown in Table 5.2 shows that the highest levels of phage 
gene transcription are in sample PN6 followed by sample PN4, then PN5.  
 
To analyse the phage genes with the highest levels of transcription a bar graph of the mean 
RPKM values per gene and the standard deviation was plotted, shown in Figure 5.3.  
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Figure 5.3. Mean RPKM values and STDev of reads per putative gene encoding ORF of 
phage ϕNV3 as calculated using Artemis v16.0.0.1 genome browser.  
 
 
 
 
 
As shown in Figure 5.3, the genes with the largest levels of transcription (Gp28-34 and Gp42-
50) are clustered towards the right of the graph, corresponding to the mid to late genes of the 
phage genome. The two genes with the highest level of expression are Gp33 and 34, encoding 
a putative capsid protein and scaffolding protein respectively.  
 
 
 
5.4      Differential gene expression  
 
In total, the expression of 4895 P. agarici NCPPB 2472 genes were analysed, 9 returned padj 
of below 0.01 (0.18%), 24 with a padj of less than 0.05 (0.49%) and 39 with a padj of less than 
0.1. Of the 39 genes with a padj of less than 0.1, 26 were up-regulated and 13 were down 
regulated, the full differential gene expression results are visualised in an MA-plot in Figure 
5.4.  Full results of all genes with a padj of <0.1 is available in Appendix 4, Table Ap4.1 
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Figure 5.4. MA-plot of DEseq2 [267] comparison results of phage treated vs. untreated 
samples, genes with an padj value below the threshold of 0.1 are indicated in red.  
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Further analysis of the differential gene expression data revealed an operon of four genes that 
showed a mean log2 fold increase of 1.15 between the control and infected samples, with padj 
values of below 0.05. The genes in this operon and their precise log2 fold changes are outlined 
below in Table 5.3.  
 
Table 5.3. Differential gene expression data of an unidentified operon of P. agarici NCPPB 
2472. 
 
Locus Tag Predicted Function Log2Fold Change Padj 
RS16090 DUF3050 domain-containing 
protein 
1.159423991 0.0216997 
RS16095 P-aminobenzoate N-oxygenase 
AurF 
1.002180797 0.0280734 
RS16100 peptide transporter 1.239879524 0.0003224 
RS16105 SRPBCC family protein 1.202543288 8.38E-06 
 
 
The normalised count data for the differentially expressed operon outlined in Table 5.3 is 
visualised graphically in Figure 5.5.  
 
Figure 5.5. Mean normalized count data and SEM+ for gene cluster.  
 
 
A large number of the differentially expressed genes were identified as hypothetical proteins, 
however the host DNA polymerase II (RS18970) showed a log2fold increase of 0.694 in 
expression in phage treated samples.  
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The tmRNA encoding gene ssrA shows significantly increased expression in phage treated 
samples with a log2fold increase of 1.64 and a padj of 8.67E-15. However, the gene encoding 
the associated ATP-dependent zinc protease HflB is under-expressed with a log2fold decrease 
of 0.77 and a padj of 0.019. A Clp protease ATP-binding subunit (RS14345) also shows similar 
levels of under-expression with log2fold decrease of 0.75 and a padj of 0.02.  
 
 
5.5      Discussion 
 
The RNA of phage infected and non-infected P. agarici NCPPB 2472 was isolated with a wide 
variation of final concentrations and RIN scores. However, all samples were successfully 
sequenced by Source Bioscience, with the resulting FastQ files being aligned to a concatenated 
sequence of the phage ϕNV3 and P. agarici, with the number of aligned reads varying between 
50.2-70.4 million, shown in Figure 5.1.  
 
These aligned reads were then counted by gene for P. agarici NCPPB 2472 as previously 
identified by the NCBI Prokaryotic Genome Annotation Pipeline (as described in Section 
3.3.3), using the summarizeOverlaps function of the GenomicAlignments package of 
Bioconductor. The number of reads counted are shown in Table 5.2, with a significantly 
(p=0.018) lower number of counts for P. agarici genes in the phage infected than in the 
uninfected samples, with a 57% reduction in mean reads mapped to the bacterial genome. This 
reduction is likely due to the high levels of phage gene transcripts present in the infected 
samples and host RNA degradation at this particular timepoint, as has been previously reported 
by Lavigne et al. [313] with phage LUZ19  and P. aeruginosa PAO1 where it was observed 
that the total proportion of phage RNA to bacterial RNA increased from 23.6% to 60.2% 
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between 5 to 15 minutes after infection, which corresponds to early to mid/late stages of 
infection of the LUZ19 replication cycle.  
 
A PCA plot was constructed from the rld results in order to results in order to identify any 
initial clustering based on phage infection or bacterial cell line, shown in Figure 5.2, from 
which it is apparent that the phage infected sample PN4 cluster heavily with the non-infected 
samples, likewise PN5 is remarkably close to the non-infected cluster. Also evident is that the 
phage infected sample PN6 is the furthest outlier of the infected samples in both the x and y 
axes. This may broadly indicate that phage treatment does not have a significant effect on 
bacterial transcription levels at this time point of the phage lifecycle, however it is also likely 
due to the MOI of phage used. At a MOI of 1, which was the MOI used in this study, the total 
percentage of infected cells would be approximately 63.2% and the percentage uninfected 
approximately 36.8%, this would indicate that over a third of the returned RNA would be from 
uninfected P. agarici which when combined with the high levels of phage transcription and 
normalisation process could obscure or reduce differences in gene expression in the infected 
samples; in future studies a higher MOI of between 5 (99.3% infected) to 10 (100% infected) 
would prevent this source of error.  
 
Phage gene expression was analysed using the RPKM values calculated using Artemis 
v16.0.0.1 genome browser, due to difficulties in constructing a functioning feature file 
containing both bacterial and phage genes. Total RPKM values of all putative genes identified 
in Section 4.2.2, illustrated in Table 5.2, which shows that the highest levels of phage gene 
transcription are in sample PN6 followed by sample PN4, then PN5.  
This appears to contradict the data shown in the PCA plot in Figure 5.2, which shows that 
sample PN4 clusters more closely with the uninfected samples. If the clustering was due to 
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level of phage gene transcription and thereby the level of phage infection we would instead 
expect to see sample PN5 to be clustered more with the uninfected than PN4.  
 
The mean RPKM values for each putative phage gene of ϕNV3 are shown graphically in Figure 
5.3 which shows that the genes with the highest level of transcription at this time point of phage 
infection are between Gp28-34 and Gp42-50, which correspond to the mid to late genes of the 
ϕNV3 genome. The genes with the highest levels of transcription are Gp34 (36,736), Gp48 
(26,452), Gp33 (24,757) and Gp42 (21,263) which correspond to the capsid protein, Rzl-like 
protein, scaffolding protein and a novel hypothetical protein respectively. The sampling time 
point chosen of 45 minutes for our samples corresponds to the beginning of the rise period of 
phage ϕNV3, as demonstrated in the single step growth assay previously performed (Figure 
4.12) in Section 4.2.4, therefore we would expect to see the highest level of transcription in 
genes involved with progeny virion production and host cell lysis as observed. Likewise, the 
lowest levels of transcription observed were in the early, host preparation, and mid genes 
(ORFs Gp 1-30).  
These results are similar to those reported by Zhao et al. [314] in their transcriptomic analysis 
of the interaction between P. aeruginosa and the temperate phage PaP3, where they 
demonstrated that the late genes of PaP3 were expressed beginning at 30 minutes, the 
beginning of the rise period in the single step growth curve of PaP3 and the ‘early’ and ‘middle’ 
genes peaking in expression between 5-10 minutes and 10-30 minutes respectively. Likewise, 
these phage expression results are similar to those also reported by Lavigne et al. [313] with 
phage LUZ19, where at the mid/late timepoint the highest levels of gene transcription was 
observed in ORFs corresponding to capsid and head decoration proteins.  
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Differential gene expression analysis of phage infected P. agarici and non-infected P. agarici 
samples was performed using DESeq2, in order to potentially identify expression changes in 
genes previously identified in the P. agarici genome associated with phage resistance. Of the 
4,895 genes analysed only 39 (0.79%) differentially expressed genes had a padj of <0.1. Of 
these 39 genes, 26 were upregulated and 13 downregulated in the infected verses non-infected 
samples. This is in sharp contrast to the previously mentioned study by Zhao et al. [314], who 
reported a figure of 38% of the 5633 assayed genes of P. aeruginosa being differentially 
expressed in PaP3 infected versus non-infected cells with 98% of the differentially expressed 
genes being down regulated in the infected cells; as well as the previously mentioned study by 
Lavigne et al. [313] who identified 220 genes in P. aeruginosa PAO1 that were up-regulated 
and 13 operons that were downregulated during LUZ19 infection.  
 
Analysis of the differential gene expression data revealed the presence of a single four gene 
operon, the precise function of which is unknown, which showed a log2 fold increase in 
expression of approximately 1.15 between the control and the infected samples, as shown in 
Table 5.3. While the majority of genes identified to be differentially expressed were predicted 
to be hypothetical proteins the host DNA polymerase II (RS18970) showed a small log2fold 
increase (0.694) with a padj of 0.017.  
 
The tmRNA encoding gene ssrA shows significantly increased expression in phage treated 
samples with a log2fold increase of 1.64 and a padj of 8.67E-15. tmRNA is involved in trans-
translation and the release of all the components of a translation complex which has stalled 
during protein synthesis and tagging the unfinished peptide for degradation and facilitates the 
degradation of the malfunctioning mRNA [315]. However, the gene encoding the associated 
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ATP-dependent zinc protease HflB is under-expressed with a log2fold decrease of 0.77 and a 
padj of 0.019.  
 
No statistically significant gene expression was identified in any of the phage resistance 
systems previously identified in the P. agarici NCPPB 2472 genome in Section 3.2.6.  
This included in any of the identified CRISPR-associated proteins, with padj values varying 
between 0.99 and 0.97; it has been reported that cas1 and cas2 expression is required for new 
spacer region acquisition [244], we would therefore expect to see an increase in the expression 
of the cas1 and cas3 genes (RS05180, RS05185) if the cells were undergoing the acquisition 
of phage spacers at this time point.  
 
It is likely that the differential gene expression data is not statistically valid when taking into 
consideration the extremely low percentage of differentially expressed genes (0.79%) and that 
this was due to the large difference in reads attributed to bacterial genes compared to 
bacteriophage genes caused by the extremely high levels of phage gene transcription and 
possible host RNA degradation. The consequent high degree of normalisation required would 
then most likely mask any true differentially expressed genes.  
 
In any future work, as previously mentioned, a significantly higher MOI of between 5-10 would 
be needed in order to ensure all cells were infected with phage, as well as using a timepoint 
earlier in the phage replication cycle in order to reduce the imbalance in phage to bacterial 
transcripts; furthermore using RT-qPCR for identifying differential transcription in bacterial 
genes would by-pass the issue of large numbers of phage transcripts, however this approach 
would be impractical for large numbers of bacterial genes, therefore sequencing to a higher 
depth may increase the likelihood of changes in bacterial transcription being observed.  
 197 
 
 
 
 
 
Chapter 6:  
Discussion and Proposed Further Work 
 
 
  
 198 
The purpose of this study has been to elucidate the genetics of the phage-bacterium-host 
interactions of mushroom pathogenic Pseudomonas species.  
 
I have successfully isolated and sequenced the genome of the mushroom pathogen P. tolaasii 
2192T, which is available under the accession code NZ_CP020369, including the identification 
of a total of 6,286 putative gene encoding ORFs. Six NRPS proteins were identified within the 
P. tolaasii 2192T genome that are orthologous to those required for tolaasin biosynthesis, 
although further work would be needed to confirm these predicted functions.  
A putative pyocin encoding gene cluster was likewise identified within the genome that is 
likely of phage origin, that will also need further work to confirm.  
No CRISPR elements were identified in the genome of P. tolaasii 2192T. However, I have 
identified a biosynthetic gene cluster with predicted proteins orthologous to those required for 
alginate biosynthesis as well as multiple restriction endonuclease enzymes that can potentially 
act as phage resistance systems.  
 
I have likewise successfully isolated and sequenced the genome of the mushroom pathogen P. 
agarici NCPPB 2472, which is available under the accession code NZ_CP014135, including 
the construction of a scaffold genome and made significant progress in finalising the genome 
via stitching of the remaining contig sequences. However, future work would involve 
completing the sequencing of the remaining junctions and assembly of the sequences into a 
complete genome sequence. I have identified 4,901 putative gene encoding ORFs within the 
P. agarici 2472 genome including 10 NRPS/polyketide synthase proteins, although it has not 
been possible to identify their products and further work could address this shortcoming.  
Similar to the work performed on P. tolaasii 2192T I have identified a putative pyocin encoding 
biosynthetic gene cluster within the P. agarici 2472 genome. I have also identified a 
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biosynthetic gene cluster with significant similarities in amino acid identify and gene 
organisation to the achromobactin biosynthesis cluster of P. syringae pv. syringae B728a, 
which I hypothesise to be involved in the production of achromobactin in P. agarici NCPPB 
2472, further work would be needed to confirm this prediction however. Most notably I have 
identified a complete Type I-F CRISPR/Cas system within the genome of P. agarici NCPPB 
2472, including the identification of 34 spacer regions, of which one showed similarity to a 
known plasmid sequence involved in the production of naphthalene degrading enzymes. I have 
also identified multiple restriction endonuclease enzymes and their associated 
methyltransferase enzymes as well as a complete biosynthetic cluster with proteins orthologous 
to those required for alginate production, however further work would be needed to confirm 
the function of this cluster. 
 
During my investigations of P. tolaasii 2192T and P. agarici NCPPB 2472 I have identified a 
potentially new species, Pseudomonas sp. NS1, which shows significant genomic similarities 
with both the P. azotoformans species and P. fluorescens species. I have isolated and sequenced 
the full genome of P. sp. NS1 and made it publicly available under the accession code 
CP022960. I have identified a large biosynthetic gene cluster containing multiple NRPSs that 
shows significant nucleotide and amino acid similarity as well as gene organisation to the 
known WLIP production cluster 2 of Pseudomonas fluorescens strain LMG 5329; I have also 
demonstrated that P. sp. NS1 is capable of WLIP production and therefore provided strong 
evidence that this biosynthetic cluster does produce the WLIP.  
Similar to both P. agarici NCPPB 2472 and P. tolaasii 2192T I have also identified a 
biosynthetic gene cluster predicted to produce alginate and multiple putative restriction 
endonuclease enzymes, although both would require further work to confirm these predictions.  
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I have identified two new potential new species of bacteriophage capable of infecting either P. 
tolaasii 2192T or P. agarici NCPPB 2472.  
The first, Pseudomonas phage NV1, which is a narrow host range phage having only been 
demonstrated to be capable of infecting and lysis of P. tolaasii 2192T cells. I have isolated and 
sequenced the full genome of this phage, identifying that it shares significant nucleotide 
identity and genome organisation to the Pseudomonas fluorescens phage UFV-P2. However, 
the identity is below the DNA sequence identity threshold of 95% guideline set by the ICTV 
for delineation of a new phage species, and thus with the full genome sequence differences and 
differing host range I suggest that Pseudomonas phage NV1 is a new species of Luz24likevirus.  
Further work involving phage NV1 would be needed to further characterise the growth and 
lifecycle, as well as identifying the host cell surface receptor and identifying whether resistance 
of P. tolaasii NCPPB 2192T to phage NV1 is acquired through a change in P. tolaasii 
phenotype. 
 
The second phage identified, Pseudomonas phage ϕNV3, is likewise a narrow host range 
phage, having only been demonstrated to be capable of infecting and lysing P. agarici NCPPB 
2472 cells. I have extensively characterised the growth and replication of phage ϕNV3 
including the adsorption constant and single step growth profile and co-evolution with the host 
P. agarici NCPPB 2472.  
I have also isolated and sequenced the full genome of phage ϕNV3, including confirmation via 
extensive primer waling. I have identified that phage ϕNV3 shares significant genome 
organisation similarities with Pseudomonas phage ϕKMV as well as identifying a single 
subunit RNA polymerase which is characteristic of the Autographivirinae subfamily of 
bacteriophage. Likewise, I have also identified conserved features between the lysis cassette 
of phage ϕNV3 and ϕKMV, indicating that they share a conserved mechanism of action. I have 
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also confirmed the lytic ability of the endolysin protein of ϕNV3 as well as the complementary 
actions of the associated lysis cassette proteins and via the identification and characterisation 
of a spontaneous mutant of phage ϕNV3, phage NV6, identified the T7-like tail protein as the 
host-specificity determinant of phage ϕNV3. On the basis of the results presented in this study 
I conclude that ϕNV3 is a new species of phiKMVlikevirus within the Autographivirinae 
subfamily.  
 
While I have identified that P. agarici NCPPB 2472 rapidly develops resistance to phage ϕNV3 
I have not been able to identify the exact mechanism underlying this resistance. I believe that 
it is likely to be due to the acquisition of a phage DNA spacer within the CRISPR repeat region, 
which could be tested easily in future work by PCR of the CRISPR repeat region and 
sequencing of the resulting product, followed by screening for the acquisition of an additional 
spacer region with nucleotide identity to the genomic sequence of ϕNV3.  
 
While the attempts to create a Type IV knockout of P. agarici NCPPB 2472 to identify the 
binding receptor of ϕNV3 were unsuccessful, I have demonstrated that the technique used for 
electrocompetent cells was successful and this information could be used in further studies.  
 
 
The attempts to elucidate the changes in transcription associated with phage ϕNV3 infection 
of P. agarici NCPPB 2472 via RNA sequencing did not yield statistically significant results. 
This is most likely due to the significantly reduced read counts associated with bacterial genes 
in the phage infected samples caused by the high levels of phage RNA transcription and host 
RNA degradation. Future work on this would include the use of higher MOIs to ensure all host 
bacteria are infected with phage, an earlier timepoint in the phage infective cycle to ensure a 
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more even ratio of phage to bacterial RNA and potentially sequencing to a higher depth in 
order to identify changes in gene expression. 
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Appendix 1: Additional P. agarici NCPPB 2472 Contig Sequencing Data 
 
Reaction 1 Sequence: 
Contig 3 End -
TGTAACGCTGTAGAATTCGCCTCCCGCTGTCGATAGGTCGACAGCGCAAGTGGTT
GAAGTTGAAGCGTTTTTTGAACGAAAAGCCTTGAAAACTTCTCAAATAATCACTT
GACAGCAACTGGCGCTGCTGTAGAATGCGCGCCTCGGTTCAGCGAACAGCTCAA
CCCACCGCTCTTTAACAACTGAATCAAGCAATTCGTGTGGGTGCTTGTGGAGTCA
GACTGAATAGTCACTAGATTATCAGCATCACAAGTTACTCCGCGAGAAATCAAA
GATGTAACCAACGATTGCTGAGCCAAGTTTAGGGTTTTCTCAAAACCCAAAGATG
TTTGAACTGAAGAGTTTGATCATGGCTCAGATTGAACGCTGGCGGCAGGCCTAAC
ACATGCAAGTCGAGCGGATGAAGAGAGCTTGCTCCCGGATTCAGCGGCGGACGG
GTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGACAACGTTTCGAAAGGAA
CGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGACCTTCGGGCCTTGCG
CTATCAGATGAGCCTAGGTCGGATTAGCTAGTTGGTGAGGTAAAGGCTCACCAA
GGCGACGATCCGTAACTGGTCTGAGAGGATGATCAGTCACACTGGAACTGAGAC
ACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGGACAATGGGCGAA
AGCCTGATCCAGCCATGCCGCGTGTGTGAAGAAGGTCTTCGGATTGTAAAGCACT
TTAAGTTGGGAGGAAGGGCATTAACCTAATACGTTAGTGTTTTGACGTTACCGAC
AGAATAAGCACCGGCTAACTCTGTGCCAGCAGCCGCGGTAATACAGAGGGTGCA
AGCGTTAATCGGAATTACTGGGCGTAAAGCGCGCGTAGGTGGTTGGTTAAGTTG
GATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCCAAAACTGGCCAGCTAG
AGTAGGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATA
GGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTCATACTGACACTGAGGT
GCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAA
CGATGTCAACTAGCCGTTGGGAACCTTGAGTTCTTAGTGGCGCAGCTAACGCATT
AAGTTGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACG
GGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAAC
CTTACCAGGCCTTGACATCCAATGAATCTTCCAGAGATGGAGGAGTGCCTTCGGG
AACATTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGTAACGAGCGCAACCCTTGTCCTTAGTTACCAGCACGTGATGGTGG
GCACTCTAAGGAGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCA
AGTCATCATGGCCCTTACGGCCTGGGCTACACACGTGCTACAATGGTCGGTACAA
AGGGTTGCCAAGCCGCGAGGTGGAGCTAATCCCATAAAACCGATCGTAGTCCGG
ATCGCAGTCTGCAACTCGACTGCGTGAAGTCGGAATCGCTAGTAATCGCGAATC
AGAATGTCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCAT
GGGAGTGGGTTGCACCAGAAGTAGCTAGTCTAACCTTCGGGAGGACGGTTACCA
CGGTGTGATTCATGACTGGGGTGAAGTCGTAACAAGGTAGCCGTAGGGGAACCT
GCGGCTGGATCACCTCCTTAATCGACGACATCAGCTGCTGCATAAGTACCCACAC
GAATTGCTTGATTCATTGAAGAAGACGATAGAAGCAGCTCCAGGCTCTGTGATA
AAGAGCAAGGTAAAGTCCGCTTGTTACACCCAGATTCTGGGTCTGTAGCTCAGTT
GGTTAGAGCGCACCCCTGATAAGGGTGAGGTCGGCAGTTCGAATCTGCCCAGAC
CCACCAGTTACTTGGTGAGGGACTTGGCAAGAGCGCACCCCCGCCTCTGAGGTA
AAGAGCGGTGAGGTCAGGGTTTTTTGCAGTTCGAATCTGCCCAGACCCACCAGTT
TGTGTGGGAAGTGTGGTAGGAACCTGTAGATATACGGGGCCATAGCTCAGCTGG
GAGAGCGCCTGCCTTGCACGCAGGAGGTCAACGGTTCGATCCCGTTTGGCTCCAC
CATTAACTGCTTCTGATGTTAGAGCTTAGAAATGAATATTCACACACGAATATTG
ATTTCTAGTCTTTGATTAGATCGTTCTTTAAAAATTTGGGTATGTGATAGAAAGAT
AGACTGAACGTTACTTTCACTGGTAACGGATCAGGCTAAGGTAAAATTTGTGAGT
TATCTTACAGATTTTCGGCGAATGTCGTCTTCATACTGTAACCAGATTGCTTGGG
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GTTATAGGGTCAAGTGAAGAAGCGCATACGGTGGATGCCTTGGCAGTCAGAGGC
GATGAAAGACGTGGTAGCCTGCGAAAAGCTTCGGGGAGTCGGCAAACAGACTGT
GATCCGGAGATGTCTGAATGGGGGAACCCAGCCATCATAAGATGGTTATCTTGT
ACTGAATACATAGGTGCAAGAGGCGAACCAGGGGAACTGAAACATCTAAGTACC
CTGAGGAAAAGAAATCAACCGAGATTCCCTTAGTAGTGGCGAGCGAACGGGGAC
TAGCCCTTAAGTGGCTTTGAGATTAGCGGAACGCTCTGGAAAGTGCGGCCATAGT
GGGTGATAGCCCTGTACGCGAAAATCTCTTAGTCATGAAATCGAGTAGGACGGG
GCACGAGAAACCTTGTCTGAATATGGGGGGACCATCCTCCAAGGCTAAATACTA
CTGACTGACCGATAGTGAACTAGTACCGTGAGGGAAAGGCGAAAAGAACCCCGG
AGAGGGGAGTGAAATAGATCCTGAAACCGTCTGCGTACAAGCAGTGGGAGCCCA
CTTGTTGGGTGACTGCGTACCTTTTGTATAATGGGTCAGCGACTTATTTTCAGTGG
CAAGCTTAACCGAATAGGGGAGGCGTAGCGAAAGCGAGTCTTAATAGGGCGTCT
AGTCGCTGGGAATAGACCCGAAACCGGGCGATCTATCCATGGGCAGGTTGAAGG
TTGGGTAACACTAACTGGAGGACCGAACCGACTACCGTTGAAAAGTTAGCGGAT
GACCTGTGGATCGGAGTGAAAGGCTAATCAAGCTCGGAGATAGCTGGTTCTCCT
CGAAAGCTATTTAGGTAGCGCCTCATGTATCACTGTAGGGGGTAGAGCACTGTTT
CGGCTAGGGGGTCATCCCGACTTACCAAACCGATGCAAACTCCGAATACCTACA
AGTGCCGAGCATGGGAGACACACGGCGGGTGCTAACGTCCGTCGTGAAAAGGGA
AACAACCCAGACCGTCAGCTAAGGTCCCAAAGTCATGGTTAAGTGGGAAACGAT
GTGGGAAGGCTTAGACAGCTAGGAGGTTGGCTTAGAAGCAGCCACCCTTTAAAG
AAAGCGTAATAGCTCACTAGTCGAGTCGGCCTGCGCGGAAGATGTAACGGGGCT
CAAACCATGCACCGAAGCTACGGGTATCACTTAGGTGATGCGGTAGAGGAGCGT
TCTGTAAGCCTGTGAAGGTGAGTTGAGAAGCTTGCTGGAGGTATCAGAAGTGCG
AATGCTGACATGAGTAACGACAATGGGTGTGAAAAACACCCACGCCGAAAGACC
AAGGTTTCCTGCGCAACGTTAATCGACGCAGGGTGAGTCGGTCCCTAAGGCGAG
GCTGAAAAGCGTAGTCGATGGAAAACAGGTTAATATTCCTGTACTTCTGGTTATT
GCGATGGAGGGACGGAGAAGGCTAGGCCAGCTTGGCGTTGGTTGTCCAAGTTTA
AGGTGGTAGGCTGGAATCTTAGGTAAATCCGGGGTTTCAAGGCCGAGAGCTGAT
GACGAGTTACCCTTTAGGGTGACGAAGTGGTTGATGCCATGCTTCCAAGAAAAG
CTTCTAAGCTTCAGATAACCAGGAACCGTACCCCAAACCGACACAGGTGGTTGG
GTAGAGAATACCAAGGCGCTTGAGAGAACTCGGGTGAAGGAACTAGGCAAAAT
GGCACCGTAACTTCGGGAGAAGGTGCGCCGGTGAGGGTGAAGGACTTGCTCCGT
AAGCTCATGCCGGTCGAAGATACCAGGCCGCTGCGACTGTTTATTAAAAACACA
GCACTCTGCAAACACGAAAGTGGACGTATAGGGTGTGACGCCTGCCCGGTGCCG
GAAGGTTAATTGATGGGGTTAGCTCACGCGAAGCTCTTGATCGAAGCCCCGGTA
AACGGCGGCCGTAACTATAACGGTCCTAAGGTAGCGAAATTCCTTGTCGGGTAA
GTTCCGACCTGCACGAATGGCGTAACGATGGCGGCGCTGTCTCCACCCGAGACTC
AGTGAAATTGAAATCGCTGTGAAGATGCAGTGTATCCGCGGCTAGACGGAAAGA
CCCCGTGAACCTTTACTATAGCTTTGCACTGGACTTTGAATTTGCTTGTGTAGGAT
AGGTGGGAGGCTTTGAAGCGTGGACGCCAGTTCGCGTGGAGCCAACCTTGAAAT
ACCACCCTGGCAACTTTGAGGTTCTAACTCAGGTCCGTTATCCGGATCGAGGACA
GTGTATGGTGGGTAGTTTGACTGGGGCGGTCTCCTCCTAAAGAGTAACGGAGGA
GTACGAAGGTGCGCTCAGACCGGTCGGAAATCGGTCGTAGAGTATAAAGGCAAA
AGCGCGCTTGACTGCGAGACAGACACGTCGAGCAGGTACGAAAGTAGGTCTTAG
TGATCCGGTGGTTCTGTATGGAAGGGCCATCGCTCAACGGATAAAAGGTACTCC
GGGGATAACAGGCTGATACCGCCCAAGAGTTCATATCGACGGCGGTGTTTGGCA
CCTCGATGTCGGCTCATCACATCCTGGGGCTGAAGCCGGTCCCAAGGGTATGGCT
GTTCGCCATTTAAAGTGGTACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCG
GTCCCTATCTGCCGTGGACGTTTGAGATTTGAGAGGGGCTGCTCCTAGTACGAGA
GGACCGGAGTGGACGAACCTCTGGTGTTCCGGTTGTCACGCCAGTGGCATTGCCG
 223 
GGTAGCTATGTTCGGGAAAGATAACCGCTGAAAGCATCTAAGCGGGAAACTTGC
CTCAAGATGAGATCTCACTGGAACCTTGAGTTCCCTGAAGGGCCGTCGAAGACT
ACGACGTTGATAGGTGGGGTGTGTAAGCGCTGTGAGGCGTTGAGCTAACCCATA
CTAATTGCCCGTGAGGCTTGACCCTATAACACCCAAGCAATTTGTGAACTTGAGC
CTGAAGGCCAGAGAGCAGATTGCGGGGTGTGAAGACGAAACGAACCGAAAGTT
TGTGCTGAC - Contig 21 Start  
 
Reaction 2 Sequence:  
Contig 21 End -  
ATACCCACCGAGTCTCTTCTGAGCTTCTCCACACTTTGGGCAAATGGCCTTTATCT
CGGGCAGCCGCTTGCCGATTGCGAACAGCCTGCCTGACAGCTTTTCACTAATAGC
GGGCTTAGCTTAAAGCTCACTCGCCCATCGCTATGTATCGCGTGATCGTCGAAGT
GGAGAAAAACTAAATGAGTGATGGTTATTTTATCGGCCTGGGTGACAAAACCAC
CTGCGGCGGGGAAGTTCTGGATGGTGACGAGAGAATCAATATGTTTGGCGTCCT
GCATGCCTGAGAAGGTGATCGGGTCTCATGTGGAAGGACGGAAAGACTTATCGG
ATCGTCGGTGGCGTTTCCCATATGAATAGCCATGATCGGCTGATGGCTGGCACGC
TGGATAGCCACAGCGATTGCCCCTGCAAAGCCAAACTGGTCCCCTCGGTTCTGAC
GGCTTGCTATCGTAATGGCCCCGCAACCAGCCGAGTCGCCGAGCAACCGGCCTCT
TCAGCAGCTACCAGCCGCTCGCCAGCGCCGCTTAAATCTGTTTTCTCTCCTCCAA
GCCCTCCAGCCCCAGGGATATTCAGCCGCGTGGAGCCCCAGGAGCCGGGTTTCC
ATGTAGTGCCCAAAAGCATGACCCGCGAGGCACTGGAGGCCACGCTGTTCCCCA
CGCCCGACTCGGCGGTGATGCGCAAGTTCCGGGCGCTCAACCCTTATCGTGGCGA
CGTCAAGGCCGGATCGCTGATCGTCCTTGGCGATCCGAACAACCTGCTCTGTACC
CGCGAAGAGGCGCAGTTGATGGCGGCGGCGCAAGCGGTGCATGCCGAGCTGGA
ACCCCTGACACCGGAACAAGCCGACTTCATGCAGCGCCACAGTGTCGAAATTGC
CAGTTTTGCCGGCCATGCTTNCAATCT - Contig 38 Start 
 
Reaction 18 Sequence 
Contig 11 End - 
CAAAGAAGAAGGCGAAGTAACGGTCAAGGGCGCCAACGCCGGCCATGCCACCG
AAGCCAACATGGACCGCCTGGACAACGCCGGCGGTGCCGCCGCCCTCGAAGCCC
GTGCCGTGACCGCCAACGACTCCGCCGCGATCATCCGCGCCAAGGCCGCTCTCG
ACGCCCTCGATGTCGCCGAAGGCCTGGCCGAACTCGAAGGCGCCTCGGCTCGGG
TCGCCGTCGATGAAAAGCGCATGATCAACTGCCGCGCCGACCTCAACCAGCTCG
TCCCCTTCAAGTACGACTGGGCCTGGCAGAAGTACCTCGACGGCTGCGCCAACC
ACTGGATGCCGCAAGAGGTCAACATGACCGCCGACATCGCCCTGTGGAAAAACC
CCGAAGGCCTGACCGACGACGAGCGCCGCATCGTCATGCGCAACCTCGGCTTCTT
CTCCACCGCCGACTCCCTGGTGGCCAACAACCTGGTACTGGCCGTCTACCGCCTG
ATCACCAACCCCGAGTGCCGCCAGTACATCCTGCGCCAGGCCTTCGAAGAGGCC
ATCCACACCCACGCCTATCAGTACTGCATCGAATCGCTGGCCATGGATGAAGGC
GAAATCTTCAACATGTACCACGAGATTCCTTCGGTGGCGAAAAAGGCCGCCTGG
GGCCTGAAGTACACCCGTTCGATCTCCGATCCGAAGTTCGAGACCGGTACCGTCG
ACACCGACAAGGAACTGCTGCGCAACCTGATCGCCTACTACTGCGTGCTCGAAG
GTATCTTCTTCTACTGTGGCTTCACCCAGATCCTGTCCATGGGCCGGCGCAACAA
GATGACC - Contig 9 Start 
 
Reaction 19 Sequence  
Contig 9 End - 
CATCGTAGGCGAAGGTTTCGCTATGGCCCCGTGGGTTCTCCTGGGTGGCGATGAT
TCGGTCGGTGGCGTCGTAGTGCAGGTGTTGACGCTGGTCGCGGCGGGCGGGGTT
 224 
ATCGCGTTCGTCACGCTCGATCAGGTTGTCGAGGACATCGTATTCGAAGTATTTA
TTCCGGGCGGCAGATAGCATTTCCGGCTGGTTGTTCGGGCGGCGCACCCGTGAGC
GCAGGCGTCCGCACCGGTCATACTCGCTGCGGGTGTTGAGTTGTCCCTGGGTGCG
CGAGAGTTCGCGGTGCAGGCGGTCGCGTTCGAAGTCGCTGATGACCTCGCCGTC
GAGGTTGAGCTGATGCAGGTGGCCACTGCCGTAATACAGCCGATTGAGCCAGCG
CCCATCGGGTAGCTGCGTCTGGCTCAGGTTGCCCAGTTCGTCGTAGTGATGCTGC
AAGCTGCCGGCTGCGCTCTGTTCTTCCAGCAACCGGCCGAGGGCGTCATAGGCG
AAGTTGAGTGTTTGTTCATTACCGTCATGGTCGGTAAAGGTGATGGCGGTCACTT
GGTCCAGCCGGTCGTAGCTGTAGGTGGTGCGGCCATCGGCGGTGATCTTGGCGAT
CAGGCGACCCAGTGCATCGCGTTCCAATTGATGGACGATAGGAGCCGGAGTCGG
GCTTCCATCCTCTTGAGGCGCTGGCAAGTGTTCAATGGCGACTACGTTGTCGTGC
GTGTCATAGCTGTACTGCCGGGCGCTGCCGTCCAGATCCTGTTGGCGGATCCGGC
GGTCGTTGGCATCCCAGGCAAAGCGGTAACTTTCCCCGTTCTCGTTGGTCAGTGC
CTGCAAGCGGCCATAGGCGTCGTAGTGGTATTCGATCTGTCGGCCAAGGGCGTC
GGTGCGTTGGCGTACCTGGCCGCGTCGGTTGTACTGGTAGCGCGTGCTGCCGCCA
GCGGCGTCGATATGGGCGATCAGTTGGCCGTGGGCGTCGCGCTGGTAGTGGTCG
AAGCGGTCCACGGGCCGTTCGGTTTGCAGCAGTCGGCCTTGAGCATCGCGTTGGT
AGTGCACCCGTTCGCCAAAGGCATCGGCCACCGTACACAGGTGGCCGCGTCGGT
CGTAGTAAAAGTCCGTGGGATAGTCGGAGCAATCGGCGTGGTAGGTCAGTTGCC
CGCATTCGTTCCAGCGCAAGGTTCGGCTTTTGCCCGTGGCATCGATGATTTCCAC
CACCTGGCCGAAGGCATCGTAGCGATAGGTGGTGGTGTGCCCCAGCGGGTCGGT
TTCGCTGAGGCAGTTGCCGCGTTGGTCGTAGCGGTACTGCCAGGCCTGGCCGGCG
GCATCGGTTTGCACTTGGGGCAGCGACCAGTGTTCCAGCCACAGGGTGGAGTCG
ATACGGCCCAATGGGTCTTCGCTGGTGGACAGGTTGCCGGAGGCGTCGTAGCTG
AAGCGCCAGTGTCCGTCCTGCGGATCAATGGCGCCGAGTAGCTGGCGTTCGTCGT
TCCACTGAAATTGCCAGGTATGGCCGAGGGGGTCGGTGTAGGCGGTGATCTGGT
ACTGGCGGTTCCACTGGAGGGTGCTGACACGCCGTAAACCATCGGTAATACGTG
TGATGCCAGCCTCCAGGTCGTAGTCGAACTGGTAGTCATCGCCGTCATCGGTCCA
GTGCCGGGTGACGCGCCATTCCTGTGTTTTTTGTGTTTTCTGTGTTTCTTGTGTTTC
CTGTGTTTCGATCAGCGCCCATTGATAGAAACAACGCAGGCCGCTGGGCAATTG
GTGTTCGACCAGGCGCCGGTGTTCGTCATAGGCAAAACGCCGCTGAACTTGCCCT
GTGGCATCGCGAACTTCACTCAGGTCGCCCGCCGCATCGTAGTCATAGCTGACCA
GCACTTCGCGGGTTTGATCGGGGTACAGGCGTTCGATCTGGCCGATACGCCGAG
GCCCTTGGGGGCTGTGGTAGATCAGTTCCACCTGGACTTGGTCGAAGGTGTCACG
CAAGCGAATCAGCGTGCCCGACTTGCTGTAGTCGAGGTAGAGCCGGTTGTCGTTG
CGGTCGCCCAACTGGCTCAGGCGCAGTCGCGAGGGATCGGCGAGGGTCGGTTCA
AACAGCCGGTACAGCCCGTCCTCGCTCTCGATCAGCAACTGCCCGTTGTCGTGGC
GCCGCACGCTCAAGCCTTCGCCGGCACTGAACACCGCATGGCCCAGCGGGATTG
AGCCCATATCGATCTGTCGGGCCTGCTCGTCGGTGTAGATCAGCCGTTCGCCGCC
TTCGGGACGGGCTTCGAGGCGCACGTTGATTTCATACGGCAGGCTCCAGCCCTGG
CCGAGCAAACTGTCGTGGCGTTCATCGCGGCTGTTGTAGAAGCGTTGCCAGTCGA
GGGGCAGCAAACCGGGCAAGGCGAAATCGAGCTCGTCCTCGCCGCCCAGCACCT
TGGCACCAGTGGCGGCGTGGACCGGGTTAGGCGAGCCGGACATCGCCGCGCTCA
GGGCGTTGCTGACCTGGCCGGTGCCCCATGACGTCAGTCCGCCGACCAGCATGC
AGGGCAATTGGCTGAAAAACTTCGCGCCGCCACCGCGCAACATCAACAAGGTGC
CCACCGCCAGGCCCACGCCGGGGGGCTTGCCGCTGCGGATTTCGCGTATCACCAC
GGGCGCGCCACCGATGCGCACATTGGGTGAAATCAGCCCGTTGACCGCACCGAC
CCGAGCCTCGCAGGTGCTGCGATCACCCGTGCGCACGGCGGGCTGGCCGTTGAT
GGTGACTTTGCTGGAGCCTTCGGCGAGATAGACCTGGGGCATCGGCGGGTGTTTG
TCGCAGGCCACGCGATCATAAGGGCTGGGAATGGCGCCGGGCGCGGGGGTGGCG
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ACGGTGGGCCGCCATAGCTGGGAAAAGAAGCCCTGGGCGATATCCAGGTAGCCA
GCGGACTCGCCGGCCAGTACCGGGCCGATCCTGCCAGCGGCGCGGGCGGCGGGC
TTGCCGTTGATAAAGGTGTCGGGCGAGCCGGTGGTGATATGGGCCTGGACCGTG
GGCGGAAACAGCGCATTGCTTAGCCAGTCGCAGAGCTGTTTCACCTCCTCGTCGG
TGCCGGTCTGGTTCATGCCGACGCCGACCGCAATGCCCACCGCGCTCCCGAGTAC
GAGGCAGCCCAGCCCACCGGTGGCGACGGTGATACCCGTTGCCGCGACAACCGC
CGTGGTGGCCAGTGCGCCGACCGCGACAGAGGCGGCGATTTCCAGGACTCCGCC
CAGGAGGTCGGCCATCGGCGCGGTGTGCAGCAGGGCATCGCCTTCGC - Contig 42 
Start 
 
Reaction 23 Sequence  
Contig 29 End - 
ACCACCTACAGCTACGACCGGCTGGACCAAGTGACCGCCATCACCTTTACCGACC
ATGACGGTAATGAACAAACACTCAACTTCGCCTATGACGCCCTCGGCCGGTTGCT
GGAAGAACAGAGTGCAGCGGGTAGCTTGCAGCATCACTACGACGAACTGGGCAA
CCTGAGCCAGACGCAGCTACCCGATGGTCGCTGGCTCAATCGGCTGTATTACGGC
AGTGGCCACCTGCACCAGCTCAACCTCGACGGCGAGGTCATCAGCGACTTCGAA
CGCGACCGCCTGCACCGCGAACTCTCGCGCACCCAGGGACAACTCAACACCCGC
AGCGAGTATGACCGGTGCGGACGCCTGCGCTCACGGGTGCGCCGCCCGAACAAC
CAGCCGGAAATGCTATCTGCCGCCCGGAATAAATACTTCGAATACGATGTCCTCG
ACAACCTGATCGAGCGTGACGAACGCGATAACCCCGCCCGCCGCGACCAGCGTC
AACACCTGCACTACGACGCCACNGACCGAATCATCGCCACCCAGGAGAACCCAC
GGGGCCATAGCGAAACCTTCGCCTACGATGCCGCCGCCAACCTGCTCAACGGCC
AGCAACAAAACGCGGNACGGGTGCTGCACAACAAGCTGCTGACCTATCAGGACA
AACGCTATCGCTACGATGGCTTTGGCCGCATGATCGAAAAACGCAGCGCCAGCC
ATCGGGTACAACGTTTTGCCTATGACGCCGAACACCGCCTGATCGAAGTCCACAA
CCAGGACGGCGTCCGCGAAACCGTGGTGCGCATGACCTACGACCCGCTGGGCCG
GCGCATCGGCAAAACCGAACACAACCACAACGGCTATTTGCTGGGCGAAACCCG
TTTTACCTGGGACGGTTTGCGGCTGTTGCAGGAACACAAGAACACCCAAACCAG
CCTCTACCTGTATGTCGACGANAGCTATGAACCGTTGGCGCGGGTCGATGGCCTC
GGCGACGTGCAGAAAATCCGCTACTACCACACCGACCCCAACGGCCTGCCCGAG
CAACTGACGGAGGCCGAT Contig 6 Start 
 
Reaction 26 Sequence  
Contig 24 End -  
TGTATACCCACCGAGTCTCTTCTGAGCTTCTCCACACTTTGGGCAAATGGCCTTTA
TCTCGGGCAGCCGCTTGCCGATTGCGAACAGCCTGCCTGACAGCTTTTCACTAAT
AGCGGGCTTAGCTTAAAGCTCACTCGCCCATCGCTATGTATCGCGTGATCGTCGA
AGTGGAGAAAAACTAAATGAGTGATGGTTATTTTATCGGCCTGGGTGACAAAAC
CACCTGCGGCGGGGAAGTTCTGGATGGTGACGAGAGAATCAATATGTTTGGCGT
CCTGCATGCCTGCGAAGGTGATCGGGTCTCATGTGGAAAAGGACGGAAAGACTT
ATCGGATCGTCGGTGGCGTTTCTCATATGAATAGCCATGGTCGGCTGATGGCTGG
CACGCTGGATAGCCACAGCGATTGCCCCTGCAAAGCCAAACTGGTCCCCTCGGTT
CTGACGGCTTGCTATCGTAATGGACCCGCAACCAGCCGAGTCGCCGAGCAACCG
GCCTCTTCAGCAGCTACCAGCCGCTCGCCAGCGCCGCTTAAATCTGTTTTCTCTCC
TCCAAGCCCTCCAGCCCCAGGGATATTCAGCCGCGTGGAGCCCCAGGAGCCGGG
TTTCCATGTAGTGCCCAAAAGCATGACCCGCGAGGCACTGGAGGCCACGCTGTTC
CCCACGCCCGACTCGGCGGTGATGCGCAAGTTCCGGGCGCTCAACCCTTATCGTG
GCGACGTCAAGGCCGGATCGCTGATCGTCCTTGGCGATCCGAACAACCTGCTCTG
TACCCGCGAAGAGGCGCAGTTGATGGCGGCGGCGCAAGCGGTGCATGCCGAGCT
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GGAACCCCTGACACCGGAACAAGCCGACTTCATGCAGCGCCACAGTGTCGAAAT
TGCCAGTTTTGCCGGCCATGCCTCAA - Contig 15 Start  
 
Reaction 28 Sequence  
Contig 13 End - 
GCTACGACGCCAGCGCCGACGGTACGACCGCCTTCACGAATAGCGAAACGCAGG
CCGTCTTCCATCGCGATGGTCTTGATCAGCGTGACAGTCATCTGAATATTGTCAC
CTGGCATCACCATTTCAACGCCTTCTGGCAGTTCGCAGTTACCGGTCACGTCAGT
TGTACGGAAGTAGAACTGTGGACGGTAGCCTTTGAAGAACGGCGTGTGACGACC
GCCTTCTTCCTTGCTCAGAACATAGACTTCTGCAGTGAACTTGGTGTGCGGCTTG
ACCGAACCTGGCTTGACCAGAACCTGGCCACGCTCCACGTCGTCACGCTTGGTAC
CACGCAGCAGCACGCCGCAGTTCTCGCCGGCACGACCTTCGTCGAGCAGCTTGC
GGAACATTTCAACACCGGTGCAGGTGGTGGTGGTGGTATCACGCAGACCAACGA
TTTCCAGTGGATCCTGAACACGAACGATACCACGCTCGATACGACCGGTTACCAC
AGTGCCGCGACCGGAGATCGAGAACACGTCTTCGATTGGCATCAGGAACGGCTT
GTCGATAGCGCGCTCTGGCTCTGGAATGTAGCTGTCCAGAGTTTCCACCAACTTC
TTGACGGCGGTGGTGCCCATCTCGTTGTCGTCTTTACCCTCCAGCGCCATACGGG
CCGAACCGATGATGATCGGAGTGTCATCACCTGGGAAGTCGTAGGTGCTCAGCA
GGTCGCGAACTTCCATCTCAACCAGTTCCAGCAGCTCTGCGTCGTCTACCAGGTC
AGCCTTGTTCAGGAAAACCACGATGTACGGAACGCCTACCTGACGGGACAGCAG
GATGTGCTCACGGGTTTGCGGCATCGGACCATCGGCGGCCGAGCAAACCAGGAT
CGCGCCGTCCATCTGCGCAGCACCGGTGATCATGTTCTTCACGTAGTCGGCGTG -
Contig 46 Start  
 
 
 
Reaction 30 Sequence 
Contig 12 End -  
CCCGATCACCGCGTCCTGTACGCCGCGGGGATAAGCCCAATCAGTGACCCGGAA
GGGAAAACCTCATGACCGACCCTGACATCGTTGTCCCCGTTGCCCTGAAACACTC
CCAACAAGTGACCTGCAGCGCGCCCTGGTACGTGCAGAGGAGTGAATATCACCC
CATGGAGGCCACCTATCAGCCGTTGATCAACGGCGAAGAAACCTTCAAGGCCGT
GCATCTGGCGATTGCCCGAGCCACTAAAACCATCGACATCATCTGTTGGGGCTTT
CAGCCGTCGATGTATTTCATTCGCGACGGTAAAGCCCCGAGTATCGGCGAACTGC
TCAAGGCCAAGGCTCGGGAGGGAGTCAAGGTGCGCGTATTGGGATGGGAAATGC
CGCTCAACCTCGCGGGTTTCGCCGGTGAGGCGAACCTGCCCGGTAAAGGTACGG
TTCGCCTCAAGGACCGAGCCATGCAACGTTCTACTCAGGCGCAATACGACGAGG
ACCGCCGGTGGTTTGCCGAATGTGCGGTCGCGGACGACAAGGCGGCTCAGCAGG
GAGCGAGTGGGCTTCCGGTGTTTGTCAGTCGCGGTTTCGACCTGAATGAAAGAGC
CAAAATTGCCCATGAGGTGAAATACGAAGGCCTCGATCGCGAGATCAGTGACAA
GATGCGTCACACACTGAGGTGGACAGCCACCCATCACCAAAAGAGTGTGCTGGT
CGACTATGGCCTGCCGGATTGCGCCGTCGGTTTCGTCATGGGCCACAACATGCTC
GACGAATACTGGGACACCAACGCGCACTCGGCGCTGAACCGCTCCGAGGATAGT
AAGCCTGCCCCCAATAGCGGCCCGCGTGGCAATACCCCACGCCAGGATATTTCC
AGCCAGATCAGCGGGCCGATTCTGGAACACCTGCACCATAACTTCGCCAGCGCC
TGGCGTAAGGAAACCGGCGAGGACCTGCTCATTTCTCGCCAGGCCAAACAGGTG
GGACCGCACCTGAAATGCACCCCCGGTGCCACTCGCCAACTGGCCCAACTGCTA
CGCACCCAGGCGCAGTCGGGCAAGCGCGATATCGAAAGGGCTTACCTGAAAGCG
GTCAACAACGCGACCCAGTTCATCTACATCGAGAACCAGTACTTTCGCTGGCCAC
CGCTGGCCGAAGCCATCAAAAAGGCCGCGGCCGACCAGACCGGCGCGGGACGC
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GATCCCGGCTTGCATGGCGCCTTACACCTGTTCGTGATCACCAATGCCACGGACG
ATGGCATTGGCGCGGGCACGGTGAACACCCAGCGCATGCTCGACAGCCTTGGAC
GCGCCGAGACCATTCCCGAGGTCACCAAGCTGCGGCTGATCAAAAAGATCAAAA
AAGATGCCCCACCCCAACCGCAACCTGATCTGCGTGATCACGCAGGGAAGAGGG
AATTGGCTAACTGGCAGGCCGAACTTGATCGGCAAATCGAGGACGTCCAGAACA
GCACAATCGTGCCGCAGAAGGTACCGGGCCTGAAAATCCACGTGTGCTCGCTGG
TTGCGCCCGATTCACCGGCTGGGAAACCGTGGATGCCGGTCTATATCCACTCCAA
GCTGATGATCGTCAATGACNTGTTCACCACCCACGGTTCGGCCAACATCAACACC
CGCAGCATGCAGGTGG - Contig 23 Start 
 
Reaction Rb 14 Sequence  
 
AAATGCGCCTGCTCTCCTGGCCGTTGATTGCCGCAGGACAAAAAGTCTGGCTGCG
GCTGGAGGGACTGAACGCCAACAACGCGCCGCACAATCACACCCTGTGGGAAGC
CGCCACGGTTTCATCGACGTGGGTCAGCGACGGCCATGCGGAGATATTGGTACC
GGCCAGCTACCTGAGTGGATTGGGCCATGGAACTTCCCTGTCGGCGACGTTCAAG
GCGACGTTTGATCGCAGCAGCGTCGAGGCCAATGCGCTGACGTTCCCGGCGCAC
GGATTGAGGGTGGAAAACAACCCGCGCA - Contig 22/Contig 35 Overlap (Contig 22 
in Pink)  
 
Reaction Rb20 Sequence  
Contig 15 End -  
TTGAGGCATGGCCGGCAAAACTGGCAATTTCGACACTGTGGCGCTGCATGAAGT
CGGCTTGTTCCGGTGTCAGGGGTTCCAGCTCGGCATGCACCGCTTGCGCCGCCGC
CATCAACTGCGCCTCTTCGCGGGTACAGAGCAGGTTGTTCGGATCGCCAAGGAC
GATCAGCGATCCGGCCTTGACGTCGCCACGATAAGGGTTGAGCGCCCGGAACTT
GCGCATCACCGCCGAGTCGGGCGTGGGGAACAGCGTGGCCTCCAGTGCCTCGCG
GGTCATGCTTTTGGGCACTACATGGAAACCCGGCTCCTGGGGCTCCACGCGGCTG
AATATCCCTGGGGCTGGAGGGCTTGGAGGAGAGAAAACAGATTTAAGCGGCGCT
GGCGAGCGGCTGGTAGCTGCTGAAGAGGCCGGTTGCTCGGCGACTCGGCTGGTT
GCGGGTCCATTACGATAGCAAGCCGTCAGAACCGAGGGGACCAGTTTGGCTTTG
CAGGGGCAATCGCTGTGGCTATCCAGCGTGCCAGCCATCAGCCGACCATGGCTA
TTCATATGAGAAACGCCACCGACGATCCGATAAGTCTTTCCGTCCTTTCCACATG
AGACCCGATCACCTTCGCAGGCATGCAGGACGCCAAACATATTGATTCTCTCGTC
ACCATCCAGAACTTCCCCGCCGCAGGTGGTTTTGTCACCCAGGCCGATAAAATAA
CCATCACTCATTTAGTTTTTCTCCACTTCGACGATCACGCGATACATAGCGATGG
GCGAGTGAGCTTTAAGCTAAGCCCGCTATTAGTGAAAAGCTGTCAGGCAGGCTG
TTCGCAATCGGCAAGCGGCTGCCCGAGATAAAGGCCATTTGCCCAAAGTGTGGA
GAAGCTCAGAAGAGACTCGGTGGGTATGC - Contig 24 Start 
 
Reaction Rb42 Sequence  
 
ACGGGTCCGCAGCTTCCCCTGGGTCAAGTTTTTTGACGGGGACTTAGCCTCCNAA
AAGCCAGCGACCACTGTCCAGAAATGTAAGTGTAGTACGTAGTGTTTCTAGCCA
AATGGGCCGCGGAGTGCCGGGGAGGCGGTTTTTTAGGACATCGTTGTCCATCTTG
AGCTGCCGGTTCTCTTGCTCCAACTGCCGAATACGCTGCTGCTCAGGTGTCAACG
GCTTACCGATC Contig61/39 Overlap (61 End in Pink) 
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Reaction 8 (Incomplete) 
 
Contig 59 end- 
TCTGTAAGGGGCCGGGGAACACACCTTCCGAGCCCGAGCAATAAGGACGATTGT
GTCCGCGTATTTTTAAGCGGACGCAATTACCCTTAATGCCAGGATCGTCATGCGC
CAACGTAAGTCATACCCGAAATCCTTCAAGACCCAAGTCGTTCAAGAGTGCGAG
CAGCCCGGTGTTTCCGTGGCAGCTATTGCGATGAGTCACGGGATTAATGCCAATG
TCGTTCGCCGGTGGATACCGCTTTACCGTGATCAGCAGACAGTCGCGCTGCCAGC
TTTCATTCCTTTGAAAGTCGCGCCGGCTGAACCAAAACATAAGACCGAAGCGTCG
GCGATCATTGAGCTGCCGCTTGGCGAGCAATCACTCATCGTGAAATGGCCAACTT
CCGACCCTGACGGGTGCGCCCGCTTTGTCCGAGGGCTTGTCCTTTGATCCGCATC
GATGCCATCTGGCTCGCCACCGAGCCGATGGACATGCGCGCCGGTACCGAGACG
GCATTGGCCAGGGTGATCGCGGTGTTCGGTGCGGCGAGGCCGCACTGCGCTTATC
TGTTCGCCAACCGCCGCGCCACACGCATGAAAGTTTTGGTGCATGACGGCTTCGG
TATCTGGCTGGCGGCTCGCCGATTGAACCAAGGCAAGTTCCACTGGCCAGGTATT
CGCCAAGGCTCTGAATTGGAGTTGGCTCCCGAGCAACTTCAGGCTTTAGTACTGG
GCCTGCCATGGCAACGCGTATGTTCCGGCGGCTCGATCACACTGCTTTAACGGCT
GCCATTAGCCTATCGGTCTATCGCCGCGAACTGCTTGCTCTGGCAAAATCGGCGC
CTTGACTTCGCAACCCAATCTCGATCACCTGACCCCTGAACAACTGCGCGCCTGG
CGGCGCAGTTGATGCAGCGTGTCGAAGACGCTCGACCACCAGGTCGACACGCTG
GGCAAGACGGTCGAAACGATGGGCAAGAAGATCAACCGCGATCAGACGGTGAT
CGAAAAGCTGACCCACGAGATTGCACAGCTCAAGCGTTGAAGTTGCCAAGCGCA
GGAGCAGATGAATCATGAGCAGGCGAGCCTGCTTGAGACCTGATCGATACCGAT
ATCGCGGCGATGAGGCCGAGCTTCAGGCCTGCAAATAGCCCCAGCGGCGACCGA
GAAAAAGCAAACGCCCAAGCGCACGTCGTTGCCGGCAGAGTTTCCACGCACCTT
GATCCATCACGAACCGGACAACACCCACTGCCCGTGCGGCTGCGCGCTCAAGCG
CATCGGTGAAGATGTCAGCGAAAAGCTGGATTACATGCCGGGCGTGTTTACCGTT
GAACGCCATGTTCGTGGCAAGTGGGTTTGCGATAACTGCGAAACGATGATCCAG
GCACCCGTTCCAGCGCAGGTTATTGATAAGGGCATTCCGACTGCGGGCCTACTTG
CCCACGTCATGATCGCCAAGTTTGCCGACCATCTGCCGCTTTACCGTCAGGAATC
GATATTCGGTCGAGCGGGCCTGGCGATTCCACGCTCAACCTTGGCTCAATGGGTT
GGCGTGACTGGGGTTCAGTTGCAGCCGCTGGTCCTGCTTGCGCGAGAACCCCTTC
AAACAAAACCATTT 
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Appendix 2- Complete list of Primers. 
 
Table Ap2.1: Primers derived from mapping sequencing data of P. agarici NCPPB 2472 to 
P. fluorescens A506, used for contig stitching.  
 
Primer:  Length:  Tm:  Sequence: 
Seq 1  26 61 GGCTTTTTCCAACAACCGAATCAGAC  
Seq 2  21 61 TCCACGCGCCTTAATGTCAGC  
Seq 3  28 61 GCTAAAGGTCATTGCCGAACATTCCTAG  
Seq 4  21 61 CTGTCGATAGGTCGACAGCGC  
Seq 6 21 61 CTGTCGATAGGTCGACAGCGC  
Seq 7  27 60 GGATTCGGCGCATACTGATAAAGATTG  
Seq 8  35 60 CTGACAATGCCTTTGTAGTTCTTAATCTC AAAATC  
Seq 9  25 62 GCCGAAATTCAGGTGCATGGATTCG  
Seq 10  25 61 GTCGGTGTGGTAGTAGCGGATTTTC  
Seq 11 32 61 GCAAGAGCAATCTATTCAGATGTATGTATGCG  
Seq 12  22 62 CGCACTTCTTCCAGGGTGTTGC  
Seq 13  26 60 GTGGAGTCAGGCTGAATAGTCACTAG  
Seq 14  25 60 GTGTTTTCACACGGACGACAGGC  
Seq 15  29 62 GCATATTTCAACCTCTCCAATTCCGATGC  
Seq 16  23 62 GCTGGGTGCTACCCATGTTTGTC  
Seq 17  25 60 CTCATGTAAGGCATAGGCTTGCAAC  
Seq 18  28 60 CGTTAAAAGGAGGCGCAATTCTATAGAC  
Seq 19  26 61 GAGGGTGAGAGCATGGAATTGTAAGG  
Seq 20  23 61 CTTCCAGCCAGCCTTGTTGAGAG  
Seq 21  22 61 GCGCGTTACTGAAGAGCGAGAC  
Seq 22  26 62 CTGACGATAGCTTTGCTGATGCAAGC  
Seq 23  23 62 GAAAGCAGACCGGTGGTTTCTCG  
Seq 24  22 61 CGAAGCCGACATCAGTGTGGTC  
Seq 25  24 62 GCATCGATCAACTGGCGAATCAGG  
Seq 26  25 61 CCGTTGCTCTTGCCTCTATAAGGTC  
Seq 27  25 60 GCTCGAGATCTTCCGACATCAAGAG  
Seq 28  27 61 GCTGTATTGCACATGCACAATGATGTC  
Seq 33  23 61 CAATCTGCTCTCTGGCCTTCAGG  
Seq 34  24 61 CTTGTTGCATACCCACCGAGTCTC  
Seq 38  24 61 CGTCACACTCATCCACTCATGAGC  
Seq 39  29 62 CTTGTTGTATACCCACCGAGTCTCTTCTG  
Seq 40  22 62 CCACTGTCACCATCACCGATGC  
Seq 41  28 60 CCAGCAAGTTGTAAGTTGTTGTTCTACG  
Seq 42  20 60 GCTGGAAGCCCGAATTGCTC  
Seq 43  26 61 CGATGTGGTCTTCAGTTCATCGAAGC  
Seq 44  20 60 GCTGGAAGCCCGAATTGCTC  
Seq 45  20 60 CGGGCAAAGAAGGCTGTAGC  
Seq 46  21 61 CACGTCAGGTTCAGGCCATCG  
Seq 47  24 62 GTAACTGGCGCTGCTGTAGAATGC  
Seq 48  22 61 CAGGCACTGACCAACGAGAACG  
Seq 49  23 61 GCTCACTGTCTACCTGCATGCTG  
Seq 50  23 61 GGCCCAGGTCATTCAAGAGTGTG  
Seq 53  18 61 CAACCCCGCAACGCCAAG  
Seq 54  24 61 CAGTTCTTCAGGGCTGTTGCTCTG  
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Seq 55  20 60 GCATAAGTGTGGCCGTCTGC  
Seq 56  21 60 GCAGGATCGAACAGCGCAATG  
Seq 57  22 60 GCAATTTCGCCTCTACCAGCAC  
Seq 58  17 60 CGTGCTTGGCGCACGTC  
Seq 59  25 61 TCAGCAGATCACACTCATGACAAGC  
Seq 60  24 61 CCAGACCATTGTGATCTGGTCCTG  
Seq 65  25 61 CGTCAGCATGTTCCGATAATCCGTG  
Seq 66  20 62 GGTGGCCGTGCTGATGTAGC  
Seq 67  20 60 TCGAGTCCAGGTTGTGGAGC  
Seq 68  22 60 GATCGGTAAGCCGTTGACACCT  
Seq 73  25 60 GTATCGTCAATCGCTGGAAGCAAAT  
Seq 74  22 60 CGGTGCATCAGTCAGCCATTTC  
Seq 81  20 61 CAGGTCACGCCGACTACGTG  
Seq 82  24 61 GTCGCTCTGCCAATTGAGCTACTG  
Seq 97  26 60 GTGTCTCAGAGGCGTACTCATAGATC  
Seq 98  22 60 GAAGAAGGCGAAGTAGCGGTCA  
 
Table Ap2.2: Primers derived from mapping sequencing data of P. agarici NCPPB 2472 to 
P. agarici NCPPB 2289, used for contig stitching.  
 
Primer:  Length:  Tm:  Sequence 
Seq 1  26 61 GGCTTTTTCCAACAACCGAATCAGAC  
Seq 2  21 61 TCCACGCGCCTTAATGTCAGC  
Seq 3  28 61 GCTAAAGGTCATTGCCGAACATTCCTA G  
Seq 4  25 61 CAGCCTCTATGTATTGGACGACAGC  
Seq 5  20 62 GATTGAGCCAGCGGCCATCG  
Seq 6  21 61 CTGTCGATAGGTCGACAGCGC  
Seq 7  27 60 GGATTCGGCGCATACTGATAAAGATTG  
Seq 8  35 60 CTGACAATGCCTTTGTAGTTCTTAATCT CAAAATC  
Seq 9  25 62 GCCGAAATTCAGGTGCATGGATTCG  
Seq 10 25 61 GTCGGTGTGGTAGTAGCGGATTTTC  
Seq 11  32 61 GCAAGAGCAATCTATTCAGATGTATGTA TGCG  
Seq 12  22 62 CGCACTTCTTCCAGGGTGTTGC  
Seq 13  26 60 GTGGAGTCAGGCTGAATAGTCACTAG  
Seq 14  25 60 GTGTTTTCACACGGACGACAGGC  
Seq 15  29 62 GCATATTTCAACCTCTCCAATTCCGATG C  
Seq 16  23 62 GCTGGGTGCTACCCATGTTTGTC  
Seq 17  25 60 CTCATGTAAGGCATAGGCTTGCAAC  
Seq 18  28 60 CGTTAAAAGGAGGCGCAATTCTATAGA C  
Seq 19  26 61 GAGGGTGAGAGCATGGAATTGTAAGG  
Seq 20  23 61 CTTCCAGCCAGCCTTGTTGAGAG  
Seq 21  22 61 GCGCGTTACTGAAGAGCGAGAC  
Seq 22  26 62 CTGACGATAGCTTTGCTGATGCAAGC  
Seq 23  23 62 GAAAGCAGACCGGTGGTTTCTCG  
Seq 24  22 61 CGAAGCCGACATCAGTGTGGTC  
Seq 25  24 62 GCATCGATCAACTGGCGAATCAGG  
Seq 25  24 62 GCATCGATCAACTGGCGAATCAGG  
Seq 26  25 61 CCGTTGCTCTTGCCTCTATAAGGTC  
Seq 26  25 61 CCGTTGCTCTTGCCTCTATAAGGTC  
Seq 26  25 61 CCGTTGCTCTTGCCTCTATAAGGTC  
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Seq 27  25 60 GCTCGAGATCTTCCGACATCAAGAG  
Seq 28  27 61 GCTGTATTGCACATGCACAATGATGTC  
Seq 29  20 62 GGGCTTTAGGCGGCACTCAG  
Seq 30  22 62 CACGTCGATGGGTTTCAGGCAC  
Seq 31  22 61 CACTTCCGACGCGGTCTAAACG  
Seq 32  23 62 GCAGGCCTATGCCTTACATGAGC  
Seq 33  23 61 CAATCTGCTCTCTGGCCTTCAGG  
Seq 34  24 61 CTTGTTGCATACCCACCGAGTCTC  
Seq 35  24 60 GTCTGCCAATGCCCAAATTCTACG  
Seq 36  24 60 CTCTATCTCCGCGGCGTTATAGAC  
Seq 37  23 61 GAGGTGAAGCAGTTCTGCGACTG  
Seq 38  24 61 CGTCACACTCATCCACTCATGAGC  
Seq 39  29 62 CTTGTTGTATACCCACCGAGTCTCTTCT G  
Seq 40  22 62 CCACTGTCACCATCACCGATGC  
Seq 41  28 60 CCAGCAAGTTGTAAGTTGTTGTTCTAC G  
Seq 42  20 60 GCTGGAAGCCCGAATTGCTC  
Seq 43  26 61 CGATGTGGTCTTCAGTTCATCGAAGC  
Seq 44  23 61 GGCCGCTGTCGTCCAATACATAG  
Seq 45  20 60 CGGGCAAAGAAGGCTGTAGC  
Seq 46  21 61 CACGTCAGGTTCAGGCCATCG  
Seq 47  24 62 GTAACTGGCGCTGCTGTAGAATGC  
Seq 48  22 61 CAGGCACTGACCAACGAGAACG  
Seq 49  23 61 GCTCACTGTCTACCTGCATGCTG  
Seq 50  23 61 GGCCCAGGTCATTCAAGAGTGTG  
Seq 52  25 61 GCCATGAATGCTTGATCAAACCCAG  
Seq 53  18 61 CAACCCCGCAACGCCAAG  
Seq 54  24 61 CAGTTCTTCAGGGCTGTTGCTCTG  
Seq 54  24 61 CAGTTCTTCAGGGCTGTTGCTCTG  
Seq 55  20 60 GCATAAGTGTGGCCGTCTGC  
Seq 56  21 60 GCAGGATCGAACAGCGCAATG  
Seq 57  22 60 GCAATTTCGCCTCTACCAGCAC  
Seq 58  17 60 CGTGCTTGGCGCACGTC  
Seq 59  25 61 TCAGCAGATCACACTCATGACAAGC  
Seq 60  24 61 CCAGACCATTGTGATCTGGTCCTG  
Seq 62  25 60 CCATCAGCAAAGCACTCGATTACAG  
Seq 63  20 60 GTCTTGGCTTTGCGGGACTG  
Seq 65  25 61 CGTCAGCATGTTCCGATAATCCGTG  
Seq 66  20 62 GGTGGCCGTGCTGATGTAGC  
Seq 67  20 60 TCGAGTCCAGGTTGTGGAGC  
Seq 68  22 60 GATCGGTAAGCCGTTGACACCT  
Seq 73  25 60 GTATCGTCAATCGCTGGAAGCAAAT  
Seq 74  22 60 CGGTGCATCAGTCAGCCATTTC  
Seq 77  22 61 GCAAGCTCTCTTCATCCGCTCG  
Seq 78  20 60 GTGTGTAAGCGCTGTGAGGC  
Seq 82  24 61 GTCGCTCTGCCAATTGAGCTACTG  
Seq 83  21 60 AATGGCTTGCTCGAACCGTTG  
Seq 83  21 60 AATGGCTTGCTCGAACCGTTG  
Seq 83  21 60 AATGGCTTGCTCGAACCGTTG  
Seq 84  19 60 CGTGCCTGATTCGATGCCG  
Seq 84  19 60 CGTGCCTGATTCGATGCCG  
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Seq 86  23 61 GACTTGCCACGGCTGATTTACGT 
Seq 87  20 60 TGCCATTTATGCGGCAGCAA  
Seq 91  21 60 GGTGTAGTCACCTACCGTGCC  
Seq 92  20 60 ACCGTGGATGTGCTCGATCA  
Seq 93  22 60 TCGAACAGGAAGCGGACTTTGT  
Seq 94  20 61 AACATGACTGGCCGCTGGTC  
Seq 95  22 60 TGCCAGCCATGGAAGATCTGTA  
Seq 95  22 60 TGCCAGCCATGGAAGATCTGTA  
Seq 97  26 60 GTGTCTCAGAGGCGTACTCATAGATC  
Seq 98  22 60 GAAGAAGGCGAAGTAGCGGTCA  
Seq 99  24 60 CGGAGCAGACCAGTATGAACAGAG  
Seq 100  23 60 GTCATGAAAGCGCCACCACTAAC  
Seq 101  21 61 ACGGTTCGGCCAACATCAACA  
Seq 102  20 61 GCTTATCACCGCGGCGTACA  
Seq 103  21 61 GCTCCTTCAGCAGGTGGTTGT  
Seq 104  21 61 AGCTATCTCAAAGCGCGAGGC  
Seq 107  22 60 CGAATTGATCCAGCAGCAAGCC  
Seq 108  20 61 GCTGACCGCTGTCGTCCAAT  
Seq 113  22 60 GCTGGCGAACGACAGCAATAAC  
Seq 114  20 60 TGGTGCAAACCACGTTCACC  
 
Table Ap2.3: Bacteriophage ϕNV3 forward primers, used for primer walking.  
 
Name: Start (bp) : Length:  Tm: Sequence:  
Nv3a-F1 1 19 62 TCCCGACCCCTAGCAGCTC 
Nv3a-F2 1420 19 60 CAGCAAGGCAGCACAGGAC 
Nv3a-F3 2788 19 59 CACGCAGCGACTAGATGGG 
Nv3a-F4 4151 19 60 CGCTACATGCATCGCCAGC 
Nv3a-F5 5488 20 59 CCCAAGCTCAAACCGCTACC 
Nv3a-F6 6827 18 62 GCGGGTGCCTTCGGTACC 
Nv3a-F7 8212 21 60 CCACAGGAGACTGAGGTGGAC 
Nv3a-F8 9619 19 59 CGATGGCGGTGATGATCGC 
Nv3a-F9 10958 19 61 GCTGGCTGACCGACTCAGC 
Nv3a-F10 12,291 20 61 CTGGTGCCCACAGATCTGCC 
Nv3a-F11 13,646 19 59 CTGGAACCAAGGTGAGGCC 
Nv3a-F12 14,992 20 60 CTGCCGGCTCTGTAACATGC 
Nv3a-F13 16,348 20 61 CCCGAGCTAAGGCCAACACC 
Nv3a-F14 17,700 20 62 CCGTTCTGAAGGGCACCTGC 
Nv3a-F15 19,053 21 59 CGAACGTTCCTGCATGAGTCC 
Nv3a-F16 20,401 20 59 CGCTAGTGCGCAAGGTAGAC 
Nv3a-F17 21,753 19 60 AGGAGTACTGGTGCTGGGC 
Nv3a-F18 23,121 21 61 CATTAAGCGCTCGCAAGGTGC 
Nv3a-F19 24,468 20 61 ATTGCGTACCTCGAAGCCGC 
Nv3a-F20 25,817 20 61 CTCGTAAGGCGATCACCGGC 
Nv3a-F21 27,185 21 60 CGCCAAAGACTTCACCGTGAC 
Nv3a-F22 28,528 21 61 CCGGGCAGGTTATCCTGATGC 
Nv3a-F23 29,875 20 62 CTAGCGGTATCGTGCAGCGC 
Nv3a-F24 31,224 25 61 GACTTCCAGAAGTTCCAGAACAGCC 
Nv3a-F25 32,561 22 61 CTTGCTGCAATCAAGCAGGAGC 
Nv3a-F26 33,936 21 62 CAGCGCTGTCCAACGTACTGC 
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Nv3a-F27 35,278 20 61 GGCAACCATTATGCACCGGC 
Nv3a-F28 36,618 21 60 CCTTGCAGGAGGGTCTACTCC 
Nv3a-F29 37,984 20 61 GCCGGGCGTACGTGATATCC 
Nv3a-F30 39,313 21 61 GGGTATACCTGTTCCTGCGGC 
Nv3a-F31 40,659 20 61 CGGTAACGGTGGTGACGAGC 
Nv3a-F32 42,017 21 61 GCTGGATTAAGCTCCTGGGGC 
Nv3a-F33 42,678 19 62 CTAACGGCGCCATCACCGC 
 
Table Ap2.4: Bacteriophage ϕNV3 reverse primers, used for primer walking.  
 
Name: Start (bp):  Length: Tm: Location:  
Nv3a-R1 687 19 62 GCCAAGAGGTAAGGCGCGC 
Nv3a-R2 2025 19 61 GTCCGCCGGATCAGTGTGT 
Nv3a-R3 3301 19 60 CGCTTGGAAGTCGAACGCC 
Nv3a-R4 4649 20 60 GGATTCAACGTGGTCGCAGG 
Nv3a-R5 5965 19 61 CCTGCAATGCACCCGTTGC 
Nv3a-R6 7310 20 61 CCGGCAACTCTGGCAGTACG 
Nv3a-R7 8644 21 61 GCTCGTCTTACCCGCATCAGG 
Nv3a-R8 9996 19 61 GGTCGAAGCGAAGGCGGAT 
Nv3a-R9 11344 20 59 GTCCTCCTTGGTGACGTTGC 
Nv3a-R10 12689 19 62 CTGCTGGAACTCAGCCCGC 
Nv3a-R11 14041 19 60 CGGCAGCTTGGTTAGCTGC 
Nv3a-R12 15384 22 61 CAGTAGTGGTGTAGCTCCACGC 
Nv3a-R13 16746 20 62 CGTTATCGGTGCAGCCGGAC 
Nv3a-R14 18103 19 59 GACCAGCGGAACAGAGTGC 
Nv3a-R15 19442 20 62 CCAGTTCTTCTTCGGCGGCC 
Nv3a-R16 20793 23 61 GGACTTGACATGGAGCTACTGCC 
Nv3a-R17 22132 19 61 CTCACCTCCGGGCATACGC 
Nv3a-R18 23490 20 60 GCGATTGGTTCACTGCGACG 
Nv3a-R19 24842 19 62 AGTTTGAACCACGCCGCCG 
Nv3a-R20 26217 19 62 CGGCTCGTCAAGGGAGGGT 
Nv3a-R21 27571 20 61 CGTAGTGGGCAGACTCGCAG 
Nv3a-R22 28928 21 61 TACTCGAACTCCCCGGTGTCC 
Nv3a-R23 30268 20 62 AGCAAGGAAGGGCTTGGTGC 
Nv3a-R24 31620 21 61 CGGGTACTTGTCTGCCAGTGC 
Nv3a-R25 32966 20 61 CCGCCAACGAGAGCCATACC 
Nv3a-R26 34302 20 61 CCAACCTATACCCCGCTGGC 
Nv3a-R27 35655 21 61 CCCAGTCCACATCTTTGCCGT 
Nv3a-R28 37010 20 60 CCGAACTCCTCCGGGCATAG 
Nv3a-R29 38363 19 61 CAGGGGCGTAGTCGCTAGC 
Nv3a-R30 39786 20 61 CCTTGTCACCGGAGCCAGAG 
Nv3a-R31 41134 20 61 CCCTCAAGGGCGTCGATACG 
Nv3a-R32 42448 20 62 CCTTGGCCAAGTTCAGGCCG 
Nv3a-R33 43131 21 61 CACATAGAACGCGCACAGGGA 
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Appendix 3: Full Phage Genome Tables  
 
Table Ap3.1 All identified ORFs of phage NV1 including their function as predicted by BlastP, including Accession codes of homologous 
protein in phage UFV-P2 (if applicable) and Query Cover, E-value and Identity scores as identified by BlastP. 
 
Gp 
No:  Start:  End:  Strand:  Predicted Function: 
Homolog (UFV-
P2):  Cover:  Evalue:  Ident:  
1 980 1321 + Hypothetical Protein YP_006907083.2 80% 5.00E-27 67% 
2 1351 1836 + Hypothetical Protein YP_006907082.2 98% 4.00E-96 48% 
3 1709 2077 + Hypothetical Protein YP_007518458.1 45% 2.00E-21 71% 
4 2546 2776 + Hypothetical Protein YP_007518462.1 97% 5.00E-19 54% 
5 3279 3479 + Hypothetical Protein YP_007518465.1 100% 1.00E-35 89% 
6 3466 3795 + Hypothetical Protein YP_007518466.1 98% 9.00E-29 47% 
7 3792 4031 + Hypothetical Protein N/A N/A N/A N/A 
8 4031 4243 + Hypothetical Protein YP_007518467.1 85% 7.00E-30 83% 
9 4224 4628 + Hypothetical Protein YP_006907081.1 94% 3.00E-57 65% 
10 4712 4903 + Novel Hypothetical Protein N/A N/A N/A N/A 
11 5060 5890 + Putative Transposase  YP_006907080.2 100% 0.00E+00 99% 
12 6062 6400 + Hypothetical Protein YP_007518468.1 75% 5.00E-30 67% 
13 6541 6753 + Hypothetical Protein YP_007518470.1 100% 1.00E-31 76% 
14 6877 7689 + Hypothetical Protein YP_007518471.1 99% 7.00E-80 48% 
15 7693 8571 + Hypothetical Protein YP_006907079.1 100% 4.00E-109 55% 
16 8583 9380 + Hypothetical Protein YP_006907078.1 100% 3.00E-175 89% 
17 9377 9937 + Hypothetical Protein N/A N/A N/A N/A 
18 9913 11067 + Putative Amidoligase YP_006907076.1 100% 0.00E+00 78% 
19 11098 12567 + Putative Glutamine Amidotransferase YP_006907074.1 99% 0.00E+00 81% 
20 12570 12788 + Hypothetical Protein YP_007518472.1 100% 2.00E-42 94% 
21 12926 13801 + Putative ATP-grasp Enzyme YP_006907073.1  100% 2.00E-159 76% 
22 13794 14189 + Hypothetical Protein YP_006907072.2 99% 5.00E-78 84% 
23 14189 14485 + Hypothetical Protein YP_007518474.1 100% 4.00E-56 87% 
24 14445 16199 + Putative DNA Primase/Helicase YP_006907071.2 100% 0.00E+00 96% 
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25 16138 16689 + Putative DNA Polymerase Part I  YP_006907070.2 93% 1.00E-109 88% 
26 16646 16957 + Hypothetical Protein N/A N/A N/A N/A 
27 17121 17351 + Hypothetical Protein YP_007518477.1 100% 2.00E-34 75% 
28 17364 17567 + Hypothetical Protein YP_007518478.1 100% 3.00E-31 84% 
29 17588 17845 + Putative Holin YP_007518479.1 100% 5.00E-51 94% 
30 17827 18060 + Hypothetical Protein YP_007518480.1 93% 8.00E-12 40% 
31 18099 18527 + Hypothetical Protein N/A N/A N/A N/A 
32 18496 18717 + Hypothetical Protein N/A N/A N/A N/A 
33 18725 20365 + Putative DNA Polymerase Family A YP_006907069.2 100% 0.00E+00 95% 
34 20432 21028 + Hypothetical Protein YP_006907068.1 99% 1.00E-116 86% 
35 21006 21473 + Hypothetical Protein YP_006907067.2 74% 5.00E-66 83% 
36 21473 21733 + Hypothetical Protein YP_007518485.1 88% 2.00E-19 71% 
37 21751 22128 + Hypothetical Protein YP_007518486.1 69% 4.00E-18 47% 
38 22125 23009 + Putative 5'-3' Exonuclease YP_006907065.2 100% 0.00E+00 91% 
39 22984 23982 + Hypothetical Protein YP_006907064.1 100% 0.00E+00 74% 
40 23888 24250 + Putative Endonuclease YP_006907063.2 100% 2.00E-68 87% 
41 24216 24971 + Hypothetical Protein YP_006907062.1 100% 0.00E+00 97% 
42 25190 25396 + Hypothetical Protein YP_007518490.1 100% 1.00E-41 97% 
43 25525 25881 - Hypothetical Protein YP_006907061.1  100% 5.00E-60 75% 
44 25881 26768 - Putative Phage Structural Protein  YP_006907060.1 99% 0.00E+00 86% 
45 26779 29952 - Putative Phage Structural Protein  YP_006907059.1 100% 0.00E+00 90% 
46 29959 31674 - Putative Phage Structural Protein  YP_006907058.1 100% 0.00E+00 82% 
47 31676 32080 - Putative Phage Structural Protein  YP_006907057.1 100% 2.00E-84 97% 
48 32080 32607 - Putative Phage Particle Protein YP_006907056.1 100% 2.00E-113 99% 
49 32699 33022 - Putative Phage Particle Protein YP_006907056.1 90% 1.00E-41 85% 
50 33003 33437 - Hypothetical Protein YP_006907055.2 100% 1.00E-90 87% 
51 33434 34147 - Hypothetical Protein  YP_006907054.2 100% 3.00E-129 87% 
52 34147 35691 - Putative Phage Particle Protein YP_006907053.1 100% 0.00E+00 83% 
53 35699 36334 - Putative Tail Fiber Protein YP_006907052.1 100% 1.00E-134 88% 
54 36324 36575 - Hypothetical Protein N/A N/A N/A N/A 
55 36557 36751 - Hypothetical Protein YP_006907051.2 100% 3.00E-32 91% 
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56 36755 37384 - Putative Phage Structural Protein  YP_006907050.1 100% 3.00E-145 96% 
57 37388 37570 - Hypothetical Protein  YP_006907049.2 100% 3.00E-35 93% 
58 37759 38712 - Putative Major Capsid Protein YP_006907048.1 100% 0.00E+00 96% 
59 38730 39728 - Putative Scaffolding Protein  YP_006907047.1 99% 1.00E-168 75% 
60 39718 39969 - Hypothetical Protein YP_007641362.1 100% 5.00E-48 88% 
61 39969 42107 - Putative Portal Protein YP_006907046.2 97% 0.00E+00 95% 
62 42086 43531 - Putatitve Terminase Large Subunit YP_006907045.1 100% 0.00E+00 91% 
63 43535 44074 - Putative Lysozyme YP_006907044.2 93% 1.00E-111 93% 
64 43962 44435 - Putative Terminase Small Subunit YP_006907043.1 100% 4.00E-92 83% 
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Table Ap3.2 All identified ORFs of phage ϕNV3 including their function as predicted by BlastP, including closest amino acid homolog by 
species and Query Cover, E-value and Identity scores as identified by BlastP. 
 
 
Gp 
No:  Start:  End:  Predicted Function  Closest Similarity:  Cover:  E value:  Ident:  
1 2302 2688 Hypothetical protein Pseudomonas phage VSW-3 81% 2.00E-35 54% 
2 2900 3427 Hypothetical protein Pseudomonas phage phikF77 77% 3.00E-40 49% 
3 3424 3639 Novel Hypothetical protein N/A N/A N/A N/A 
4 3867 4079 Hypothetical protein Pseudomonas phage PAK_P5 98% 8.00E-08 41% 
5 4140 4499 Novel Hypothetical protein N/A N/A N/A N/A 
6 4489 4737 Novel Hypothetical protein N/A N/A N/A N/A 
7 4730 4918 Novel Hypothetical protein N/A N/A N/A N/A 
8 4915 5172 Novel Hypothetical protein  N/A N/A N/A N/A 
9 5218 5406 Hypothetical protein Pseudomonas phage phi-2 56% 7.00E-04 57% 
10 5436 5891 Hypothetical protein Pseudomonas phage phikF77 70% 3.00E-18 47% 
11 6014 6457 Novel Hypothetical protein N/A N/A N/A N/A 
12 6641 7135 Hypothetical protein Pseudomonas phage UNO-SLW4 91% 8.00E-25 37% 
13 7159 7995 Putative DNA primase Pseudomonas phage LUZ19 93% 8.00E-81 51% 
14 8047 9357 Putative DNA helicase Pseudomonas phage vB_Pae-TbilisiM32 97% 1.00E-160 55% 
15 9350 9913 Hypothetical protein 
Pseudomonas phage vB_PaeP_PPA-
ABTNL 88% 3.00E-10 29% 
16 9913 10812 Putative ATP-dependent DNA ligase Ralstonia phage RSB3 100% 1.00E-70 44% 
17 10897 11223 Novel Hypothetical protein  N/A N/A N/A N/A 
18 11322 11518 Novel Hypothetical protein N/A N/A N/A N/A 
19 11583 13943 Putative DNA polymerase I Pseudomonas phage phiNFS 99% 0 66% 
20 13990 15006 Hypothetical protein  Pseudomonas phage phi-2 92% 1.00E-93 51% 
21 15008 15967 Putative Integrase Pseudomonas phage phi-2 92% 5.00E-113 58% 
22 15948 16424 Putative DNA Endonuclease VII  Pseudomonas phage phiKMV 69% 1.00E-47 66% 
23 16432 17652 Putative DNA Exonuclease Pseudomonas phage phi-2 81% 3.00E-179 74% 
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24 17663 18091 Hypothetical protein Pseudomonas phage Andromeda 86% 1.00E-65 81% 
25 18088 18270 Novel Hypothetical protein N/A N/A N/A N/A 
26 18414 20870 Putative RNA Polymerase 
Pseudomonas phage vB_PaeP_PPA-
ABTNL 99% 0.00E+00 51% 
27 21028 21271 Hypothetical protein Pseudomonas phage phikF77 100% 8.00E-15 48% 
28 21270 21701 Hypothetical protein Pseudomonas phage LKD16 94% 5.00E-26 41% 
29 21679 22149 Putative DNA Endonuclease Pseudomonas phage phi-2 98% 2.00E-34 44% 
30 22363 22500 Putative virion structural protein Pseudomonas phage phikF77 97% 7.00E-12 66% 
31 22510 24048 Putative head-tail connector protein Pseudomonas phage vB_Pae-TbilisiM32 99% 0.00E+00 65% 
32 24048 25013 Putative scaffolding protein Pseudomonas phage LKD16 100% 6.00E-49 42% 
33 25069 26061 Putative capsid protein  Pseudomonas phage phikF77 100% 0.00E+00 74% 
34 26161 26715 Putative tail tubular protein A  
Pseudomonas phage vB_PaeP_PPA-
ABTNL 100% 2.00E-57 49% 
35 26712 29183 Putative tail tubular protein B  Pseudomonas phage LKD16 99% 0.00E+00 47% 
36 29183 29728 Putative internal virion protein A Pseudomonas phage LKD16 98% 2.00E-49 49% 
37 29721 32381 
Putative baseplate hub subunit and 
tail lysozyme Pseudomonas phage phiKMV 99% 0.00E+00 49% 
38 32390 36322 Putative internal core protein  Pseudomonas phage phiKMV 100% 0.00E+00 59% 
39 36323 38689 Putative T7-like tail protein Pseudomonas phage MPK7 17% 3.00E-19 43% 
40 38640 38936 Novel Hypothetical protein N/A N/A N/A N/A 
41 39005 39184 Novel Hypothetical protein N/A N/A N/A N/A 
42 39215 39532 Putative DNA Maturase A Pseudomonas phage LKA1 89% 3.00E-25 54% 
43 39529 41301 Putative DNA Maturase B Pseudomonas phage phiNFS 98% 0.00E+00 79% 
44 41303 41542 Putative pinholin Pseudomonas phage phiKMV 81% 2.00E-19 63% 
45 41526 42026 Putative lysozyme  Pseudomonas phage MPK7 83% 5.00E-72 75% 
46 41975 42307 Putative Rz-like protein Pseudomonas phage LUZ19 96% 2.00E-14 42% 
47 42165 42410 Putative Rzl-like protein Pseudomonas phage LKA1 46% 2.00E-06 55% 
48 42388 42715 Hypothetical protein Pseudomonas phage phi-2 51% 3.40E+00 46% 
49 42729 42911 Novel Hypothetical protein N/A N/A N/A N/A 
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 baseMean 
log2Fold 
Change lfcSE stat pvalue padj P4 P5 P6 PN4 PN5 PN6 
RS24005 39706.802 -6.447 0.345 -18.688 6.21E-78 3.04E-74 950.17 661.59 1087.39 44007.70 102839.44 88694.52 
ssrA 1334955.215 -1.640 0.189 -8.692 3.55E-18 8.67E-15 598588.72 657415.73 690028.48 1703937.31 2098988.72 2260772.33 
RS16105 205.223 -1.198 0.206 -5.813 6.13E-09 9.99E-06 122.00 118.48 131.25 248.05 308.46 303.10 
RS04440 1485.348 -0.801 0.153 -5.231 1.69E-07 2.06E-04 1068.54 1122.80 1058.02 1788.77 1921.96 1952.01 
RS16100 840.808 -1.236 0.242 -5.110 3.23E-07 3.16E-04 522.35 454.84 523.56 853.63 1346.56 1343.91 
RS23260 21763.386 -0.875 0.193 -4.539 5.64E-06 4.60E-03 14391.96 17938.53 13756.57 25676.30 28013.68 30803.27 
RS24275 4935.152 -1.156 0.257 -4.491 7.09E-06 4.95E-03 3008.88 3014.54 3145.14 4575.57 7850.95 8015.83 
RS24525 19086.990 -1.213 0.279 -4.352 1.35E-05 8.23E-03 11756.36 10626.03 12136.14 16890.83 30608.92 32503.66 
RS13830 30.191 -1.514 0.354 -4.273 1.93E-05 9.45E-03 14.54 15.90 17.06 41.92 32.63 59.09 
RS17680 1552.339 -0.787 0.183 -4.293 1.77E-05 9.45E-03 1146.91 1118.03 1155.15 2290.70 1815.18 1788.07 
RS04410 416.473 -0.836 0.203 -4.121 3.78E-05 1.66E-02 282.39 306.15 310.82 621.88 522.01 455.60 
RS18970 1721.115 -0.694 0.169 -4.103 4.07E-05 1.66E-02 1260.43 1276.27 1404.84 1920.37 2289.74 2175.04 
RS06350 165.249 -0.953 0.233 -4.083 4.45E-05 1.67E-02 108.67 104.17 124.61 193.32 195.75 264.97 
RS16090 84.998 -1.155 0.285 -4.048 5.17E-05 1.73E-02 49.69 47.71 57.80 90.84 157.20 106.75 
RS23105 206.453 -0.938 0.233 -4.030 5.57E-05 1.73E-02 137.76 131.21 153.99 217.77 275.84 322.16 
RS07595 10603.102 0.990 0.246 4.027 5.65E-05 1.73E-02 14079.68 13790.06 14441.70 8113.52 8260.26 4933.40 
RS21855 407.818 -0.762 0.192 -3.965 7.34E-05 1.99E-02 263.40 325.23 320.29 499.60 489.39 549.00 
hflB 24881.951 0.773 0.195 3.971 7.17E-05 1.99E-02 29479.17 30576.37 34130.36 19544.87 20385.18 15175.74 
RS16095 97.522 -0.998 0.257 -3.880 1.05E-04 2.44E-02 66.66 57.25 70.12 108.30 124.57 158.22 
RS22880 836.743 0.753 0.193 3.900 9.63E-05 2.44E-02 962.70 1084.63 1098.76 567.14 729.63 577.60 
rnpB 1263911.359 -1.846 0.474 -3.891 1.00E-04 2.44E-02 482360.27 539283.38 629076.74 802993.51 3756891.67 1372862.58 
RS14345 28914.912 0.746 0.193 3.868 1.10E-04 2.44E-02 37033.69 35131.17 36517.88 23251.68 23988.85 17566.20 
RS15670 95.934 -0.968 0.253 -3.832 1.27E-04 2.70E-02 65.85 69.18 59.23 133.92 148.30 99.13 
RS18775 74.087 -1.211 0.329 -3.676 2.37E-04 4.63E-02 50.09 42.14 39.33 64.05 136.44 112.47 
RS12730 447.489 -0.641 0.174 -3.684 2.30E-04 4.63E-02 326.82 375.33 346.83 540.36 569.47 526.13 
RS22885 3586.449 0.623 0.173 3.612 3.04E-04 5.72E-02 4307.69 4443.48 4290.34 2474.70 3146.91 2855.58 
RS13280 3684.993 0.933 0.261 3.583 3.40E-04 6.15E-02 4888.22 4929.34 4694.03 3010.40 2906.66 1681.32 
RS07600 1026.488 0.890 0.250 3.556 3.76E-04 6.57E-02 1340.42 1318.41 1344.67 926.99 711.84 516.60 
RS19360 663.999 0.635 0.180 3.532 4.12E-04 6.95E-02 765.15 799.16 861.38 569.47 516.08 472.75 
RS12095 50.730 -1.059 0.301 -3.513 4.44E-04 7.23E-02 31.51 30.22 38.38 85.01 56.35 62.91 
RS18635 227.909 -0.705 0.201 -3.504 4.59E-04 7.23E-02 177.35 174.94 170.10 302.79 237.28 305.00 
RS02040 10435.994 0.669 0.191 3.493 4.78E-04 7.30E-02 13663.17 11026.80 13744.73 8260.25 8829.72 7091.29 
RS13245 18062.289 0.813 0.233 3.483 4.96E-04 7.35E-02 25366.61 19598.87 24086.08 13292.33 15829.44 10200.40 
RS10945 218.514 -0.862 0.249 -3.462 5.36E-04 7.70E-02 153.11 191.64 120.82 279.50 314.39 251.63 
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Table Ap4.1.   Complete RNA sequencing results of the differentially expressed genes as calculated by DESeq2 with a padj of <0.1.
RS12065 296.642 -0.610 0.177 -3.443 5.76E-04 7.82E-02 238.35 229.81 235.96 365.67 370.75 339.31 
RS03480 1493.979 0.688 0.199 3.450 5.60E-04 7.82E-02 2066.79 1646.82 1816.58 1262.39 1195.29 976.01 
RS22640 192.155 -0.655 0.194 -3.383 7.16E-04 8.97E-02 140.99 149.49 156.83 231.75 243.21 230.66 
RS22890 5980.916 0.536 0.158 3.386 7.09E-04 8.97E-02 6707.36 7671.13 6857.91 4950.56 5077.76 4620.78 
RS14695 10384.225 -1.278 0.377 -3.391 6.97E-04 8.97E-02 5266.75 7520.84 5403.79 11027.25 8957.26 24129.45 
RS20420 197.489 0.900 0.267 3.376 7.36E-04 8.99E-02 279.15 302.96 188.10 128.10 151.26 135.34 
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Table Ap4.2 Full results of the Jspecies AniB results for analysis of the Pseudomonas sp. NS1(2017) genome to closely related strains. 
 
 
P. sp 
NS1 
P. azotoformans 
S4 
P. 
azotoformans 
F77 
P. 
fluorescens 
PICF7 
P. 
fluorescens 
UK4 
P. fluorescens 
Pf0-1 
P.  fluorescens 
F113 
P. agarici 
2472 
P. fluorescens 
LMG 5329 
P. sp NS1 * 93.32 [82.22] 89.72 [77.57] 
90.72 
[76.13] 
83.25 
[60.78] 79.91 [58.72] 79.60 [54.86] 
78.19 
[46.79] 93.43 [81.97] 
P. azotoformans 
S4 
93.06 
[81.21] * 89.65 [75.97] 
90.47 
[73.73] 
83.57 
[61.20] 79.69 [59.23] 79.63 [54.00] 
78.05 
[47.28] 95.56 [84.83] 
P. azotoformans 
F77 
89.94 
[78.95] 90.02 [78.90] * 
89.61 
[77.35] 
83.43 
[61.92] 80.09 [59.55] 79.80 [56.25] 
78.47 
[47.21] 90.05 [78.22] 
P. fluorescens 
PICF7 
91.22 
[82.13] 91.08 [81.07] 89.86 [82.11] * 
83.41 
[65.95] 79.99 [62.37] 80.04 [60.05] 
78.66 
[49.01] 91.08 [80.02] 
P. fluorescens 
UK4 
83.67 
[66.72] 84.07 [67.42] 83.86 [66.70] 
83.58 
[66.42] * 80.10 [59.86] 80.36 [56.34] 
78.99 
[48.23] 83.74 [66.43] 
P. fluorescens 
Pf0-1 
80.16 
[61.13] 80.14 [62.15] 80.24 [60.29] 
79.89 
[59.64] 
79.95 
[56.98] * 81.53 [62.59] 
78.84 
[49.16] 80.19 [61.37] 
P. fluorescens 
F113 
79.73 
[53.93] 79.96 [53.55] 79.77 [54.37] 
79.61 
[54.51] 
79.96 
[50.76] 81.51 [58.31] * 
78.97 
[44.88] 79.95 [53.21] 
P. agarici 2472 
78.92 
[54.41] 78.89 [55.73] 79.09 [54.05] 
78.94 
[52.97] 
79.29 
[51.23] 79.28 [55.03] 79.55 [53.93] * 78.97 [55.54] 
P. fluorescens 
LMG 5329 
93.28 
[81.20] 95.59 [85.14] 89.68 [75.89] 
90.48 
[73.27] 
83.11 
[59.49] 79.79 [58.12] 79.62 [53.70] 
78.15 
[47.41] * 
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Table Ap4.3.  Full results of the Jspecies AniM results for analysis of the Pseudomonas sp. NS1(2017) genome to closely related strains. 
 P. sp NS1 
P. azotoformans 
S4 
P. azotoformans 
F77 
P. fluorescens 
PICF7 
P. fluorescens 
UK4 
P. fluorescens 
Pf0-1 
P.  fluorescens 
F113 
P. agarici 
2472 
P. fluorescens 
LMG 5329 
P. sp NS1 * 0.99858 0.99663 0.99819 0.97568 0.94809 0.96877 0.95169 0.99892 
P. azotoformans 
S4 0.99858 * 0.99625 0.99737 0.9718 0.94495 0.96403 0.94736 0.99941 
P. azotoformans 
F77 0.99663 0.99625 * 0.99739 0.97997 0.93905 0.97056 0.95052 0.9975 
P. fluorescens 
PICF7 0.99819 0.99737 0.99739 * 0.97987 0.94596 0.97197 0.95542 0.9981 
P. fluorescens 
UK4 0.97568 0.9718 0.97997 0.97987 * 0.93581 0.98022 0.97202 0.97537 
P. fluorescens 
Pf0-1 0.94809 0.94495 0.93905 0.94596 0.93581 * 0.94687 0.93481 0.94523 
P. fluorescens 
F113 0.96877 0.96403 0.97056 0.97197 0.98022 0.94687 * 0.97282 0.96802 
P. agarici 2472 0.95169 0.94736 0.95052 0.95542 0.97202 0.93481 0.97282 * 0.951 
P. fluorescens 
LMG 5329 0.99892 0.99941 0.9975 0.9981 0.97537 0.94523 0.96802 0.951 * 
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Table Ap4.4: Full results of Phage/Host Co-Evolution Study of ϕNV3 and P. agarici NCPPB 2472.  
 
 
 
 
 
 
 
 
 
 
 
 
Bacteria	Transfer	No.
Phage	Transfer	No. T0 T1 T2 T2 T3 T4 T4 T5 T6
Repeat	1	(%	resistant) 12.50 68.75 37.50 100.00 56.25 50.00 100.00 68.75 100.00
Repeat	2	(%	resistant) 6.25 62.50 37.50 43.75 37.50 31.25 75.00 75.00 50.00
Repeat	3	(%	resistant) 6.25 25.00 18.75 68.75 62.50 37.50 100.00 100.00 43.75
Repeat	4	(%	resistant) 12.50 56.25 25.00 37.50 37.50 31.25 87.50 50.00 37.50
Repeat	5	(%	resistant) 18.75 43.75 12.50 50.00 100.00 68.75 100.00 100.00 75.00
Mean	(%) 11 51 26 60 59 44 93 79 61
Transfer	1	 Transfer	3	 Transfer	5	
Bacteria	Transfer	No.
Phage	Transfer	No. T6 T7 T8 T8 T9 T10
Repeat	1	(%	resistant) 87.50 87.50 100.00 100.00 100.00 100
Repeat	2	(%	resistant) 100.00 43.75 100.00 100.00 100.00 100
Repeat	3	(%	resistant) 81.25 100.00 62.50 100.00 100.00 100
Repeat	4	(%	resistant) 50.00 43.75 56.25 100.00 100.00 100
Repeat	5	(%	resistant) 25.00 100.00 100.00 100.00 100.00 100
Mean	(%) 69 75 84 100 100 100
Transfer	7	 Transfer	9	
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Table Ap4.5: Complete table of results of the putative achromobactin biosynthesis cluster of P. agarici NCPPB 2472.  
 
P. agarici 
Locus 
Tag:  Predicted Function:  
Length 
(bp): Protein ID:  P. syringae Locus Tag:  
 Length 
(bp): Protein ID: 
Cover 
(%): 
Ident 
(%):  
RS04660 RNA polymerase sigma factor 509 WP_026013089.1 Psyr_2580 509 YP_235657.1 99 87 
RS04665 
sugar ABC transporter substrate-
binding protein 962 WP_060783937.1 Psyr_2581 965 YP_235658.1 99 73 
RS04670 
TonB-dependent siderophore 
receptor 2402 WP_060782254.1 Psyr_2582 2408 YP_235659.1 100 81 
RS04675 
aspartate aminotransferase family 
protein 1376 WP_017131159.1 Psyr_2583 1376 YP_235660.1 100 88 
RS04680 AcsD protein 1784 WP_060782255.1 Psyr_2584 1784 YP_235661.1 100 81 
RS04685 diaminopimelate decarboxylase 1223 WP_060782256.1 Psyr_2585 1208 YP_235662.1 98 80 
RS04690 MFS transporter 1394 WP_060783938.1 Psyr_2586 1406 YP_235663.1 100 86 
RS04695 AcsC protein 1865 WP_060782257.1 Psyr_2587 1859 YP_235664.1 96 82 
RS04700 
siderophore biosynthesis protein 
SbnG 773 WP_060782258.1 Psyr_2588 776 YP_235665.1 100 86 
RS04705 AcsA protein 1868 WP_060782259.1 Psyr_2589 1883 YP_235666.1 99 83 
RS04710 
iron ABC transporter substrate-
binding protein 896 WP_017131166.1 Psyr_2590 905 YP_235667.1 98 76 
RS04715 
siderophore ABC transporter 
permease 989 WP_017131167.1 Psyr_2591 989 YP_235668.1 100 80 
RS04720 iron ABC transporter permease 1031 WP_060782260.1 Psyr_2592 1031 YP_235669.1 100 85 
RS04725 
iron-enterobactin transporter 
ATP-binding protein 791 WP_017131169.1 Psyr_2593 791 YP_235670.1 100 91 
RS04730 
siderophore-iron reductase, Fe-S 
cluster protein 779 WP_060782261.1 Psyr_2594 779 YP_235671.1 100 75 
RS04735 
S-adenosylmethionine--2-
demethylmenaquinone 
methyltransferase 632 WP_060782262.1 Psyr_2595 644 YP_235672.1 96 72 
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Figure Ap4.6: Molecular phylogenetic analysis of bacteriophage large terminase subunit genes by Maximum Likelihood. The evolutionary 
history was inferred by using the maximum likelihood method based on the Tamura-Nei model. The tree with the highest log likelihood (-
19125.23) is shown (1000 bootstrap replicates) [257]. Initial tree for the heuristic search was obtained automatically by applying the Maximum 
Parsimony method [258]. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis involved 
25 nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing data were 
eliminated. There were a total of 804 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 [256] and tree edited using 
iTOL v4 [316]. 
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Figure Ap4.7: Effect of expression of a lysis protein construct containing the NV1 putative 
lysozyme encoding gene on optical density of BL21-AI E. coli following induction with 0.2% 
L-arabinose at T=0. The control comprised of an uninduced BL21-AI containing the lyozyme 
construct. Mean values of 6 replicates are plotted, error bars= +/- SEM. 
 
 
Figure Ap4.8: Effect of expression of a lysis protein construct containing the NV1 putative 
holin encoding gene on optical density of BL21-AI E. coli following induction with 0.2% L-
arabinose at T=0. The control comprised of an uninduced BL21-AI containing the holin 
construct. Mean values of 6 replicates are plotted, error bars= +/- SEM. 
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